Medicare Program: Changes to the Medicare Claims and Medicare Prescription Drug Coverage Determination Appeals Procedures, 49513-49529 [2018-21223]
Download as PDF
49513
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
EPA-APPROVED IOWA REGULATIONS—Continued
Iowa citation
State
effective
date
Title
*
*
EPA approval date
*
*
Explanation
*
*
*
Chapter 33—Special Regulations and Construction Permit Requirements for Major Stationary Sources—Prevention of Significant
Deterioration (PSD) of Air Quality
567–33.1 ........
Purpose ............................
4/18/2018
567–33.3 ........
Special Construction Permit Requirements for
Major Stationary
Sources in Areas Designated Attainment or
Unclassified (PSD).
4/18/2018
*
*
*
*
*
*
[Date of publication of the
final rule in the Federal
Register], [Federal
Register citation of the
final rule].
[Date of publication of the
final rule in the Federal
Register], [Federal
Register citation of the
final rule].
*
*
PART 70—STATE OPERATING PERMIT
PROGRAMS
3. The authority citation for part 70
continues to read as follows:
*
Provisions of the 2010 PM2.5 PSD—Increments,
SILs and SMCs rule (75 FR 64865, October 20,
2010) relating to SILs and SMCs that were affected by the January 22, 2013, U.S. Court of Appeals decision are not SIP approved. Iowa’s rule
incorporating EPA’s 2007 revision of the definition
of ‘‘chemical processing plants’’ (the ‘‘Ethanol
Rule,’’ published May 1, 2007) or EPA’s 2008 ‘‘fugitive emissions rule,’’ (published December 19,
2008) are not SIP-approved.
*
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
■
42 CFR Parts 405 and 423
Authority: 42 U.S.C. 7401 et seq.
[CMS–4174–P]
4. Amend appendix A to part 70 by
adding new paragraph (t) under Iowa to
read as follows:
■
Appendix A to Part 70—Approval
Status of State and Local Operating
Permits Programs
*
*
*
*
*
*
*
*
*
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Proposed rule.
(t) The Iowa Department of Natural
Resources submitted for program approval
revisions to rules 567–22.103, 567–22.106,
567–22.107, and 567–30.4. The state effective
date is April 18, 2018. This revision is
effective [date 60 days after date of
publication of the final rule in the Federal
Register].
*
*
*
*
*
[FR Doc. 2018–21287 Filed 10–1–18; 8:45 am]
amozie on DSK3GDR082PROD with PROPOSALS1
BILLING CODE 6560–50–P
VerDate Sep<11>2014
16:46 Oct 01, 2018
Medicare Program: Changes to the
Medicare Claims and Medicare
Prescription Drug Coverage
Determination Appeals Procedures
AGENCY:
Iowa
*
RIN 0938–AT27
Jkt 247001
This proposed rule would
revise the regulations setting forth the
appeals process that Medicare
beneficiaries, providers, and suppliers
must follow in order to appeal adverse
determinations regarding claims for
benefits under Medicare Part A and Part
B or determinations for prescription
drug coverage under Part D. These
changes would help streamline the
appeals process and reduce
administrative burden on providers,
suppliers, beneficiaries, and appeal
adjudicators. These revisions, which
include technical corrections, would
also help to ensure the regulations are
clearly arranged and written to give
stakeholders a better understanding of
the appeals process.
DATES: To be assured consideration,
comments must be received at one of
SUMMARY:
PO 00000
Frm 00016
Fmt 4702
Sfmt 4702
*
*
the addresses provided below, no later
than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, please refer
to file code CMS–4174–P. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address only: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–4174–P, P.O. Box 8013, Baltimore,
MD 21244–1850.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address only: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–4174–P, Mail
Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Joella Roland, (410) 786–7638 or
Nishamarie Sherry, (410) 786–1189.
SUPPLEMENTARY INFORMATION: Inspection
of Public Comments: All comments
E:\FR\FM\02OCP1.SGM
02OCP1
49514
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
amozie on DSK3GDR082PROD with PROPOSALS1
received before the close of the
comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
I. Background
As specified under sections 1869 and
1860D–4 of the Social Security Act (the
Act) and their implementing
regulations, once Medicare makes a
coverage or payment determination
under Medicare Parts A, B, or D,
affected parties have the right to appeal
the decision through four levels of
administrative review. If a minimum
amount in controversy (AIC) is met,
parties can then appeal the decision to
federal district court.
Section 1869 of the Act sets forth the
process for appealing Parts A and B
claim determinations. For most Part A
and B claims, the initial determination
is made by a Medicare Administrative
Contractor (MAC). If a party is
dissatisfied with the initial
determination, the party may request a
redetermination by the MAC, which is
a review by MAC staff not involved in
the initial determination. If a party is
dissatisfied with the MAC’s
redetermination, the party may request
a Qualified Independent Contractor
(QIC) reconsideration consisting of an
independent review of the
administrative record, including the
redetermination. Provided a minimum
AIC is met, parties then have the option
to appeal to the Office of Medicare
Hearings and Appeals (OMHA) where
they may receive either a hearing or
review of the administrative record by
an Administrative Law Judge (ALJ), or a
review of the administrative record by
an attorney adjudicator. Parties then
have the option to appeal to the
Medicare Appeals Council (the Council)
within the Departmental Appeals Board,
where an Administrative Appeals Judge
examines their claim. A party can then
appeal the decision to federal district
court if certain requirements are met,
including a minimum AIC.
The appeals process described above
for Parts A and B claim determinations
was initially proposed in the November
15, 2002 Federal Register (67 FR
69312), which was promulgated to
implement section 521 of the Medicare,
Medicaid, and SCHIP Benefits
Improvement and Protection Act of
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
2000 (Pub. L. 106–554). This process
was implemented in an interim final
rule with comment period published on
March 8, 2005 (the 2005 interim final
rule with comment period) (70 FR
11420), which also set forth new
provisions to implement the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (Pub. L. 108–
173). Correcting amendments to the
2005 interim final rule were published
on June 30, 2005 (70 FR 37700) and
August 26, 2005 (70 FR 50214), and the
final rule was published on December 9,
2009 (74 FR 65296). Subsequent
revisions to implement section 201 of
the Strengthening Medicare and
Repaying Taxpayers Act of 2012 (Pub. L.
112–242) were published on February
27, 2015 (80 FR 10611). These appeals
procedures for Part A and B claims are
set forth in regulations at part 405,
subpart I.
Section 1860D–4 of the Act sets forth
the appeals process for Part D coverage
determinations. Under Medicare Part D,
the Part D plan sponsor issues a
coverage determination. If this coverage
determination is appealed, the Part D
plan sponsor reviews the determination,
which is known as a redetermination. If
a party is dissatisfied with the
redetermination, the party may request
a reconsideration by an independent
review entity. Similar to the appeals
process for Parts A and B claim
determinations, provided a minimum
AIC is met, parties then have the option
to appeal to OMHA where they may
receive either a hearing or review of the
administrative record by an ALJ, or a
review of the administrative record by
an attorney adjudicator. If not satisfied
with OMHA’s decision, a party then
may appeal to the Council. The Council
decision then may be appealed to
federal district court if certain
requirements are met, including a
minimum AIC. These procedures are set
forth in regulations at part 423, subparts
M and U.
On January 17, 2017, we issued a final
rule entitled ‘‘Medicare Program:
Changes to the Medicare Claims and
Entitlement, Medicare Advantage
Organization Determination, and
Medicare Prescription Drug Coverage
Determination Appeals Procedures’’ (82
FR 4974) (the January 17, 2017 final
rule), which revised the Parts A, B, C,
and D appeals procedures. The goals of
this rulemaking were to streamline the
appeals process, increase consistency in
decision-making, improve efficiency for
both appellants and adjudicators, and
provide particular benefit to
beneficiaries by clarifying processes and
adding provisions for increased
assistance when they are unrepresented.
PO 00000
Frm 00017
Fmt 4702
Sfmt 4702
On April 16, 2018, we issued a final rule
(83 FR 16440) that made additional
changes to subparts M and U in order
to implement section 704 of the
Comprehensive Addiction and Recovery
Act of 2016 (Pub. L. 114–198), along
with other changes.
Through our experience
implementing the current appeals
process, and through additional
research, we have identified several
opportunities to streamline the claims
appeals process and reduce associated
burden on providers, beneficiaries, and
appeals adjudicators. We have also
identified several technical corrections
that should be made to correct crossreferences, inconsistent definitions, and
confusing terminology.
II. Provisions of the Proposed
Regulations
A. Removal of Requirement That
Appellants Sign Appeal Requests
(§§ 405.944, 405.964, 405.1112, and
423.2112)
Existing regulations at part 405,
subpart I; and part 423, subparts M and
U, specify the required elements of
requests for Medicare Parts A and B
claims appeals and for Medicare Part D
coverage determination appeals,
respectively. Generally, when a
contractor or plan issues a Part A or B
initial determination or a Part D
coverage determination, it notifies the
provider, supplier, and/or beneficiary
and offers the opportunity to appeal. If
this determination is appealed, the
contractor or plan reviews the
determination, which, in Medicare Parts
A, B and D appeals, is known as a
redetermination (see §§ 405.940 and
423.580). This can be followed by a
review by an independent contractor
consisting of an independent review of
the administrative record, including the
redetermination, which is known as a
reconsideration (§§ 405.960 and
423.600). If a minimum amount-incontroversy is met, parties then have the
option to appeal to the OMHA where
the administrative record may be
reviewed by an attorney adjudicator or
an ALJ or a hearing may be held by an
ALJ (§§ 405.1000 et seq. and 423.2000 et
seq.). Parties then have the option to
appeal to the Council within the
Departmental Appeals Board where an
Administrative Appeals Judge reviews
their claim (§§ 405.1100 et seq. and
423.2100 et seq.).
Appeal requests can be made using
different standard forms. These standard
forms include the following: Medicare
Redetermination Request Form (CMS–
20027); Medicare Reconsideration
Request Form (CMS–20033); Request for
E:\FR\FM\02OCP1.SGM
02OCP1
amozie on DSK3GDR082PROD with PROPOSALS1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
Administrative Law Judge Hearing or
Review of Dismissal (OMHA–100); and
Request for Review of Administrative
Law Judge (ALJ) Medicare Decision/
Dismissal (DAB–101). A written request
that is not made on a standard form is
also accepted if it contains certain
required elements. For example, see,
§§ 405.944(b), 405.964(b), 405.1014(a),
405.1112, 423.2014(a), 423.2112.
As discussed previously, all Medicare
Parts A, B, and D appeal requests must
contain the information specified in our
regulations. In addition, for Parts A and
B claims appeal requests at the
redetermination, reconsideration, and
Council review levels (§§ 405.944(b)(4),
405.964(b)(4), and 405.1112(a)), and for
Part D coverage determination appeal
requests at the Council level
(§ 423.2112(a)(4)), the appellants must
sign their appeal requests. However,
there is no signature requirement when
the appellant requests OMHA review of
Parts A and B claim determinations, or
when the appellant requests a
redetermination, reconsideration, or
OMHA review of Part D coverage
determinations. In addition, there is no
requirement that appellants sign appeals
requests for appeals of Part C
organization determinations.
In order to promote consistency
between appeal levels, ensure
transparency in developing our appeal
request requirements, help ensure that
we do not impose nonessential
requirements on appellants, reduce the
burden on appellants, and improve the
appeals process based on our
experience, we are proposing that
appellants in Medicare Parts A and B
claim and Part D coverage
determination appeals be allowed to
submit appeal requests without a
signature. Specifically, we are proposing
to revise §§ 405.944(b)(4), 405.964(b)(4),
405.1112(a), and 423.2112(a)(4) to
remove the requirement of the
appellant’s signature for appeal
requests.
As discussed previously, there is no
requirement that appellants sign appeal
requests when appealing their cases to
OMHA, for the Part C organization
determination appeals process, or at the
redetermination and reconsideration
levels of Part D appeals. However, the
other requirements for appeal requests
are substantially similar between levels
of appeal and appeals processes, or
there is a clear reason for the differing
requirements. For example, the
requirements for Part A and B appeal
requests at the redetermination and
reconsideration levels are identical with
the exception of the reconsideration
requirement that the name of the
contractor be listed on the
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
reconsideration appeal request
(§§ 405.944 and 405.964). The rationale
for the requirement that the name of the
contractor be included on
reconsideration appeal requests is that
without this information, the
independent contractor does not have a
method of determining which contractor
made the initial determination and
redetermination, and is unable to get the
case file. Since the contractor doing the
redetermination is the same contractor
who performed the initial
determination, it is not necessary that
this information be included in the
redetermination appeal request.
By contrast, we do not believe there
is a compelling reason to require that a
signature be included on
redetermination, reconsideration, and
Council-level appeal requests, but not
on OMHA appeal requests. Removing
the requirement that appellants sign
their appeal requests, would help
promote consistency between appeal
request requirements, thus making the
appeals process easier for parties to
understand.
Eliminating the requirement that
appellants sign their appeal requests
would reduce the burden of developing
the appeal request and appealing
dismissals of appeal requests for lack of
a signature to the next level of review
(for example, §§ 405.952(b), 405.972(b)).
Allowing adjudicators to review appeal
requests without signatures would allow
them to focus their attention on the
merits of the appeal, rather than having
to dismiss potentially meritorious
appeals for a lack of a signature.
When we promulgated the
requirement for appellants to sign the
appeal requests in regulations, we
included a signature on the appeal
request to ensure that the person
requesting the appeal was a proper party
to the appeal. Through experience, we
have found that, in practice, little
verification of the signature is possible.
To determine if the appeal requestor is
a proper party to the appeal, the
adjudicator uses the name of the
beneficiary and name of the party listed
on the appeal request, in addition to the
information listed in the case file.
The other appeal request
requirements consist of fields that are
necessary for the adjudicators to
properly process the appeal request. As
discussed previously, the name of the
contractor who made the
redetermination is required for the
independent contractor to review the
case file. The Part A and B
redetermination appeal request
requirement to include the disputed
service and/or item enables the
PO 00000
Frm 00018
Fmt 4702
Sfmt 4702
49515
contractor to determine the merit of the
appellant’s claim.
Thus, we believe there is no need for
a signature on an appeal request at this
time and propose to eliminate that
requirement. However, if, we find in the
future that there are other reasons that
would warrant an appellant’s signature
on an appeal request (for example, for
a good-faith attestation), we would reexamine the possibility of adding the
requirement back in. However, given
that our existing statutory authority
limits our ability to enforce certain
attestations, we find the signature
requirement unnecessary.
We are inviting public comments on
our proposal to revise §§ 405.944(b)(4),
405.964(b)(4), 405.1112(a), and
423.2112(a)(4) of the regulations to
remove the requirement that the
appellant sign the appeal request.
B. Change to Timeframe for Vacating
Dismissals (§§ 405.952, 405.972,
405.1052, and 423.2052)
The regulations at §§ 405.952(d),
405.972(d), 405.1012(e), and 423.2052(e)
allow adjudicators to vacate a dismissal
of an appeal request for a Medicare Part
A or B claim or Medicare Part D
coverage determination within 6 months
of the date of the notice of dismissal.
This allows sufficient time for
adjudicators to carefully evaluate their
dismissals while taking into account the
principle of administrative finality.
Through experience, we have
concluded that the timeframe for
vacating a dismissal would be better
expressed in calendar days, rather than
months, for two reasons. First, all
timeframes in the regulations under part
405, subpart I and part 423 subpart U,
associated with the filing of appeal
requests, adjudication periods,
reopening of prior determinations, and
other time-limited procedural actions
are expressed in calendar days, not
months. For example, see §§ 405.942
and 423.2056. Second, applying a
timeframe based on days, rather than
months, leads to more consistency in
interpretation and actual timeframes. A
timeframe based on months could be
subject to varying interpretations, as the
number of days in a consecutive 6month period varies from 181 to 184
days. For example, if an ALJ or attorney
adjudicator’s dismissal is dated August
31 of one calendar year, advancing the
timeframe 6 months to February could
be confusing for parties and
adjudicators because February does not
contain 30 or 31 days. Also, given that
February has only 28 or 29 days (in a
leap year), any 6-month period that
includes February would be shorter
than other 6 month periods, leading to
E:\FR\FM\02OCP1.SGM
02OCP1
49516
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
some inconsistency in the actual
timeframe for vacating a dismissal.
To provide more consistency and
predictability for appellants and
adjudicators, and better conformity with
other timeframes in the part 405,
subpart I and part 423 subpart U, we are
proposing to revise the timeframe for
vacating a dismissal from 6 months to
180 days in §§ 405.952(d), 405.972(d),
405.1052(e), and 423.2052(e).
amozie on DSK3GDR082PROD with PROPOSALS1
C. Technical Correction to Regulations
To Change Health Insurance Claim
Number (HICN) References to Medicare
Numbers (§§ 405.910, 405.944, 405.964,
405.1014, 405.1112, 423.2014, and
423.2112)
Section 501 of the Medicare Access
and CHIP Reauthorization Act of 2015
(MACRA) (Pub. L. 114–10), added
section 205(c)(2)(C)(xiii) of the Act to
prohibit Social Security Numbers (or
derivatives) from being displayed on
Medicare cards. As a result, CMS is
undertaking efforts to issue new
Medicare cards, which contain a
randomly generated Medicare
Beneficiary Identifier (MBI), rather than
the Social Security Number-based
Health Insurance Claim Number (HICN)
that is on the current Medicare cards. In
order to ensure that appellants can
easily submit appointment of
representative documentation and
appeal requests, we would accept this
documentation with HICNs or MBIs.
Consistent with these efforts, we are
proposing to remove references to the
Social Security Number-based HICN on
Medicare cards that are included in the
Medicare appeals regulations, and to
replace them with references to
Medicare number to clarify that either a
HICN or MBI can be included on
appointment of representative
documentation and appeal requests.
Accordingly, we are proposing to revise
the following provisions of Medicare
regulations to remove the words ‘‘health
insurance claim’’ from the phrase
‘‘Medicare health insurance claim
number’’ so that there is only a
reference to ‘‘Medicare number’’:
§§ 405.910(c)(5), 405.944(b)(2),
405.964(b)(2), 405.1014(a)(1)(i),
405.1112(a), 423.2014(a)(1)(i), and
423.2112(a)(4).
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
D. Removal of Redundant Regulatory
Provisions Relating to Medicare Appeals
of Payment and Coverage
Determinations and Conforming
Changes (§§ 423.562, 423.576, 423.602,
423.604, 423.1970, 423.1972, 423.1974,
423.1976, 423.1984, 423.1990, 423.2002,
423.2004, 423.2006, 423.2014, 423.2020,
423.2044, 423.2100, and 423.2136)
The January 17, 2017 final rule
revised certain Medicare procedures for
appeals of payment and coverage
determinations for items and services
furnished to Medicare beneficiaries and
enrollees. Since the publication of this
final rule, we have identified four
regulatory provisions in part 423,
subpart U that are redundant. In order
to reduce potential confusion, we are
proposing to remove redundant
provisions at §§ 423.1970, 423.1972,
423.1974, and 423.1976 and, where
necessary, incorporate appropriate
provisions in other sections of the
regulations.
Section 423.1970 of the regulations
relating to the rights of enrollees to an
ALJ hearing provides—
• In paragraph (a), that, if the amount
remaining in controversy after the
independent review entity (IRE)
reconsideration meets the threshold
requirement established annually by the
Secretary, an enrollee who is
dissatisfied with the IRE reconsideration
determination has a right to a hearing
before an ALJ;
• In paragraph (b)(1), the
methodology for computing the AIC
when the basis for appeal is the refusal
by the Part D plan sponsor to provide
drug benefits;
• In paragraph (b)(2), the
methodology for computing the AIC
when the basis for appeal is an at-risk
determination made under a drug
management program in accordance
with § 423.153(f); and
• In paragraph (c), the requirements
for aggregating appeals to meet the AIC.
Section 423.2002 also contains
provisions on the right to an ALJ
hearing. This section contains crossreferences to the provisions in
§ 423.1970, and also—
• Establishes a 60-calendar day
timeframe for filing a written request for
an ALJ hearing following receipt of the
written notice of the IRE’s
reconsideration; and indicates the AIC
requirement must be met to be entitled
to an ALJ hearing;
• Provides the circumstances under
which an enrollee may request that an
ALJ hearing be expedited;
• Establishes a 5-calendar day
presumption for receipt of the
reconsideration following the date of the
PO 00000
Frm 00019
Fmt 4702
Sfmt 4702
written reconsideration, unless there is
evidence to the contrary; and
• Provides that, for purposes of the
section, requests for hearing are
considered as filed on the date they are
received by the office specified in the
IRE’s reconsideration.
Because §§ 423.1970 and 423.2002
both address the right to an ALJ hearing,
and because there is a possibility that
confusion may arise from having two
sections with the same title in the same
CFR subpart, we are proposing to
remove § 423.1970. Because
§ 423.1970(a) is redundant of
§§ 423.2000(a) and 423.2002(a)(2) in
describing that an enrollee has a right to
an ALJ hearing when the enrollee is
dissatisfied with an IRE reconsideration
and meets the AIC requirement, we
believe § 423.1970(a) should be
eliminated. We are proposing to relocate
§ 423.1970(b) and (c) to new proposed
§ 423.2006 (‘‘Amount in controversy
required for an ALJ hearing and judicial
review’’) as paragraphs (c) and (d),
respectively.
In addition, we are proposing to
remove the reference to ‘‘CMS’’ in
§ 423.1970(b) (relocated to proposed
§ 423.2006(c)) to clarify that
adjudicators, not CMS, ultimately
compute the amount remaining in
controversy in determining whether the
AIC threshold is met for an ALJ hearing
or review of an IRE dismissal, and
judicial review.
We believe having one section titled
‘‘Right to an ALJ hearing’’ at § 423.2002
and another section titled ‘‘Amount in
controversy required for an ALJ hearing
and judicial review’’ at § 423.2006 is
more consistent with the corresponding
rules in 42 CFR part 405, subpart I for
appeals of Medicare Part A and Part B
initial determinations (§§ 405.1002 and
405.1006). For consistency with
§ 423.2000(a) and language that was
removed from § 423.1970(a), we are also
proposing to add language to
§ 423.2002(a) providing that the right to
an ALJ hearing is available to enrollees
who are dissatisfied with the IRE’s
reconsideration determination.
In order to further increase
consistency with § 405.1006 and
consolidate the Medicare Part D appeals
rules regarding the AIC, we are
proposing to incorporate provisions in
proposed new § 423.2006(a) and (b) that
are similar to those provisions
contained at § 405.1006(b) and (c),
describing the amounts in controversy
required for an ALJ hearing and judicial
review, respectively, including the
annual adjustment of these amounts. In
order to more clearly state the AIC
requirements for appeals of Part D
prescription drug plan coverage
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
amozie on DSK3GDR082PROD with PROPOSALS1
determinations, without the need for
multiple statutory and regulatory crossreferences, we are proposing that new
§ 423.2006 would include the following:
• At proposed paragraph (a)(1), a
provision similar to § 405.1006(b)(1)
that the required amount remaining in
controversy must be $100 increased by
the percentage increase in the medical
care component of the Consumer Price
Index for All Urban Consumers (U.S.
city average) as measured from July
2003 to the July preceding the current
year involved.
• At proposed paragraph (a)(2), a
provision similar to § 405.1006(b)(2)
that, if the figure in § 423.2006(a)(1) is
not a multiple of $10, it is rounded to
the nearest multiple of $10, and that the
Secretary will publish changes to the
AIC requirement in the Federal Register
when necessary.
• At proposed paragraph (b), a
provision similar to § 405.1006(c) that,
to be entitled to judicial review, the
enrollee must meet the AIC
requirements of this subpart and have
an amount remaining in controversy of
$1000 or more, adjusted as specified in
proposed § 423.2006(a)(1) and (2).
• At proposed paragraph (c), a
provision similar to current
§ 423.1970(b) explaining how the
amount remaining in controversy is
calculated.
• At proposed paragraph (d), the text
currently found in § 423.1970(c)
concerning aggregation of appeals to
meet the amount in controversy.
Finally, we are proposing to update or
remove the cross-references to
§ 423.1970 in §§ 423.562(b)(4)(iv),
423.576, 423.602(b)(2), 423.1984(c);
423.2002(a) introductory text and (a)(2),
and (b)(3), 423.2004(a)(2), and
423.2044(c) and to add a cross-reference
to § 423.2006 in § 423.1990(b)(3) in
place of the language ‘‘established
annually by the Secretary.’’
Section 423.1972, titled ‘‘Request for
an ALJ hearing,’’ provides the
procedures an enrollee must follow
when filing a request for hearing as
follows:
• Paragraph (a) provides that a
written request must be filed with the
OMHA office specified in the IRE’s
reconsideration notice.
• Paragraph (b) provides the
timeframe for filing a request.
• Paragraph (c)(1) states that if a
request for hearing clearly shows that
the AIC is less than that required under
§ 423.1970, the ALJ or attorney
adjudicator dismisses the request.
• Paragraph (c)(2) provides that if,
after a hearing is initiated, the ALJ finds
that the AIC is less than the amount
required under § 423.1970, the ALJ
discontinues the hearing and does not
rule on the substantive issues raised in
the appeal.
With the exception of paragraph
(c)(2), all of the provisions in § 423.1972
are duplicative of or incorporate by
reference other provisions found in
§ 423.2002(a) and (d) (Right to an ALJ
hearing), § 423.2014(d)(2) and (e)
(Request for an ALJ hearing or a review
of an IRE dismissal), § 423.2020 (Time
and place for a hearing before an ALJ),
and § 423.2052(a)(2) (Dismissal of a
request for a hearing before an ALJ or
request for review of an IRE dismissal).
In order to eliminate the redundancy
and potential confusion, we are
proposing to remove § 423.1972 in its
entirety. As a part of this proposed
change, we also are proposing to update
or remove the cross-references to
§ 423.1972 in §§ 423.604, 423.1984(c),
423.2014(d) introductory text and (e)(1),
and 423.2020(a). We do not believe it is
necessary to retain § 423.1972(c)(2) in
another location because ALJs have
broad authority to regulate the course of
the hearing. In the rare circumstances
described in § 423.1972(c)(2) where an
ALJ does not make a finding regarding
the AIC until after a hearing is initiated,
the ALJ may discontinue the hearing
and issue a dismissal under
§§ 423.2002(a)(2) and 423.2052(a)(2).
Section 423.1974, titled ‘‘Council
review,’’ provides that an enrollee who
is dissatisfied with an ALJ’s or attorney
adjudicator’s decision or dismissal may
request that the Council review the
ALJ’s or attorney adjudicator’s decision
or dismissal as provided in § 423.2102.
This provision is similar to § 423.2100,
titled ‘‘Medicare Appeals Council
review: general.’’ To eliminate the
redundancy, we are proposing to
remove the language of § 423.1974 and
incorporate it in § 423.2100(a). This
language would replace the language in
§ 423.2100(a). We also are proposing to
update or remove the cross-references to
49517
§ 423.1974 in §§ 423.562(b)(4)(v) and
423.1984(d).
Section 423.1976, titled ‘‘Judicial
review,’’ provides the following:
• In paragraph (a), that an enrollee
may request judicial review of an ALJ’s
or attorney adjudicator’s decision if the
Council denied the enrollee’s request for
review and the AIC meets the threshold
requirement established annually by the
Secretary.
• In paragraph (b), that the enrollee
may request judicial review of a Council
decision if it is the final decision of
CMS and the AIC meets the threshold
established in paragraph (a)(2).
• In paragraph (c), that, in order to
request judicial review, an enrollee
must file a civil action in a district court
of the United States in accordance with
section 205(g) of the Act.
With the exception of paragraph (a),
these provisions are largely duplicative
of other provisions contained in
§ 423.2136, also titled ‘‘Judicial review.’’
To eliminate this redundancy, we are
proposing to remove the provisions of
§ 423.1976 and revise § 423.2136 as
follows:
• Section 423.2136(a) would be
redesignated as § 423.2136(a)(1). The
cross-reference to § 423.1976 would be
removed, and language from
§ 423.1976(b) would be incorporated in
§ 423.2136(a)(1)(i) and (ii) and revised
by replacing ‘‘CMS’’ with ‘‘the
Secretary’’ for consistency with the
language in section 1876(c)(5)(B) of the
Act and § 423.2140, and replacing
‘‘paragraph (a)(2) of this section’’ with
‘‘§ 423.2006’’ which we are proposing to
add to the regulations to address the
AIC requirements.
• Language at § 423.1976(a) would be
revised to incorporate a reference to
§ 423.2006 and the authorizing language
from § 423.2136(a) (proposed
§ 423.2136(a)(1)) and moved to new
§ 423.2136(a)(2).
• We also are proposing to update or
remove the cross-references to
§ 423.1976 in §§ 423.562(b)(4)(vi),
423.576, and 423.2136(b)(1). We seek
comment on these proposed changes.
In summary, we are proposing to
remove or relocate language as shown in
the following table:
Current section
Proposed new
section
Proposed action
Rationale
§ 423.1970(a) ...........................................
N/A ...................
Remove ..................................................
§ 423.1970(b) ...........................................
§ 423.2006 ........
§ 423.1970(c) ...........................................
...........................
Remove and incorporate revised language at proposed new § 423.2006(c).
Remove and incorporate at proposed
new § 423.2006(d).
Similar language exists in
§§ 423.2000(a) and 423.2002(a)(2).
Increases consistency with § 405.1006.
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
PO 00000
Frm 00020
Fmt 4702
Sfmt 4702
E:\FR\FM\02OCP1.SGM
02OCP1
amozie on DSK3GDR082PROD with PROPOSALS1
49518
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
Current section
Proposed new
section
Proposed action
N/A ...........................................................
N/A ...........................................................
§ 423.2006(a) ...
§ 423.2006(b) ...
§ 423.1972(a), § 423.1972(b),
§ 423.1972(c)(1).
N/A ...................
Add language concerning AIC computation not previously outlined in 42 CFR
part 423.
Remove ..................................................
§ 423.1972(c)(2) ......................................
§ 423.1974 ...............................................
N/A ...................
N/A ...................
§ 423.1976(a) ...........................................
N/A ...................
§ 423.1976(b) ...........................................
...........................
§ 423.1976(c) ...........................................
N/A ....................
E. Change to Timeframe for Council
Referral (§ 405.1110 and § 423.2110)
The regulations at §§ 405.1110(a) and
(b)(2) and 423.2110(a) and (b)(2) give
CMS or its contractors 60 calendar days
after the date or issue date, respectively,
of OMHA’s decision or dismissal to
refer the case to the Council. In the case
of Part A and Part B appeals, CMS or its
contractors are sent the decision notice
when they are a party to the hearing or
soon after the hearing occurred. For Part
D appeals, as specified in
§ 423.2046(a)(1), the decision notice is
sent to the enrollee, plan sponsor, and
IRE.
Our regulations generally include
regulatory timeframes that start when
CMS or its contractors receive the
decision notice, rather than the date the
decision notice was issued. For
example, § 405.1010(b)(3), which
addresses the timing of when CMS or its
contractor may elect to participate in an
ALJ hearing, provides that CMS or its
contractor must send notice of its intent
to participate, if no hearing is
scheduled, no later than 30 calendar
days after notification that a request for
hearing was filed or, if a hearing is
scheduled, no later than 10 calendar
days after receiving the notice of
hearing. The rationale for starting the
timeframe in § 405.1010(b)(3) after
receipt of the notice was to ensure that
CMS or its contractors have sufficient
time to conduct a thorough evaluation
of the facts and the case.
For the same reason, we are proposing
to revise the timeframe in §§ 405.1110(a)
and (b)(2) and 423.2110(a) and (b)(2) for
CMS or it contractors to refer a case to
the Council such that the timeframe
would begin after the ALJ’s or attorney
adjudicator’s decision or dismissal is
received. Starting the timeframe after
CMS or its contractor receives OMHA’s
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
Remove ..................................................
Remove and incorporate into
§ 423.2100(a).
Remove and incorporate revised language at new § 423.2136(a)(2).
Remove and incorporate revised language at proposed new
§ 423.2136(a)(1).
Remove ..................................................
written decision or dismissal would
help ensure that CMS and its
contractors have sufficient time to
decide whether the case is the type of
case that should be referred to the
Council for review. This proposed
change would help ensure that even if
CMS and its contractors receive a
delayed notice, they would have
sufficient time to decide whether the
case should be referred to the Council.
In order to ensure consistent
implementation of this proposal, we
also are proposing to add new
§§ 405.1110(e) and 423.2110(e) to
provide that the date of receipt of the
ALJ’s or attorney adjudicator’s decision
or dismissal is presumed to be 5
calendar days after the date of the notice
of the decision or dismissal, unless
there is evidence to the contrary. This
would help facilitate the Council’s
determination on the timeliness of the
referral by establishing a date by which
the Council may presume that CMS or
its contractor received the decision from
OMHA. This 5 day mailing presumption
is consistent with the presumption
included in §§ 405.1102(a)(2) and
423.2102(a)(3) with respect to the
timeframe for requesting Council review
following an ALJ’s or attorney
adjudicator’s decision or dismissal.
For these reasons, we are proposing to
revise the Council referral timeframes in
§§ 405.1110(a) and (b)(2) and
423.2110(a) and (b)(2), and proposing to
add §§ 405.1110(e) and 423.2110(e) as
discussed previously.
F. Technical Correction to Regulation
Regarding Duration of Appointed
Representative in a Medicare Secondary
Payer Recovery Claim (§ 405.910)
Section 405.910 sets forth provisions
addressing the appointment of
representatives in a Medicare Parts A
PO 00000
Frm 00021
Rationale
Fmt 4702
Sfmt 4702
Similar language exists in
§§ 423.2002(a) and (d),
423.2014(d)(2) and (e), 423.2020,
and 423.2052(a)(2) and reduces redundancy.
Unnecessary.
Reduces redundancy.
Similar language exists in
§ 423.2136(b)(1).
and B claims appeals, including for
secondary payer recovery claims.
Specific requirements regarding the
duration of time that an appointment of
representative instrument is valid are
provided under § 405.910(e).
On February 27, 2015, we published
a final rule entitled ‘‘Medicare Program;
Right of Appeal for Medicare Secondary
Payer Determinations Relating to
Liability Insurance (Including SelfInsurance), No-Fault Insurance, and
Workers’ Compensation Laws and Plans
(80 FR 10611). In that final rule, we
added paragraph (e)(4) to § 405.910 in
order to provide applicable plans with
the benefit of the existing rule for
Medicare secondary payers regarding
the duration of appointment for an
appointed representative. Within this
added provision, we included a citation
to § 405.906(a)(1)(iv), as the regulation
establishing party status for applicable
plans. This citation is an incorrect crossreference; and the correct crossreference is § 405.906(a)(4). We are
proposing to revise § 405.910(e)(4) to
correct the cross-reference. This
proposed correction would not alter any
existing processes or procedures within
the Medicare claims appeals process.
G. Technical Correction to Actions That
Are Not Initial Determinations
(§ 405.926)
Section 405.926 sets forth actions that
are not considered initial
determinations subject to the
administrative appeals process under
part 405, subpart I. On October 4, 2016,
we issued a final rule entitled
‘‘Medicare and Medicaid Programs;
Reform of Requirements for Long-Term
Care Facilities’’ (81 FR 68688 through
68872) that moved the definition of
‘‘transfer and discharge’’ in § 483.12 to
the definitions under § 483.5.
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
Accordingly, we updated the crossreference to ‘‘§ 483.5’’ within
§ 405.926(f) to the cross-reference to
‘‘§ 483.5(n)’’. However, the citation of
§ 483.5(n) is an incorrect crossreference.
To correct this error, we are proposing
to revise § 405.926(f) to remove the
incorrect reference to ‘‘§ 483.5(n)’’ and
replace it with the cross-reference
‘‘§ 483.5 definition of ‘transfer and
discharge’ ’’. This proposed technical
correction would serve to correct an
incorrect citation. It would not alter any
existing processes or procedures within
the Medicare claims appeals process.
amozie on DSK3GDR082PROD with PROPOSALS1
H. Changes To Enhance Implementation
of Rule Streamlining the Medicare
Appeals Procedures (§§ 405.970,
405.1006, 405.1010, 405.1014, 405.1020,
405.1034, 405.1046, 405.1052, 405.1056,
423.1014, 423.1990, 423.2002, 423.2010,
423.2016, 423.2032, 423.2034, 423.2036,
423.2052, and 423.2056)
Since we published the January 17,
2017 final rule, we have identified
several provisions that, upon further
review, pose unanticipated challenges
with implementation, which are
explained in this section. In addition,
there are other regulatory provisions
that we believe require additional
clarification and the correction of
technical errors and omissions. In the
proposals listed in this section, we seek
to help ensure the provisions are
implemented as intended, provide
clarification, and correct technical
errors and omissions. Our proposed
changes are as follows.
1. Amount in Controversy (AIC)
(§ 405.1006)
Section 405.1006 addresses the AIC
required for an ALJ hearing and judicial
review, and § 405.1006(d) provides the
methodology for computing the AIC. In
general, the AIC is computed as the
amount that the provider or supplier
bills for the items and services in the
disputed claim, reduced by any
Medicare payments already made or
awarded for the items or services, and
further reduced by any deductible and/
or coinsurance amounts that may be
collected for the items or services. In the
January 17, 2017 final rule, we created
several exceptions to this general
computation methodology for situations
where we believed an alternative
methodology would more accurately
describe the amount actually in dispute.
Among these alternatives was the
calculation methodology specified in
§ 405.1006(d)(4), which states that when
an appeal involves an identified
overpayment, the AIC is the amount of
the overpayment specified in the
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
demand letter for the items or services
in the disputed claim. For appeals
involving an estimated overpayment
amount determined through the use of
statistical sampling and extrapolation,
§ 405.1006(d)(4) further provides that
the AIC is the total amount of the
estimated overpayment determined
through extrapolation, as specified in
the demand letter.
When we created this exception, we
did not account for the possibility that
the amount of the overpayment or
estimated overpayment specified in the
demand letter might change throughout
the administrative appeals process if, for
example, an adjudicator finds that some
of the items or services for which an
overpayment was demanded are
covered and payable, or alternatively, if
an adjudicator raises a new issue that
results in the denial of additional items
or services. Even outside the
administrative appeals process, the
amount of an overpayment may be
revised by a CMS contractor (for
example, following a discussion period
with the contractor that initially
determined the overpayment). Although
some of these situations may result in
the issuance of a revised demand letter,
such a letter may not always be issued
during the pendency of the appeals
process.
To account for situations where the
amount of an overpayment specified in
the demand letter does not reflect
subsequent adjustments to the amount
remaining in controversy, we are
proposing to revise § 405.1006(d)(4) to
state that when an appeal involves an
identified overpayment, the AIC is the
amount of the overpayment specified in
the demand letter, or the amount of the
revised overpayment if the amount
originally demanded changes as a result
of a subsequent determination or
appeal, for the items or services in the
disputed claim. For appeals involving
an estimated overpayment amount
determined through the use of statistical
sampling and extrapolation, we are
further proposing to revise
§ 405.1006(d)(4) to state that the AIC is
the total amount of the estimated
overpayment determined through
extrapolation, as specified in the
demand letter, or as subsequently
revised.
2. Submissions by CMS and CMS
Contractors (§§ 405.1010 and 405.1012)
In § 405.1010(b)(1), we stated that if
CMS or a CMS contractor elects to
participate in the proceedings on a
request for hearing before receipt of a
notice of hearing, or when notice of
hearing is not required, it must send
written notice of its intent to participate
PO 00000
Frm 00022
Fmt 4702
Sfmt 4702
49519
to the parties who were sent a copy of
the notice of reconsideration, and to the
assigned ALJ or attorney adjudicator, or
if the appeal is not assigned, to a
designee of the Chief ALJ. We discussed
in the January 17, 2017 final rule that
the requirement to notify the parties
who were sent a copy of the notice of
reconsideration helps ensure that the
potential parties to a hearing, if a
hearing is conducted, would receive
notice of the intent to participate (82 FR
5016). However, the final regulation at
§ 405.1010(b)(1) does not account for
requests for reconsideration that are
escalated from the QIC level to the
OMHA level of appeal without a notice
of reconsideration having been issued.
In order to help ensure that the
potential parties to a hearing would
receive notice of CMS’ or the
contractor’s intent to participate and
address reconsideration escalations
from the QIC to OMHA, we are
proposing to revise § 405.1010(b)(1) to
require that, for escalated requests for
reconsideration, notice of the intent to
participate would also be sent to any
party that filed a request for
reconsideration or was found liable for
the services at issue subsequent to the
initial determination, which we believe
is consistent with circumstances under
which a party would receive notice of
a hearing under § 405.1020. (Section
405.1020(c)(1) also provides that a
notice of hearing is sent to all parties
that participated in the reconsideration.
However, we do not believe this
provision is necessary in circumstances
where the QIC has not issued a
reconsideration because, in practice,
there is generally no opportunity for
participation in these circumstances by
parties other than the party that filed the
request for reconsideration.) For the
same reason, we also are proposing to
revise § 405.1010(c)(3)(ii)(A), which
currently requires that copies of CMS or
contractor position papers or written
testimony that are submitted before
receipt of a notice of hearing must be
sent to the parties who were sent a copy
of the notice of reconsideration. We are
proposing to revise
§ 405.1010(c)(3)(ii)(A) to instead provide
that copies are sent to the parties that
are required to be sent a copy of the
notice of intent to participate in
accordance with § 405.1010(b)(1). No
corresponding revisions to § 423.2010
are needed because escalation is not
available in Medicare Part D appeals.
In § 405.1010(b)(3)(ii), we stated that
if CMS or a CMS contractor elects to
participate after a hearing is scheduled,
it must send written notice of its intent
to participate no later than 10 calendar
days ‘‘after receiving the notice of
E:\FR\FM\02OCP1.SGM
02OCP1
amozie on DSK3GDR082PROD with PROPOSALS1
49520
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
hearing.’’ Upon reviewing the revised
rules, we noticed an inconsistency
between this language and the language
in § 405.1012(a)(1), which requires CMS
or a CMS contractor electing to be a
party to a hearing to send written notice
of its intent to be a party no later than
10 calendar days ‘‘after the QIC receives
the notice of hearing.’’ We explained in
the January 17, 2017 final rule (82 FR
5020) that the timeframe in
§ 405.1012(a)(1) was based on receipt of
the notice of hearing by the QIC because
notices of hearing are currently sent to
the QIC in accordance with
§ 405.1020(c). We believe these
requirements should be consistent and
the timeframes should begin on the
same date, regardless of whether CMS or
a CMS contractor is electing to be a
party or participant. We also believe
that the regulations should provide
flexibility for CMS to designate another
contractor, other than the QIC, to
receive notices of hearing under
§ 405.1020(c) if that contractor is then
tasked with disseminating the notice of
hearing to other CMS contractors.
Therefore, and as discussed in this
section with regard to notices of
hearing, we are proposing to revise
§ 405.1020(c)(1) to provide for this
flexibility.
For conformity with proposed revised
§ 405.1020(c)(1) and to resolve the
existing inconsistency in
§§ 405.1010(b)(3)(ii) and 405.1012(a)(1),
we are proposing to revise both sections
to provide that written notice of the
intent to participate or intent to be a
party must be submitted no later than 10
calendar days after receipt of the notice
of hearing by the QIC or another
contractor designated by CMS to receive
the notice of hearing. No corresponding
revision is needed to the part 423,
subpart U rules because notices of
hearing are sent to both the Medicare
Part D plan sponsor and the IRE.
In § 405.1010(c)(3)(i), we state that
CMS or a CMS contractor that filed an
election to participate must submit any
position papers or written testimony
within 14 calendar days of its election
to participate if no hearing has been
scheduled, or no later than 5 calendar
days prior to the hearing if a hearing is
scheduled, unless the ALJ grants
additional time to submit the position
paper or written testimony. In the
January 17, 2017 final rule (82 FR 5017),
we discussed that the requirement to
submit any written testimony within 14
calendar days of the election to
participate if no hearing has been
scheduled helps to ensure that the
position paper and/or written testimony
are available when determinations are
made to schedule a hearing or issue a
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
decision based on the record in
accordance with § 405.1038.
Although § 405.1010(c)(3)(i) allows an
ALJ to extend the 5-calendar day
submission timeframe for cases in
which a hearing is scheduled, the
regulation text may be unclear as to
whether the same discretion is afforded
to ALJs or attorney adjudicators with
respect to the 14-calendar day
submission timeframe for cases in
which no hearing has been scheduled.
Our intent was to apply this
discretionary extension in both
circumstances, as evidenced by the
corresponding regulation at
§ 423.2010(d)(3)(i), which allows an ALJ
or attorney adjudicator to grant
additional time to submit a position
paper or written testimony both in cases
where a hearing has been scheduled and
in cases where no hearing has been
scheduled (82 FR 5019). Accordingly, to
clarify our intent and help ensure
consistency between the part 405 and
part 423, we are proposing to revise
§ 405.1010(c)(3)(i) to clarify that an ALJ
or attorney adjudicator may also extend
the 14-calendar day timeframe for
submission of position papers and
written testimony in cases in which no
hearing has been scheduled.
In § 405.1012(b), we stated that if
CMS or a CMS contractor elects to be a
party to the hearing, it must send
written notice of its intent to the ALJ
and to ‘‘the parties identified in the
notice of hearing.’’ Upon reviewing the
revised rules, we noticed an
inconsistency between this language
and the language in § 405.1010(b)(2),
which states that if CMS or a CMS
contractor elects to participate after
receipt of a notice of hearing, it must to
send written notice of its intent to
participate to the ALJ and ‘‘the parties
who were sent a copy of the notice of
hearing.’’ Although the standard for
who must receive notice is the same, the
way in which it is articulated is
different, which we believe may lead to
confusion. To prevent potential
confusion and help ensure consistency
in the regulations, we are proposing to
revise § 405.1012(b)(2) by replacing the
language ‘‘identified in the notice of
hearing’’ with ‘‘who were sent a copy of
the notice of hearing’’. No
corresponding revision is needed to the
part 423, subpart U rules because only
the enrollee is a party to a Medicare Part
D appeal and CMS, the IRE, and the Part
D plan sponsor may only request to be
nonparty participants.
Finally, § 405.1012(e)(1) states the
circumstances under which an ALJ or
attorney adjudicator may determine that
a CMS or contractor election to be a
party to a hearing made under
PO 00000
Frm 00023
Fmt 4702
Sfmt 4702
§ 405.1012 is invalid. Because
§ 405.1012(a) only permits CMS or a
contractor to elect to be a party after the
QIC receives a notice of hearing, and
only an ALJ may schedule and conduct
a hearing, we believe the determination
as to whether an election made under
§ 405.1012 is valid should be left to the
assigned ALJ. Therefore, we are
proposing in § 405.1012(e)(1) to replace
the phrase ‘‘ALJ or attorney adjudicator’’
with ‘‘ALJ.’’ No corresponding revision
is needed to the part 423, subpart U
rules because only the enrollee is a
party to a Medicare Part D appeal and
CMS, the IRE, and the Part D plan
sponsor may only request to be
nonparty participants.
3. Extension Requests (§§ 405.1014 and
423.2014)
Prior to the January 17, 2017 final
rule, § 405.1014(c)(2) provided that any
request for an extension of the time to
request a hearing must be in writing,
give the reasons why the request for a
hearing was not filed within the stated
time period, and must be filed with the
entity specified in the notice of
reconsideration. In the January 17, 2017
final rule, this provision was relocated
to § 405.1014(e)(2) and revised, in part,
to state that any request for an extension
of the time to request a hearing or
review of a QIC dismissal must be filed
with the request for hearing or request
for review. This change was motivated
by questions from appellants concerning
whether a request for an extension
should be filed without a request for
hearing so that a determination could be
made on the extension request before
the request for hearing was filed (82 FR
5038). However, in our attempt to
provide clarity to appellants, we created
a requirement that, in its strictest
interpretation, would foreclose an
appellant from requesting an extension
of the time to request a hearing or
review after a request for hearing is
filed. The need for such a request to be
made may arise when an appellant—
particularly an unrepresented
beneficiary—is not aware that a request
for hearing is untimely at the time of
filing. In these situations, OMHA
frequently requests that the appellant
provide an explanation for the untimely
filing and, if the OMHA adjudicator
finds good cause for the untimely filing,
the time period for filing is extended in
accordance with § 405.1014(e)(3).
In order to remedy this situation, we
are proposing to revise § 405.1014(e)(2)
to provide that requests for extension
must be filed with the request for
hearing or request for review, or upon
notice that the request may be dismissed
because it was not timely filed. We also
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
are proposing a corresponding revision
to § 423.2014(e)(3) for extension
requests filed by Medicare Part D
enrollees.
amozie on DSK3GDR082PROD with PROPOSALS1
4. Notice of Hearing (§ 405.1020)
In § 405.1020(c)(1), we require that a
notice of hearing be sent to all parties
that filed an appeal or participated in
the reconsideration, any party who was
found liable for the services at issue
subsequent to the initial determination
or may be found liable based on a
review of the record, the QIC that issued
the reconsideration, and CMS or a
contractor that elected to participate in
the proceedings in accordance with
§ 405.1010(b) or that the ALJ believes
would be beneficial to the hearing,
advising them of the proposed time and
place of the hearing. However, this rule
does not account for requests for
reconsideration that are escalated from
the QIC level to the OMHA level of
appeal without a reconsideration having
been issued.
To help ensure that the QIC, and other
CMS contractors who receive notice of
scheduled hearings through the QIC,
receive notice of all scheduled hearings,
we are proposing to revise
§ 405.1020(c)(1) to require that notice be
sent to the QIC that issued the
reconsideration or from which the
request for reconsideration was
escalated. As discussed in section II.H.3.
of this proposed rule with regard to
CMS and CMS contractor submissions,
we also are proposing to provide future
flexibility for CMS to designate another
contractor to receive notices of hearing
by revising § 405.1020(c)(1) to state, in
part, that the notice of hearing may
instead be sent to another contractor
designated by CMS to receive it. No
corresponding revisions are needed in
§ 423.2020(c)(1) because escalation is
not available in Medicare Part D
appeals, and notices of hearing are sent
to both the Medicare Part D plan
sponsor and the IRE.
5. Request for an In-Person or Video
Teleconference (VTC) Hearing
(§§ 405.1020 and 423.2020)
Section 405.1020(i)(1) and (i)(5)
provides that if an unrepresented
beneficiary who filed the request for
hearing objects to a video-teleconference
(VTC) hearing or to the ALJ’s offer to
conduct a hearing by telephone, or if a
party other than an unrepresented
beneficiary who filed the request for
hearing objects to a telephone or VTC
hearing, an ALJ may grant the
unrepresented beneficiary’s or other
party’s request for an in-person or VTC
hearing if it satisfies the requirements in
§ 405.1020(i)(1) through (3), with the
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
concurrence of the Chief ALJ or a
designee and upon a finding of good
cause. Prior to the January 17, 2017 final
rule, § 405.1020(i) dealt exclusively
with a party’s request for an in-person
hearing and § 405.1020(i)(5) required
concurrence of the Managing Field
Office ALJ and a finding of good cause
for an ALJ to grant the request. (As we
discussed in the January 17, 2017 final
rule, the position of Managing Field
Office ALJ was replaced by the position
of Associate Chief ALJ, and we replaced
the reference to ‘‘Managing Field Office
ALJ’’ in § 405.1020(i)(5) with ‘‘Chief ALJ
or a designee’’ to provide greater
flexibility in the future as position titles
change.) Managing Field Office ALJ
concurrence and a finding of good cause
were not required prior to the January
17, 2017 final rule for requests for a VTC
hearing because VTC was the default
method of hearing.
When we revised § 405.1020(i) in the
January 17, 2017 final rule to reflect the
change from VTC to telephone hearing
as the default method for appearances
by parties other than unrepresented
beneficiaries, we neglected to restrict
the requirement for the concurrence of
the Chief ALJ or designee to requests for
in-person hearing, in accordance with
§ 405.1020(b)(1)(ii) and (b)(2)(ii). In
addition, we neglected to clarify that,
because VTC is the default hearing
method for unrepresented beneficiaries,
a finding of good cause is not required
when an unrepresented beneficiary who
filed the request for hearing objects to
an ALJ’s offer to conduct a hearing by
telephone and requests a VTC hearing.
Accordingly, we are proposing to revise
§ 405.1020(i)(5) to clarify that
concurrence of the Chief ALJ or
designee is only required if the request
is for an in-person hearing, and that a
finding of good cause is not required for
a request for VTC hearing made by an
unrepresented beneficiary who filed the
request for hearing and objects to an
ALJ’s offer to conduct a hearing by
telephone. We also are proposing
corresponding revisions to
§ 423.2020(i)(5) for objections filed by
Medicare Part D enrollees.
In reviewing the January 17, 2017
final rule, we also noted potential
confusion about whether § 405.1020(e)
or (i) applies to objections to the place
of a hearing when the objection is
accompanied by a request for a VTC or
an in-person hearing. While an
objection to a hearing being conducted
by telephone or VTC may broadly
qualify as an objection to the place of
the hearing under § 405.1020(e), our
intent was for § 405.1020(i) to apply to
such an objection when the objection is
accompanied by a request for a different
PO 00000
Frm 00024
Fmt 4702
Sfmt 4702
49521
hearing format, because § 405.1020(i) is
specific to an objection to the scheduled
hearing format and request for an
alternate hearing format. To mitigate the
potential confusion as to which
provisions applies, we are proposing to
revise § 405.1020(e) by adding
paragraph (e)(5) to make clear that it
applies only when the party’s or
enrollee’s objection does not include a
request for an in-person or VTC hearing.
We also are proposing a corresponding
revision to § 423.2020(e) concerning a
Medicare Part D enrollee’s objection to
the time and place of hearing.36.
Dismissal of a Request for a Hearing
(§§ 405.1052 and 423.2052)
Section 405.1052(a) describes the
situations under which an ALJ may
dismiss a request for hearing (other than
withdrawals of requests for hearing,
which are described in § 405.1052(c)).
Although paragraph (a) pertains only to
ALJ dismissals, paragraphs (a)(3), (4)(i),
(5), and (6) contain inadvertent
references to attorney adjudicators.
• Paragraph (a)(3) states that an ALJ
may dismiss a request for hearing when
the party did not request a hearing
within the stated time period and the
ALJ or attorney adjudicator has not
found good cause for extending the
deadline, as provided in § 405.1014(e).
• Paragraph (a)(4)(i) provides that
when determining whether the
beneficiary’s surviving spouse or estate
has a remaining financial interest, the
ALJ or attorney adjudicator considers
whether the surviving spouse or estate
remains liable for the services that were
denied or a Medicare contractor held
the beneficiary liable for subsequent
similar services under the limitation of
liability provisions based on the denial
of the services at issue. (As discussed in
section II.H.10. of this proposed rule, we
are proposing to change the reference to
‘‘limitation of liability’’ to ‘‘limitation
on liability.’’)
• Paragraph (a)(5) states that an ALJ
or attorney adjudicator dismisses a
hearing request entirely or refuses to
consider any one or more of the issues
because a QIC, an ALJ or attorney
adjudicator, or the Council has made a
previous determination or decision
under part 405, Subpart I about the
appellant’s rights on the same facts and
on the same issue(s) or claim(s), and this
previous determination or decision has
become binding by either administrative
or judicial action.
• Paragraph (a)(6) states that an ALJ
or attorney adjudicator may conclude
that an appellant has abandoned a
request for hearing when OMHA
attempts to schedule a hearing and is
unable to contact the appellant after
making reasonable efforts to do so.
E:\FR\FM\02OCP1.SGM
02OCP1
amozie on DSK3GDR082PROD with PROPOSALS1
49522
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
As discussed of in the January 17,
2017 final rule (82 FR 4982), our intent
in finalizing the attorney adjudicator
proposals was to provide authority for
attorney adjudicators to dismiss a
request for hearing only when an
appellant withdraws his or her request
for an ALJ hearing, and not under any
other circumstances. We further
explained that attorney adjudicators
could not dismiss a request for hearing
due to procedural issues or make a
determination that would result in a
dismissal of a request for an ALJ hearing
(other than a determination that the
appellant had withdrawn the request for
hearing) (82 FR 5008 and 5009).
Therefore, we are proposing to revise
§ 405.1052(a)(3), (a)(4)(i), and (a)(6) to
remove the reference to attorney
adjudicators and paragraph (a)(5) to
remove the first reference to an attorney
adjudicator. We also are proposing
corresponding corrections to
§ 423.2052(a)(3), (5), and (6) for
dismissals of Part D requests for hearing.
Prior to the January 17, 2017 final
rule, § 405.1052(b) required that notice
of a dismissal of a request for hearing be
sent to all parties at their last known
address. We explained in the final rule
that the requirement to send notice of
the dismissal to all parties was overly
inclusive and caused confusion by
requiring notice of a dismissal to be sent
to parties who have not received a copy
of the request for hearing or request for
review that is being dismissed (82 FR
5086). Therefore, we revised this
provision (and moved it to
§ 405.1052(d)) to state that OMHA mails
or otherwise transmits a written notice
of a dismissal of a request for hearing or
review to all parties who were sent a
copy of the request for hearing or review
at their last known address.
However, in our effort to better tailor
the list of recipients, we neglected to
specify that notice is also sent to the
appellant—who must receive notice of
the dismissal, but would not have
received a copy of its own request for
hearing or review—and to account for
CMS or a CMS contractor who elected
to be a party to the appeal. We believe
that CMS or a CMS contractor that is a
party to an appeal has an interest in the
outcome of the appeal and should be
notified if the request for hearing or
review is dismissed. Section 405.1046
helps ensure that CMS or CMS
contractors who are a party to a hearing
receive notice of the decision by
requiring that the decision be sent to all
parties at their last known address. In
order to help ensure CMS and CMS
contractors are afforded similar notice of
dismissals, and that the appellant is
notified of a dismissal of its request for
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
hearing or review, we are proposing to
revise § 405.1052(d) to require that
notice be sent to the appellant, all
parties who were sent a copy of the
request for hearing or review at their last
known address, and to CMS or a CMS
contractor that is a party to the
proceedings on a request for hearing. No
corresponding revision to § 423.2052 is
needed because only the enrollee is a
party to a Medicare Part D appeal and
receives notice of the dismissal.
7. Remanding a Dismissal of a Request
for Reconsideration (§§ 405.1056,
405.1034, 423.2034, and 423.2056)
Section 405.1056(a)(1) provides that if
an ALJ or attorney adjudicator requests
an official copy of a missing
redetermination or reconsideration for
an appealed claim in accordance with
§ 405.1034, and the QIC or another
contractor does not furnish the copy
within the timeframe specified in
§ 405.1034, the ALJ or attorney
adjudicator may issue a remand
directing the QIC or other contractor to
reconstruct the record or, if it is not able
to do so, initiate a new appeal
adjudication. Section 405.1056(a)(2)
provides that if the QIC does not furnish
the case file for an appealed
reconsideration, an ALJ or attorney
adjudicator may issue a remand
directing the QIC to reconstruct the
record or, if it is not able to do so,
initiate a new appeal adjudication. In
§ 405.1056(d), an ALJ or attorney
adjudicator will remand a case to the
appropriate QIC if the ALJ or attorney
adjudicator determines that a QIC’s
dismissal of a request for
reconsideration was in error.
Occasionally, an ALJ or attorney
adjudicator may need to remand a
request for review of a dismissal of a
reconsideration request for reasons
similar to those specified in
§ 405.1056(a)(1) and (2) because the ALJ
or attorney adjudicator is unable to
obtain an official copy of the dismissal
determination, or because the QIC does
not furnish the case file for an appealed
dismissal. By restricting the bases for
remand under § 405.1056(a)(1) and (2)
to appeals of reconsiderations, we
inadvertently made these reasons
unavailable for remands of requests for
review of a dismissal under
§ 405.1056(d). Therefore, we are
proposing to revise § 405.1056(d) by
redesignating existing paragraph (d) as
paragraph (d)(1), and adding paragraph
(d)(2) to state that an ALJ or attorney
adjudicator may also remand a request
for review of a dismissal in accordance
with the procedures in paragraph (a) of
the section if an official copy of the
notice of dismissal or case file cannot be
PO 00000
Frm 00025
Fmt 4702
Sfmt 4702
obtained from the QIC. We also are
proposing corresponding revisions to
§ 423.2056(d) for Medicare Part D
remands of a request for review of an
IRE’s dismissal of a request for
reconsideration. This proposed change
would necessitate two additional
revisions.
First, §§ 405.1056(g) and 423.2056(g),
which discuss reviews of remands by
the Chief ALJ or designee, state that the
review of remand procedures are not
available for and do not apply to
remands that are issued under
§§ 405.1056(d) or 423.2056(d),
respectively. In the January 17, 2017
final rule, we explained that this
limitation was due to the fact that
remands issued on review of a QIC’s or
IRE’s dismissal of a request for
reconsideration (that is, based on a
determination that the QIC’s or IRE’s
dismissal was in error) are more akin to
a determination than a purely
procedural mechanism (82 FR 5069
through 5070). Because remands issued
under new proposed §§ 405.1056(d)(2)
and 423.2056(d)(2) would be procedural
remands, we are proposing to revise
§§ 405.1056(g) and 423.2056(g) by
replacing the references to paragraph (d)
with a reference to paragraph (d)(1), so
that remands issued under paragraph
(d)(2) would be subject to the review of
remand procedures in paragraph (g).
Second, we are proposing to revise
§§ 405.1034(a)(1) and 423.2034(a)(1) to
provide that the request for information
procedures in these paragraphs apply
not only to requests for official copies of
redeterminations and reconsiderations,
but also to requests for official copies of
dismissals of requests for
redetermination or reconsideration.
8. Notice of a Remand (§ 405.1056)
Section 405.1056(f) provides that
OMHA mails or otherwise transmits
written notice of a remand of a request
for hearing or request for review to all
of the parties who were sent a copy of
the request for hearing or review, at
their last known address, and to CMS or
a contractor that elected to be a
participant in the proceedings or party
to the hearing. However, § 405.1056(f)
does not require that notice be sent to
the appellant, who would not have
received a copy of its own request for
hearing or review. For the same reasons
described in section II.H.6 above with
regard to notices of dismissal, we are
proposing to revise § 405.1056(f) to
require that notice be sent to the
appellant, all parties who were sent a
copy of the request for hearing or review
at their last known address, and to CMS
or a contractor that elected to be a
participant in the proceedings or party
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
to the hearing. No corresponding
revision to part 423, subpart U is needed
because § 423.2056(f) already provides
that notice is sent to the enrollee, who
is the only party to a Part D appeal.
In addition, § 405.1056(f) provides
that the notice of remand states that
there is a right to request that the Chief
ALJ or a designee review the remand.
However, § 405.1056(g) states that the
review of remand procedures are not
available for and do not apply to
remands that are issued under
§ 405.1056(d) (which, as noted in
section II.H.D.7. of this proposed rule,
we are proposing to redesignate as
§ 405.1056(d)(1)). To resolve this
discrepancy and help ensure that parties
receive accurate information regarding
the availability of the review of remand
procedures, we are proposing to revise
§ 405.1056(f) to clarify that the notice of
remand states that there is a right to
request that the Chief ALJ or a designee
review the remand, unless the remand
was issued under § 405.1056(d)(1). We
are also proposing corresponding
changes to § 423.2056(d)(1).
amozie on DSK3GDR082PROD with PROPOSALS1
9. Requested Remands (§ 423.2056)
Section 423.2056(b) provides that if
an ALJ or attorney adjudicator finds that
the IRE issued a reconsideration and no
redetermination was made with respect
to the issue under appeal or the request
for redetermination was dismissed, the
reconsideration will be remanded to the
IRE, or its successor, to readjudicate the
request for reconsideration. However,
when we finalized this provision in the
January 17, 2017 final rule, we did not
account for situations in which no
redetermination was issued because the
Medicare Part D plan sponsor failed to
meet the timeframe for a standard or
expedited redetermination, as provided
in § 423.590. In these situations,
§ 423.2056(b) does not provide a basis
for remand because the failure of the
Part D plan sponsor to provide a
redetermination within the specified
timeframe constitutes an adverse
redetermination decision, and the Part D
plan sponsor is required to forward the
enrollee’s request to the IRE within 24
hours of the expiration of the
adjudication timeframe in accordance
with § 423.590(c) (for requests for
standard redeterminations) and (e) (for
requests for expedited
redeterminations). Accordingly, we are
proposing to revise § 423.2056(b) to
clarify that this reason for remand does
not apply when the request for
redetermination was forwarded to the
IRE in accordance with § 423.590(c) or
(e) without a redetermination having
been conducted.
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
10. Other Technical Changes
In the January 17, 2017 final rule, we
amended regulations throughout 42 CFR
part 405, subparts I and J; part 422,
subpart M; Part 423, subparts M and U;
and part 478, subpart B by replacing
certain references to ALJs, ALJ hearing
offices, and unspecified entities with a
reference to OMHA or an OMHA office.
We explained that these changes were
being made to provide clarity to the
public on the role of OMHA in
administering the ALJ hearing program,
and to clearly identify where requests
and other filings should be directed (82
FR 4992). However, we neglected to
revise two existing references to ALJs in
§ 405.970(c)(2) and one existing
reference to an ALJ in § 405.970(d). To
correct our oversight, we are proposing
to revise § 405.970(c)(2) and (d) by
replacing each instance of the phrase
‘‘to an ALJ’’ with ‘‘to OMHA’’ to clarify
that appeals are escalated to OMHA,
rather than an individual ALJ.
In the January 17, 2017 final rule, in
order to reduce confusion with MACs,
we revised references to the Medicare
Appeals Council throughout part 405,
subpart I; part 422, subpart M; and part
423, subparts M and U by replacing
‘‘MAC’’ with ‘‘Council’’ (82 FR 4993).
However, we neglected to change one
reference to ‘‘MAC’’ in
§ 423.1990(d)(2)(ii). Accordingly, we are
proposing to revise § 423.1990(d)(2)(ii)
by replacing ‘‘MAC’’ with ‘‘Council.’’
In § 423.2010(d)(1), we stated that
CMS, IRE, and/or Part D plan sponsor
participation in an appeal may include
filing position papers and/or providing
testimony to clarify factual or policy
issues in a case, but it does not include
calling witnesses or cross-examining the
witnesses of an enrollee to the hearing.
This provision is similar to
§ 405.1010(c)(1), which describes the
scope of CMS and CMS contractor
participation in Medicare Part A and
Part B appeals and provides, in part,
that such participation does not include
calling witnesses or cross-examining the
witnesses of a party to the hearing.
When finalizing § 423.2010(d)(1) in the
January 17, 2017 final rule, which we
based on § 405.1010(c)(1), we
inadvertently retained the phrase ‘‘to
the hearing’’ after ‘‘enrollee’’. We
believe this phrase is unnecessary in
this context and reads awkwardly, and
are proposing to revise § 423.2010(d)(1)
to remove it.
Prior to the January 17, 2017 final
rule, § 423.2016(b)(1) provided that an
ALJ may consider the standard for
granting an expedited hearing met if a
lower-level adjudicator has granted a
request for an expedited hearing. We
PO 00000
Frm 00026
Fmt 4702
Sfmt 4702
49523
revised this paragraph in the January 17,
2017 final rule to account for the
possibility that a request for an
expedited appeal could be granted by an
attorney adjudicator. However, we
neglected to correct the existing
reference to a lower-level adjudicator
having granted a request for an
expedited hearing. Because lower-level
adjudicators do not conduct hearings,
we are proposing to revise
§ 423.2016(b)(1) by replacing ‘‘hearing’’
with ‘‘decision’’.
Section 423.2032(c) describes the
circumstances in which a coverage
determination on a drug that was not
specified in a request for hearing may be
added ‘‘to pending appeal.’’ We
inadvertently omitted the word ‘‘a’’ and
are proposing to revise § 423.2032(c) by
removing the phrase ‘‘to pending
appeal’’ and adding ‘‘to a pending
appeal’’ in its place.
Prior to the January 17, 2017 final
rule, § 423.2036(g) stated, in part, that
an ALJ may ask the witnesses at a
hearing any questions relevant to the
issues ‘‘and allow the enrollee or his or
her appointed representative, as defined
at § 423.560.’’ In the final rule, we
redesignated this paragraph as
paragraph (d), but neglected to correct
the missing language at the end of the
sentence. For consistency with
§ 405.1036(d), we are proposing to
revise § 423.2036(d) by adding ‘‘, to do
so’’ at the end of the paragraph, before
the period.
Section 423.2036(e) discusses what
evidence is admissible at the hearing,
and states that an ALJ may not consider
evidence on any change in condition of
a Part D enrollee after a coverage
determination, and further provides that
if an enrollee wishes for such evidence
to be considered, the ALJ must remand
the case to the Part D IRE as set forth
in § 423.2034(b)(2). Prior to the January
17, 2017 final rule, § 423.2034(b)(2)
stated that an ALJ will remand a case to
the appropriate Part D IRE if the ALJ
determines that the enrollee wishes
evidence on his or her change in
condition after the coverage
determination to be considered in the
appeal. In the final rule, we moved this
provision to § 423.2056(e), but neglected
to update the cross-reference to it in
§ 423.2036(e). Accordingly, we are
proposing to revise § 423.2036(e) to
replace the reference to
‘‘§ 423.2034(b)(2)’’ with the reference
‘‘§ 423.2056(e)’’.
In §§ 405.952(b)(4)(i), 405.972(b)(4)(i),
405.1052(a)(4)(i) and (b)(3)(i), and
405.1114(c)(1), when discussing
determinations as to whether a
beneficiary’s surviving spouse or estate
has a remaining financial interest in an
E:\FR\FM\02OCP1.SGM
02OCP1
49524
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
appeal, we refer to limitation on liability
under section 1879 of the Act as
‘‘limitation of liability.’’ To increase
consistency with the language used in
the statute and help reduce confusion as
to which standard is being applied, we
are proposing to replace the phrase
‘‘limitation of liability’’ with ‘‘limitation
on liability’’ in each of these sections.
We have identified one provision in
part 405, subpart I, and two provisions
in part 423, subpart U, where we used
incorrect terminal punctuation at the
end of a paragraph that is part of a list.
To correct our errors, we are proposing
to revise §§ 405.1046(a)(2)(ii),
423.2002(b)(1), and 423.2010(b)(3)(ii) by
replacing the period at the end of each
paragraph with a semicolon.
Lastly, we are proposing to revise the
authority citations for parts 405 and 423
to meet current Office of the Federal
Register regulatory drafting guidance.
The guidance requires that we use only
the United States Code (U.S.C.) citations
for statutory citation unless the citation
does not exist.
amozie on DSK3GDR082PROD with PROPOSALS1
III. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements. In
addition, appeals are considered to be
an information collection requirement
that is associated with an administrative
action pertaining to specific individuals
or entities (5 CFR 1320.4(a)(2) and (c)).
As a result, the burden for preparing
and filing an appeal is exempt from the
requirements and collection burden
estimates of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the PRA.
IV. Regulatory Impact Statement
We have examined the impact of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), Executive
Order 13563 on Improving Regulation
and Regulatory Review (January 18,
2011), the Regulatory Flexibility Act
(RFA) (September 19, 1980, Pub. L. 96–
354), section 1102(b) of the Act, section
202 of the Unfunded Mandates Reform
Act of 1995 (March 22, 1995; Pub. L.
104–4), Executive Order 13132 on
Federalism (August 4, 1999), the
Congressional Review Act (5 U.S.C.
804(2)), and Executive Order 13771 on
Reducing Regulation and Controlling
Regulatory Costs (January 30, 2017).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). A RIA must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This rule does not reach
the economic threshold and thus is not
considered a major rule.
The RFA requires agencies to analyze
options for regulatory relief of small
entities. For purposes of the RFA, small
entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
nonprofit status or by having revenues
of less than $7.5 million to $38.5
million in any 1 year. Individuals and
states are not included in the definition
of a small entity. We are not preparing
an analysis for the RFA because we have
determined, and the Secretary certifies,
that this proposed rule would not have
a significant economic impact on a
substantial number of small entities.
In addition, section 1102(b) of the Act
requires us to prepare an RIA if a rule
may have a significant impact on the
operations of a substantial number of
small rural hospitals. This analysis must
conform to the provisions of section 603
of the RFA. For purposes of section
1102(b) of the Act, we define a small
rural hospital as a hospital that is
located outside of a Metropolitan
Statistical Area for Medicare payment
regulations and has fewer than 100
beds. We are not preparing an analysis
for section 1102(b) of the Act because
we have determined, and the Secretary
certifies, that this proposed rule would
not have a significant impact on the
operations of a substantial number of
small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates require spending
in any 1 year of $100 million in 1995
dollars, updated annually for inflation.
In 2018, that threshold is approximately
$150 million. This rule would have no
consequential effect on state, local, or
tribal governments or on the private
sector.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on state and local
governments, preempts state law, or
otherwise has Federalism implications.
PO 00000
Frm 00027
Fmt 4702
Sfmt 4702
Since this regulation does not impose
any costs on state or local governments,
the requirements of Executive Order
13132 are not applicable.
Executive Order 13771, titled
Reducing Regulation and Controlling
Regulatory Costs, was issued on January
30, 2017 and requires that the costs
associated with significant new
regulations ‘‘shall, to the extent
permitted by law, be offset by the
elimination of existing costs associated
with at least two prior regulations.’’
OMB’s interim guidance, issued on
April 5, 2017, https://
www.whitehouse.gov/sites/
whitehouse.gov/files/omb/memoranda/
2017/M-17-21-OMB.pdf, explains that
‘‘E.O. 13771 deregulatory actions are not
limited to those defined as significant
under E.O. 12866 or OMB’s Final
Bulletin on Good Guidance Practices.’’
This proposed rule, if finalized, is
considered a E.O. 13771 deregulatory
action. Consistent with Executive Order
13771 requirements, when discounted
from 2016 to infinity at 7 percent, this
proposed rule would annually save
$9,497,685.00 a year.
Our proposal to remove the
requirement that appellants sign appeal
requests would result in a slight
reduction of burden to appellants by
allowing them to spend less time
developing their appeal request and
appealing dismissals of appeal requests
for lack of a signature to the next level
of review. Using the data from the
number of appeal requests received, we
estimate that approximately 4,465,000
appeal requests per year require a
signature. We estimate that it takes 1
minute to sign the appeal request.
Therefore, the reduction in
administrative time spent would be
4,465,000 × .016 hour = 71,440.00
hours.
We used an adjusted hourly wage of
$34.66 based on the Bureau of Labor
Statistics May 2016 website for
occupation code 43–9199, ‘‘All other
office and administrative support
workers,’’ which gives a mean hourly
salary of $17.33, which when multiplied
by a factor of two to include overhead,
and fringe benefits, results in $34.66 an
hour. The consequent cost savings
would be 71,440.00 × $34.66 =
$2,476,110.40 for time spent signing the
appeal requests.
Based on a sampling of the number of
appeal requests that are dismissed for
not containing a signature, we estimated
that 284,486 appeal requests are
dismissed per year for not containing a
signature on them, and 5 minutes to
request that the adjudicator vacate the
dismissal or appeal the dismissal. For
appellants, the reduction in
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
administrative time spent would be
284,486 × .0083 hours = 23,612 hours
with a consequent savings of 23,612
hours × $34.66 per hour = $818,404.00.
The total amount saved for appellants
would be $3,294,514.40, which consists
of $2,476,110.40 for time spent signing
the appeal requests added to
$818,404.00 for time saved appealing
the dismissed appeal requests.
When the cost of contractors
dismissing appeal requests for the lack
of signature is factored in, the cost
savings becomes $11,757,600. This cost
is calculated by multiplying the number
of appeal requests dismissed at the MAC
and QIC levels multiplied by the cost
that we pay the contractors to adjudicate
a dismissal. The average cost for a MAC
to dismiss an appeal request would be
$25 × 200,000 appeals dismissed for a
lack of signature per year, which
equates to $5,000,000. The average cost
for a QIC to dismiss an appeal request
would be $80 × 84,470 appeal requests
dismissed for a lack of signature per
year, which equates to a savings of
$6,757,600. When these two costs are
added together the cost savings becomes
$11,757,600.
In accordance with the provisions of
Executive Order 12866, this proposed
rule was reviewed by the Office of
Management and Budget.
V. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
List of Subjects
42 CFR Part 423
amozie on DSK3GDR082PROD with PROPOSALS1
Authority: 42 U.S.C. 263a, 405(a), 1302,
1320b–12, 1395x, 1395y(a), 1395ff, 1395hh,
1395kk, 1395rr, and 1395ww(k).
§ 405.910
[Amended]
2. Section 405.910 is amended—
a. In paragraph (c)(5), by removing the
phrase ‘‘health insurance claim’’; and
■ b. In paragraph (e)(4), by removing the
reference ‘‘§ 405.906(a)(1)(iv)’’ and
adding the reference ‘‘§ 405.906(a)(4)’’
in its place.
■
■
§ 405.926
[Amended]
3. Section 405.926 is amended in
paragraph (f) by removing the reference
‘‘§§ 483.5(n) and 483.15’’ and adding the
reference ‘‘§ 483.5 definition of ‘transfer
and discharge’ and § 483.15’’ in its
place.
■
§ 405.944
[Amended]
4. Section 405.944 is amended—
a. In paragraph (b)(2) by removing the
phrase ‘‘health insurance claim’’; and
■ b. In paragraph (b)(4) by removing the
phrase ‘‘and signature’’.
■
■
§ 405.952
[Amended]
5. Section 405.952 is amended—
a. In paragraph (b)(4)(i) by removing
the phrase ‘‘limitation of liability’’ and
adding the phrase ‘‘limitation on
liability’’ in its place; and
■ b. In paragraph (d) by removing the
phrase ‘‘6 months’’ and adding the
phrase ‘‘180 calendar days’’ in its place.
■
■
§ 405.964
[Amended]
6. Section 405.964 is amended—
a. In paragraph (b)(2) by removing the
phrase ‘‘health insurance claim’’; and
■ b. In paragraph (b)(4) by removing the
phrase ‘‘and signature’’.
■
■
[Amended]
7. Section 405.970 is amended in
paragraphs (c)(2) and (d) by removing
the phrase ‘‘to an ALJ’’ each time it
appears and adding the phrase ‘‘to
OMHA’’ in its place.
■
Administrative practice and
procedure, Diseases, Health facilities,
Health professions, Medical devices,
Medicare, Reporting and recordkeeping,
Rural areas, X-rays.
Administrative practice and
procedures, Emergency medical
services, Health facilities, Health
maintenance organizations (HMO),
Medicare, Penalties, Privacy, Reporting
and recordkeeping requirements.
For reasons stated in the preamble,
CMS proposes to amend 42 CFR parts
405 and 423 as follows:
16:46 Oct 01, 2018
1. The authority citation for part 405
is revised to read as follows:
■
§ 405.970
42 CFR Part 405
VerDate Sep<11>2014
PART 405—FEDERAL HEALTH
INSURANCE FOR THE AGED AND
DISABLED
Jkt 247001
§ 405.972
[Amended]
8. Section 405.972 is amended—
a. In paragraph (b)(4)(i) by removing
the phrase ‘‘limitation of liability’’ and
adding the phrase ‘‘limitation on
liability’’ in its place; and
■ b. In paragraph (d) by removing the
phrase ‘‘6 months’’ and adding the
phrase ‘‘180 calendar days’’ in its place.
■ 9. Section 405.1006 is amended by
revising paragraph (d)(4) to read as
follows:
■
■
PO 00000
Frm 00028
Fmt 4702
Sfmt 4702
49525
§ 405.1006 Amount in controversy
required for an ALJ hearing and judicial
review.
*
*
*
*
*
(d) * * *
(4) Overpayments. Notwithstanding
paragraph (d)(1) of this section, when an
appeal involves an identified
overpayment, the amount in controversy
is the amount of the overpayment
specified in the demand letter, or the
amount of the revised overpayment if
the amount originally demanded
changes as a result of a subsequent
determination or appeal, for the items or
services in the disputed claim. When an
appeal involves an estimated
overpayment amount determined
through the use of statistical sampling
and extrapolation, the amount in
controversy is the total amount of the
estimated overpayment determined
through extrapolation, as specified in
the demand letter, or as subsequently
revised.
*
*
*
*
*
■ 10. Section 405.1010 is amended by
revising paragraphs (b)(1), (b)(3)(ii),
(c)(3)(i), and (c)(3)(ii)(A) to read as
follows:
§ 405.1010 When CMS or its contractors
may participate in the proceedings on a
request for an ALJ hearing.
*
*
*
*
*
(b) * * *
(1) No notice of hearing. If CMS or a
contractor elects to participate before
receipt of a notice of hearing, or when
a notice of hearing is not required, it
must send written notice of its intent to
participate to—
(i) The assigned ALJ or attorney
adjudicator, or a designee of the Chief
ALJ if the request for hearing is not yet
assigned to an ALJ or attorney
adjudicator; and
(ii) The parties who were sent a copy
of the notice of reconsideration or, for
escalated requests for reconsideration,
any party that filed a request for
reconsideration or was found liable for
the services at issue subsequent to the
initial determination.
*
*
*
*
*
(3) * * *
(ii) If a hearing is scheduled, no later
than 10 calendar days after receipt of
the notice of hearing by the QIC or
another contractor designated by CMS
to receive the notice of hearing.
(c) * * *
(3) * * *
(i) Unless the ALJ or attorney
adjudicator grants additional time to
submit the position paper or written
testimony, a position paper or written
testimony must be submitted within 14
calendar days of an election to
E:\FR\FM\02OCP1.SGM
02OCP1
49526
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
participate if no hearing has been
scheduled, or no later than 5 calendar
days prior to the hearing if a hearing is
scheduled.
(ii) * * *
(A) The parties that are required to be
sent a copy of the notice of intent to
participate in accordance with
paragraph (b)(1) of this section, if the
position paper or written testimony is
being submitted before receipt of a
notice of hearing for the appeal; or
*
*
*
*
*
§ 405.1012
[Amended]
11. Section 405.1012 is amended—
a. In paragraph (a)(1) by removing the
phrase ‘‘after the QIC receives the notice
of hearing’’ and adding the phrase ‘‘after
receipt of the notice of hearing by the
QIC or another contractor designated by
CMS to receive the notice of hearing’’ in
its place;
■ b. In paragraph (b) by removing the
phrase ‘‘identified in the notice of
hearing’’ and adding the phrase ‘‘who
were sent a copy of the notice of
hearing’’ in its place; and
■ c. In paragraph (e)(1) by removing the
phrase ‘‘ALJ or attorney adjudicator’’
and adding the term ‘‘ALJ’’ in its place.
■
■
§ 405.1014
[Amended]
12. Section 405.1014 is amended—
a. In paragraph (a)(1)(i) by removing
the phrase ‘‘health insurance claim’’;
and
■ b. In paragraph (e)(2) by removing the
phrase ‘‘with the request for hearing or
request for review of a QIC dismissal’’
and adding the phrase ‘‘with the request
for hearing or request for review of a
QIC dismissal, or upon notice that the
request may be dismissed because it was
not timely filed,’’ in its place.
■ 13. Section 405.1020 is amended by
revising paragraph (c)(1), adding
paragraph (e)(5), and revising paragraph
(i)(5) to read as follows:
■
■
§ 405.1020 Time and place for a hearing
before an ALJ.
amozie on DSK3GDR082PROD with PROPOSALS1
*
16:46 Oct 01, 2018
Jkt 247001
§ 405.1034
the QIC.
Requesting information from
(a) * * *
(1) Official copies of redeterminations
and reconsiderations that were
conducted on the appealed claims, and
official copies of dismissals of a request
for redetermination or reconsideration,
can be provided only by CMS or its
contractors. Prior to issuing a request for
information to the QIC, OMHA will
confirm whether an electronic copy of
the redetermination, reconsideration, or
dismissal is available in the official
system of record, and if so will accept
the electronic copy as an official copy.
*
*
*
*
*
§ 405.1046
[Amended]
15. Section 405.1046 is amended in
paragraph (a)(2)(ii) by removing the
period at the end of the paragraph and
adding a semicolon in its place.
■ 16. Section 405.1052 is amended by
revising paragraphs (a)(3), (a)(4)(i), (a)(5)
and (6), (b)(3)(i), (d), and (e) to read as
follows:
■
*
*
*
*
(c) * * *
(1) A notice of hearing is sent to all
parties that filed an appeal or
participated in the reconsideration; any
party who was found liable for the
services at issue subsequent to the
initial determination or may be found
liable based on a review of the record;
the QIC that issued the reconsideration
or from which the request for
reconsideration was escalated, or
another contractor designated to receive
the notice of hearing by CMS; and CMS
or a contractor that elected to participate
in the proceedings in accordance with
§ 405.1010(b) or that the ALJ believes
VerDate Sep<11>2014
would be beneficial to the hearing,
advising them of the proposed time and
place of the hearing.
*
*
*
*
*
(e) * * *
(5) If the party’s objection to the place
of the hearing includes a request for an
in-person or VTC hearing, the objection
and request are considered in paragraph
(i) of this section.
*
*
*
*
*
(i) * * *
(5) The ALJ may grant the request,
with the concurrence of the Chief ALJ
or designee if the request was for an inperson hearing, upon a finding of good
cause and will reschedule the hearing
for a time and place when the party may
appear in person or by VTC before the
ALJ. Good cause is not required for a
request for VTC hearing made by an
unrepresented beneficiary who filed the
request for hearing and objects to an
ALJ’s offer to conduct a hearing by
telephone.
*
*
*
*
*
■ 14. Section 405.1034 is amended by
revising paragraph (a)(1) to read as
follows:
§ 405.1052 Dismissal of a request for a
hearing before an ALJ or request for review
of a QIC dismissal.
(a) * * *
(3) The party did not request a hearing
within the stated time period and the
ALJ has not found good cause for
extending the deadline, as provided in
§ 405.1014(e).
(4) * * *
PO 00000
Frm 00029
Fmt 4702
Sfmt 4702
(i) The request for hearing was filed
by the beneficiary or the beneficiary’s
representative, and the beneficiary’s
surviving spouse or estate has no
remaining financial interest in the case.
In deciding this issue, the ALJ considers
if the surviving spouse or estate remains
liable for the services that were denied
or a Medicare contractor held the
beneficiary liable for subsequent similar
services under the limitation on liability
provisions based on the denial of the
services at issue.
*
*
*
*
*
(5) The ALJ dismisses a hearing
request entirely or refuses to consider
any one or more of the issues because
a QIC, an ALJ or attorney adjudicator, or
the Council has made a previous
determination or decision under this
subpart about the appellant’s rights on
the same facts and on the same issue(s)
or claim(s), and this previous
determination or decision has become
binding by either administrative or
judicial action.
(6) The appellant abandons the
request for hearing. An ALJ may
conclude that an appellant has
abandoned a request for hearing when
OMHA attempts to schedule a hearing
and is unable to contact the appellant
after making reasonable efforts to do so.
*
*
*
*
*
(b) * * *
(3) * * *
(i) The request for review was filed by
the beneficiary or the beneficiary’s
representative, and the beneficiary’s
surviving spouse or estate has no
remaining financial interest in the case.
In deciding this issue, the ALJ or
attorney adjudicator considers if the
surviving spouse or estate remains liable
for the services that were denied or a
Medicare contractor held the beneficiary
liable for subsequent similar services
under the limitation on liability
provisions based on the denial of the
services at issue.
*
*
*
*
*
(d) Notice of dismissal. OMHA mails
or otherwise transmits a written notice
of the dismissal of the hearing or review
request to the appellant, all parties who
were sent a copy of the request for
hearing or review at their last known
address, and to CMS or a CMS
contractor that is a party to the
proceedings on a request for hearing.
The notice states that there is a right to
request that the ALJ or attorney
adjudicator vacate the dismissal action.
The appeal will proceed with respect to
any other parties who filed a valid
request for hearing or review regarding
the same claim or disputed matter.
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
(e) Vacating a dismissal. If good and
sufficient cause is established, the ALJ
or attorney adjudicator may vacate his
or her dismissal of a request for hearing
or review within 180 calendar days of
the date of the notice of dismissal.
■ 17. Section 405.1056 is amended by
revising paragraphs (d), (f), and (g) to
read as follows:
(e) Referral timeframe. For purposes
of this section, the date of receipt of the
ALJ’s or attorney adjudicator’s decision
or dismissal is presumed to be 5
calendar days after the date of the notice
of the decision or dismissal, unless
there is evidence to the contrary.
§ 423.1974
§ 405.1112
§ 423.1984
[Amended]
§ 405.1056 Remands of requests for
hearing and requests for review.
amozie on DSK3GDR082PROD with PROPOSALS1
*
*
*
*
*
(d) Remanding a QIC’s dismissal of a
request for reconsideration. (1)
Consistent with § 405.1004(b), an ALJ or
attorney adjudicator will remand a case
to the appropriate QIC if the ALJ or
attorney adjudicator determines that a
QIC’s dismissal of a request for
reconsideration was in error.
(2) If an official copy of the notice of
dismissal or case file cannot be obtained
from the QIC, an ALJ or attorney
adjudicator may also remand a request
for review of a dismissal in accordance
with the procedures in paragraph (a) of
this section.
*
*
*
*
*
(f) Notice of remand. OMHA mails or
otherwise transmits a written notice of
the remand of the request for hearing or
request for review to the appellant, all
of the parties who were sent a copy of
the request at their last known address,
and CMS or a contractor that elected to
be a participant in the proceedings or
party to the hearing. The notice states
that there is a right to request that the
Chief ALJ or a designee review the
remand, unless the remand was issued
under paragraph (d)(1) of this section.
(g) Review of remand. Upon a request
by a party or CMS or one of its
contractors filed within 30 calendar
days of receiving a notice of remand, the
Chief ALJ or designee will review the
remand, and if the remand is not
authorized by this section, vacate the
remand order. The determination on a
request to review a remand order is
binding and not subject to further
review. The review of remand
procedures provided for in this
paragraph are not available for and do
not apply to remands that are issued
under paragraph (d)(1) of this section.
■ 18. Section 405.1110 is amended—
■ a. In paragraph (a) by removing the
phrase ‘‘after the date’’ and adding the
phrase ‘‘of receipt’’ in its place; and
■ b. In paragraph (b)(2) by removing the
term ‘‘issued’’ and adding the term
‘‘received’’ in its place.
■ c. Adding paragraph (e).
The addition reads as follows:
§ 405.1110
motion.
Council review on its own
*
*
*
PART 423—VOLUNTARY MEDICARE
PRESCRIPTION DRUG BENEFIT
21. The authority citation for part 423
is revised to read as follows:
■
Authority: 42 U.S.C. 1302, 1306, 1395w101 through 1395w-152, and 1395hh.
§ 423.562
[Amended]
22. Section 423.562 is amended—
a. In paragraph (b)(4)(iv) by removing
the reference ‘‘§ 423.1970’’ and adding
the reference ‘‘§ 423.2006’’ in its place;
■ b. In paragraph (b)(4)(v) by removing
the reference ‘‘§ 423.1974’’ and adding
the reference ‘‘§ 423.2100’’ in its place;
and
■ c. In paragraph (b)(4)(vi) by removing
the reference ‘‘§ 423.1976’’ and adding
the cross-reference ‘‘§ 423.2006’’ in its
place.
■
■
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
[Amended]
31. Section 423.1990 is amended—
a. In paragraph (b)(3) by removing the
phrase ‘‘established annually by the
Secretary’’ and adding the phrase
‘‘specified in § 423.2006’’ in its place;
and
■ b. In paragraph (d)(2)(ii) by removing
the term ‘‘MAC’’ and adding the term
‘‘Council’’ in its place.
■ 32. Section 423.2002 is amended—
■ a. By revising paragraphs (a)
introductory text and (a)(2);
■ b. In paragraph (b)(1) by removing the
period at the end of the paragraph and
adding a semicolon in its place; and
■ c. By revising paragraph (b)(3).
The revisions read as follows.
■
■
§ 423.2002
Right to an ALJ hearing.
23. Section 423.576 is amended by
removing the reference ‘‘§ 423.1970
through § 423.1976’’ and adding the
reference ‘‘§ 423.2000 through
§ 423.2140’’ in its place.
(a) An enrollee who is dissatisfied
with the IRE reconsideration
determination has a right to a hearing
before an ALJ if—
*
*
*
*
*
(2) An enrollee meets the amount in
controversy requirements of § 423.2006.
*
*
*
*
*
(b) * * *
*
*
*
*
*
(3) An enrollee meets the amount in
controversy requirements of § 423.2006.
*
*
*
*
*
§ 423.602
§ 423.2004
§ 423.576
[Amended]
■
[Amended]
24. Section 423.602 is amended in
paragraph (b)(2)by removing the
reference ‘‘§ 423.1970’’ and adding the
cross ‘‘§ 423.2006’’ in its place.
■
§ 423.604
[Amended]
25. Section 423.604 is amended by
removing the reference ‘‘§ 423.1972’’
and adding the reference ‘‘§ 423.2014’’
in its place.
■
§ 423.1970
[Removed and reserved]
26. Section 423.1970 is removed and
reserved.
■
§ 423.1972
[Removed and reserved]
27. Section 423.1972 is removed and
reserved.
*
[Amended]
30. Section 423.1984 is amended—
a. In paragraph (c) by removing the
reference ‘‘§ 423.1970 through
§ 423.1972 and’’; and
■ b. In paragraph (d) by removing the
phrase ‘‘§ 423.1974 and’’.
§ 423.1990
[Amended]
20. Section 405.1114 is amended in
paragraph (c)(1) by removing the phrase
‘‘limitation of liability’’ and adding the
phrase ‘‘limitation on liability’’ in its
place.
[Removed and reserved]
29. Section 423.1976 is removed and
reserved.
■
§ 405.1114
■
*
§ 423.1976
■
■
■
[Removed and reserved]
28. Section 423.1974 is removed and
reserved.
■
19. Section 405.1112 is amended in
paragraph (a)—
■ a. By removing the phrase ‘‘health
insurance claim’’; and
■ b. By removing the phrase ‘‘and
signature’’.
■
49527
PO 00000
Frm 00030
Fmt 4702
Sfmt 4702
[Amended]
33. Section 423.2004 is amended in
paragraph (a)(2) by removing the
reference ‘‘§ 423.1970’’ and adding the
reference ‘‘§ 423.2006’’ in its place.
■ 34. Section 423.2006 is added to read
as follows:
■
§ 423.2006 Amount in controversy
required for an ALJ hearing and judicial
review.
(a) ALJ review. To be entitled to a
hearing before an ALJ, an enrollee must
meet the amount in controversy
requirements of this section.
(1) For ALJ hearing requests, the
required amount remaining in
controversy must be $100, increased by
the percentage increase in the medical
E:\FR\FM\02OCP1.SGM
02OCP1
amozie on DSK3GDR082PROD with PROPOSALS1
49528
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
care component of the Consumer Price
Index for All Urban Consumers (U.S.
city average) as measured from July
2003 to the July preceding the current
year involved.
(2) If the figure in paragraph (a)(1) of
this section is not a multiple of $10, it
is rounded to the nearest multiple of
$10. The Secretary will publish changes
to the amount in controversy
requirement in the Federal Register
when necessary.
(b) Judicial review. To be entitled to
judicial review, the enrollee must meet
the amount in controversy requirements
of this subpart at the time it requests
judicial review. For review requests, the
required amount remaining in
controversy must be $1,000 or more,
adjusted as specified in paragraphs
(a)(1) and (2) of this section.
(c) Calculating the amount remaining
in controversy. (1) If the basis for the
appeal is the refusal by the Part D plan
sponsor to provide drug benefits, the
projected value of those benefits is used
to compute the amount remaining in
controversy. The projected value of a
Part D drug or drugs must include any
costs the enrollee could incur based on
the number of refills prescribed for the
drug(s) in dispute during the plan year.
(2) If the basis for the appeal is an atrisk determination made under a drug
management program in accordance
with § 423.153(f), the projected value of
the drugs subject to the drug
management program is used to
compute the amount remaining in
controversy. The projected value of the
drugs subject to the drug management
program shall include the value of any
refills prescribed for the drug(s) in
dispute during the plan year.
(d) Aggregating appeals to meet the
amount in controversy. (1) Enrollee.
Two or more appeals may be aggregated
by an enrollee to meet the amount in
controversy for an ALJ hearing if—
(i) The appeals have previously been
reconsidered by an IRE;
(ii) The enrollee requests aggregation
at the same time the requests for hearing
are filed, and the request for aggregation
and requests for hearing are filed within
60 calendar days after receipt of the
notice of reconsideration for each of the
reconsiderations being appealed, unless
the deadline to file one or more of the
requests for hearing has been extended
in accordance with § 423.2014(d); and
(iii) The appeals the enrollee seeks to
aggregate involve the delivery of
prescription drugs to a single enrollee,
as determined by an ALJ or attorney
adjudicator. Only an ALJ may determine
the appeals the enrollee seeks to
aggregate do not involve the delivery of
prescription drugs to a single enrollee.
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
(2) Multiple enrollees. Two or more
appeals may be aggregated by multiple
enrollees to meet the amount in
controversy for an ALJ hearing if—
(i) The appeals have previously been
reconsidered by an IRE;
(ii) The enrollees request aggregation
at the same time the requests for hearing
are filed, and the request for aggregation
and requests for hearing are filed within
60 calendar days after receipt of the
notice of reconsideration for each of the
reconsiderations being appealed, unless
the deadline to file one or more of the
requests for hearing has been extended
in accordance with § 423.2014(d); and
(iii) The appeals the enrollees seek to
aggregate involve the same prescription
drugs, as determined by an ALJ or
attorney adjudicator. Only an ALJ may
determine the appeals the enrollees seek
to aggregate do not involve the same
prescription drugs.
§ 423.2010
[Amended]
35. Section 423.2010 is amended—
a. In paragraph (b)(3)(ii) by removing
the period at the end of the paragraph
and adding a semicolon in its place; and
■ b. In paragraph (d)(1) by removing the
phrase ‘‘to the hearing’’.
■ 36. Section 423.2014 is amended by
revising paragraphs (a)(1)(i), (d)
introductory text, and (e)(1) and (3) to
read as follows:
■
■
§ 423.2014 Request for an ALJ hearing or
a review of an IRE dismissal.
(a) * * *
(1) * * *
(i) The name, address, telephone
number, and Medicare number of the
enrollee.
*
*
*
*
*
(d) When and where to file. The
request for an ALJ hearing after an IRE
reconsideration or request for review of
an IRE dismissal must be filed:
*
*
*
*
*
(e) * * *
(1) If the request for hearing or review
is not filed within 60 calendar days of
receipt of the written IRE’s
reconsideration or dismissal, an enrollee
may request an extension for good
cause.
*
*
*
*
*
(3) The request must be filed with the
office specified in the notice of
reconsideration or dismissal, must give
the reasons why the request for a
hearing or review was not filed within
the stated time period, and must be filed
with the request for hearing or request
for review of an IRE dismissal, or upon
notice that the request may be dismissed
because it was not timely filed.
*
*
*
*
*
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
§ 423.2016
[Amended]
37. Section 423.2016 is amended in
paragraph (b)(1) by removing the term
‘‘hearing’’ and adding the term
‘‘decision’’ in its place.
■ 38. Section 423.2020 is amended by
revising paragraph (a), adding paragraph
(e)(5), and revising paragraph (i)(5) to
read as follows:
■
§ 423.2020 Time and place for a hearing
before an ALJ.
(a) General. The ALJ sets the time and
place for the hearing, and may change
the time and place, if necessary.
*
*
*
*
*
(e) * * *
(5) If the enrollee’s objection to the
place of the hearing includes a request
for an in-person or videoteleconferencing hearing, the objection
and request are considered in paragraph
(i) of this section.
*
*
*
*
*
(i) * * *
(5) The ALJ may grant the request,
with the concurrence of the Chief ALJ
or designee if the request was for an inperson hearing, upon a finding of good
cause and will reschedule the hearing
for a time and place when the enrollee
may appear in person or by videoteleconference before the ALJ. Good
cause is not required for a request for
video-teleconferencing hearing made by
an unrepresented enrollee who filed the
request for hearing and objects to an
ALJ’s offer to conduct a hearing by
telephone.
*
*
*
*
*
§ 423.2032
[Amended]
39. Section 423.2032 is amended in
paragraph (c) by removing the phrase
‘‘to pending appeal’’ and adding the
phrase ‘‘to a pending appeal’’ in its
place.
■ 40. Section 423.2034 is amended by
revising paragraph (a)(1) to read as
follows:
■
§ 423.2034
the IRE.
Requesting information from
(a) * * *
(1) Official copies of redeterminations
and reconsiderations that were
conducted on the appealed issues, and
official copies of dismissals of a request
for redetermination or reconsideration,
can be provided only by CMS, the IRE,
and/or the Part D plan sponsor. Prior to
issuing a request for information to the
IRE, OMHA will confirm whether an
electronic copy of the missing
redetermination, reconsideration, or
dismissal is available in the official
system of record, and if so will accept
the electronic copy as an official copy.
*
*
*
*
*
E:\FR\FM\02OCP1.SGM
02OCP1
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Proposed Rules
§ 423.2036
[Amended]
41. Section 423.2036 is amended—
a. In paragraph (d) by removing the
reference ‘‘§ 423.560.’’ and adding the
phrase ‘‘§ 423.560, to do so.’’ in its
place; and
■ b. In paragraph (e) by removing the
reference ‘‘§ 423.2034(b)(2)’’ and adding
the reference ‘‘§ 423.2056(e)’’ in its
place.
■
■
§ 423.2044
[Amended]
42. Section 423.2044 is amended in
paragraph (c) by removing the reference
‘‘§ 423.1970’’ and adding the reference
‘‘§ 423.2006’’ in its place.
■
§ 423.2052
[Amended]
43. Section 423.2052 is amended—
a. In paragraph (a)(3) by removing the
phrase ‘‘or attorney adjudicator’’;
■ b. In paragraph (a)(5) by removing the
phrase ‘‘or attorney adjudicator’’ the
first time it appears;
■ c. In paragraph (a)(6) by removing the
phrase ‘‘or attorney adjudicator’’; and
■ d. In paragraph (e) by removing the
phrase ‘‘6 months’’ and adding the
phrase ‘‘180 calendar days’’ in its place.
■ 44. Section 423.2056 is amended by
revising paragraphs (b), (d), (f), and (g)
to read as follows:
■
■
§ 423.2056 Remands of requests for
hearing and requests for review.
*
*
*
*
(b) No redetermination. If an ALJ or
attorney adjudicator finds that the IRE
issued a reconsideration and no
redetermination was made with respect
to the issue under appeal or the request
for redetermination was dismissed, the
reconsideration will be remanded to the
IRE, or its successor, to readjudicate the
request for reconsideration, unless the
request for redetermination was
forwarded to the IRE in accordance with
§ 423.590(c) or (e) without a
redetermination having been conducted.
*
*
*
*
*
(d) Remanding an IRE’s dismissal of
a request for reconsideration. (1)
Consistent with § 423.2004(b), an ALJ or
attorney adjudicator will remand a case
to the appropriate IRE if the ALJ or
attorney adjudicator determines that an
IRE’s dismissal of a request for
reconsideration was in error.
(2) If an official copy of the notice of
dismissal or case file cannot be obtained
amozie on DSK3GDR082PROD with PROPOSALS1
*
VerDate Sep<11>2014
16:46 Oct 01, 2018
Jkt 247001
from the IRE, an ALJ or attorney
adjudicator may also remand a request
for review of a dismissal in accordance
with the procedures in paragraph (a) of
this section.
*
*
*
*
*
(f) Notice of a remand. OMHA mails
or otherwise transmits a written notice
of the remand of the request for hearing
or request for review to the enrollee at
his or her last known address, and CMS,
the IRE, and/or the Part D plan sponsor
if a request to be a participant was
granted by the ALJ or attorney
adjudicator. The notice states that there
is a right to request that the Chief ALJ
or a designee review the remand, unless
the remand was issued under paragraph
(d)(1) of this section.
(g) Review of remand. Upon a request
by the enrollee or CMS, the IRE, or the
Part D plan sponsor filed within 30
calendar days of receiving a notice of
remand, the Chief ALJ or designee will
review the remand, and if the remand is
not authorized by this section, vacate
the remand order. The determination on
a request to review a remand order is
binding and not subject to further
review. The review of remand
procedures provided for in this
paragraph are not available for and do
not apply to remands that are issued in
paragraph (d)(1) of this section.
■ 45. Section 423.2100 is amended by
revising paragraph (a) to read as follows:
§ 423.2100 Medicare Appeals Council
review: general.
(a) An enrollee who is dissatisfied
with an ALJ’s or attorney adjudicator’s
decision or dismissal may request that
the Council review the ALJ’s or attorney
adjudicator’s decision or dismissal.
*
*
*
*
*
■ 46. Section 423.2110 is amended—
■ a. In paragraph (a) introductory text by
removing the phrase ‘‘after the date’’
and adding the phrase ‘‘of receipt’’ in its
place; and
■ b. In paragraph (b)(2) by removing the
term ‘‘issued’’ and adding the term
‘‘received’’ in its place.
■ c. Adding paragraph (e).
The addition reads as follows:
§ 423.2110
motion.
Council review on its own
*
*
PO 00000
*
49529
(e) Referral timeframe. For purposes
of this section, the date of receipt of the
ALJ’s or attorney adjudicator’s decision
or dismissal is presumed to be 5
calendar days after the date of the notice
of the decision or dismissal, unless
there is evidence to the contrary.
§ 423.2112
[Amended]
47. Section 423.2112 is amended in
paragraph (a)(4)—
■ a. By removing the phrase ‘‘health
insurance claim’’; and
■ b. By removing the phrase ‘‘and
signature’’.
■ 48. Section 423.2136 is amended by
revising paragraphs (a) and (b)(1) to read
as follows.
■
§ 423.2136
Judicial review.
(a) General rule. (1) Review of Council
decision. To the extent authorized by
sections 1876(c)(5)(B) and 1860D–4(h)
of the Act, an enrollee may obtain a
court review of a Council decision if—
(i) It is a final decision of the
Secretary; and
(ii) The amount in controversy meets
the threshold requirements of
§ 423.2006.
(2) Review of ALJ’s or attorney
adjudicator’s decision. To the extent
authorized by sections 1876(c)(5)(B) and
1860D–4(h) of the Act, the enrollee may
request judicial review of an ALJ’s or
attorney adjudicator’s decision if—
(i) The Council denied the enrollee’s
request for review; and
(ii) The amount in controversy meets
the threshold requirements of
§ 423.2006.
(b) * * *
(1) Any civil action described in
paragraph (a) of this section must be
filed in the District Court of the United
States for the judicial district in which
the enrollee resides.
*
*
*
*
*
Dated: July 16, 2018.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
Dated: September 5, 2018.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2018–21223 Filed 9–28–18; 11:15 am]
Frm 00032
*
Fmt 4702
*
Sfmt 9990
BILLING CODE 4120–01–P
E:\FR\FM\02OCP1.SGM
02OCP1
Agencies
[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Proposed Rules]
[Pages 49513-49529]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21223]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 405 and 423
[CMS-4174-P]
RIN 0938-AT27
Medicare Program: Changes to the Medicare Claims and Medicare
Prescription Drug Coverage Determination Appeals Procedures
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: This proposed rule would revise the regulations setting forth
the appeals process that Medicare beneficiaries, providers, and
suppliers must follow in order to appeal adverse determinations
regarding claims for benefits under Medicare Part A and Part B or
determinations for prescription drug coverage under Part D. These
changes would help streamline the appeals process and reduce
administrative burden on providers, suppliers, beneficiaries, and
appeal adjudicators. These revisions, which include technical
corrections, would also help to ensure the regulations are clearly
arranged and written to give stakeholders a better understanding of the
appeals process.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, please refer to file code CMS-4174-P. Because
of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address only: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-4174-P, P.O. Box 8013,
Baltimore, MD 21244-1850.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address only: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-4174-P, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Joella Roland, (410) 786-7638 or
Nishamarie Sherry, (410) 786-1189.
SUPPLEMENTARY INFORMATION: Inspection of Public Comments: All comments
[[Page 49514]]
received before the close of the comment period are available for
viewing by the public, including any personally identifiable or
confidential business information that is included in a comment. We
post all comments received before the close of the comment period on
the following website as soon as possible after they have been
received: https://www.regulations.gov. Follow the search instructions on
that website to view public comments.
I. Background
As specified under sections 1869 and 1860D-4 of the Social Security
Act (the Act) and their implementing regulations, once Medicare makes a
coverage or payment determination under Medicare Parts A, B, or D,
affected parties have the right to appeal the decision through four
levels of administrative review. If a minimum amount in controversy
(AIC) is met, parties can then appeal the decision to federal district
court.
Section 1869 of the Act sets forth the process for appealing Parts
A and B claim determinations. For most Part A and B claims, the initial
determination is made by a Medicare Administrative Contractor (MAC). If
a party is dissatisfied with the initial determination, the party may
request a redetermination by the MAC, which is a review by MAC staff
not involved in the initial determination. If a party is dissatisfied
with the MAC's redetermination, the party may request a Qualified
Independent Contractor (QIC) reconsideration consisting of an
independent review of the administrative record, including the
redetermination. Provided a minimum AIC is met, parties then have the
option to appeal to the Office of Medicare Hearings and Appeals (OMHA)
where they may receive either a hearing or review of the administrative
record by an Administrative Law Judge (ALJ), or a review of the
administrative record by an attorney adjudicator. Parties then have the
option to appeal to the Medicare Appeals Council (the Council) within
the Departmental Appeals Board, where an Administrative Appeals Judge
examines their claim. A party can then appeal the decision to federal
district court if certain requirements are met, including a minimum
AIC.
The appeals process described above for Parts A and B claim
determinations was initially proposed in the November 15, 2002 Federal
Register (67 FR 69312), which was promulgated to implement section 521
of the Medicare, Medicaid, and SCHIP Benefits Improvement and
Protection Act of 2000 (Pub. L. 106-554). This process was implemented
in an interim final rule with comment period published on March 8, 2005
(the 2005 interim final rule with comment period) (70 FR 11420), which
also set forth new provisions to implement the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 (Pub. L. 108-173).
Correcting amendments to the 2005 interim final rule were published on
June 30, 2005 (70 FR 37700) and August 26, 2005 (70 FR 50214), and the
final rule was published on December 9, 2009 (74 FR 65296). Subsequent
revisions to implement section 201 of the Strengthening Medicare and
Repaying Taxpayers Act of 2012 (Pub. L. 112-242) were published on
February 27, 2015 (80 FR 10611). These appeals procedures for Part A
and B claims are set forth in regulations at part 405, subpart I.
Section 1860D-4 of the Act sets forth the appeals process for Part
D coverage determinations. Under Medicare Part D, the Part D plan
sponsor issues a coverage determination. If this coverage determination
is appealed, the Part D plan sponsor reviews the determination, which
is known as a redetermination. If a party is dissatisfied with the
redetermination, the party may request a reconsideration by an
independent review entity. Similar to the appeals process for Parts A
and B claim determinations, provided a minimum AIC is met, parties then
have the option to appeal to OMHA where they may receive either a
hearing or review of the administrative record by an ALJ, or a review
of the administrative record by an attorney adjudicator. If not
satisfied with OMHA's decision, a party then may appeal to the Council.
The Council decision then may be appealed to federal district court if
certain requirements are met, including a minimum AIC. These procedures
are set forth in regulations at part 423, subparts M and U.
On January 17, 2017, we issued a final rule entitled ``Medicare
Program: Changes to the Medicare Claims and Entitlement, Medicare
Advantage Organization Determination, and Medicare Prescription Drug
Coverage Determination Appeals Procedures'' (82 FR 4974) (the January
17, 2017 final rule), which revised the Parts A, B, C, and D appeals
procedures. The goals of this rulemaking were to streamline the appeals
process, increase consistency in decision-making, improve efficiency
for both appellants and adjudicators, and provide particular benefit to
beneficiaries by clarifying processes and adding provisions for
increased assistance when they are unrepresented. On April 16, 2018, we
issued a final rule (83 FR 16440) that made additional changes to
subparts M and U in order to implement section 704 of the Comprehensive
Addiction and Recovery Act of 2016 (Pub. L. 114-198), along with other
changes.
Through our experience implementing the current appeals process,
and through additional research, we have identified several
opportunities to streamline the claims appeals process and reduce
associated burden on providers, beneficiaries, and appeals
adjudicators. We have also identified several technical corrections
that should be made to correct cross-references, inconsistent
definitions, and confusing terminology.
II. Provisions of the Proposed Regulations
A. Removal of Requirement That Appellants Sign Appeal Requests
(Sec. Sec. 405.944, 405.964, 405.1112, and 423.2112)
Existing regulations at part 405, subpart I; and part 423, subparts
M and U, specify the required elements of requests for Medicare Parts A
and B claims appeals and for Medicare Part D coverage determination
appeals, respectively. Generally, when a contractor or plan issues a
Part A or B initial determination or a Part D coverage determination,
it notifies the provider, supplier, and/or beneficiary and offers the
opportunity to appeal. If this determination is appealed, the
contractor or plan reviews the determination, which, in Medicare Parts
A, B and D appeals, is known as a redetermination (see Sec. Sec.
405.940 and 423.580). This can be followed by a review by an
independent contractor consisting of an independent review of the
administrative record, including the redetermination, which is known as
a reconsideration (Sec. Sec. 405.960 and 423.600). If a minimum
amount-in-controversy is met, parties then have the option to appeal to
the OMHA where the administrative record may be reviewed by an attorney
adjudicator or an ALJ or a hearing may be held by an ALJ (Sec. Sec.
405.1000 et seq. and 423.2000 et seq.). Parties then have the option to
appeal to the Council within the Departmental Appeals Board where an
Administrative Appeals Judge reviews their claim (Sec. Sec. 405.1100
et seq. and 423.2100 et seq.).
Appeal requests can be made using different standard forms. These
standard forms include the following: Medicare Redetermination Request
Form (CMS-20027); Medicare Reconsideration Request Form (CMS-20033);
Request for
[[Page 49515]]
Administrative Law Judge Hearing or Review of Dismissal (OMHA-100); and
Request for Review of Administrative Law Judge (ALJ) Medicare Decision/
Dismissal (DAB-101). A written request that is not made on a standard
form is also accepted if it contains certain required elements. For
example, see, Sec. Sec. 405.944(b), 405.964(b), 405.1014(a), 405.1112,
423.2014(a), 423.2112.
As discussed previously, all Medicare Parts A, B, and D appeal
requests must contain the information specified in our regulations. In
addition, for Parts A and B claims appeal requests at the
redetermination, reconsideration, and Council review levels (Sec. Sec.
405.944(b)(4), 405.964(b)(4), and 405.1112(a)), and for Part D coverage
determination appeal requests at the Council level (Sec.
423.2112(a)(4)), the appellants must sign their appeal requests.
However, there is no signature requirement when the appellant requests
OMHA review of Parts A and B claim determinations, or when the
appellant requests a redetermination, reconsideration, or OMHA review
of Part D coverage determinations. In addition, there is no requirement
that appellants sign appeals requests for appeals of Part C
organization determinations.
In order to promote consistency between appeal levels, ensure
transparency in developing our appeal request requirements, help ensure
that we do not impose nonessential requirements on appellants, reduce
the burden on appellants, and improve the appeals process based on our
experience, we are proposing that appellants in Medicare Parts A and B
claim and Part D coverage determination appeals be allowed to submit
appeal requests without a signature. Specifically, we are proposing to
revise Sec. Sec. 405.944(b)(4), 405.964(b)(4), 405.1112(a), and
423.2112(a)(4) to remove the requirement of the appellant's signature
for appeal requests.
As discussed previously, there is no requirement that appellants
sign appeal requests when appealing their cases to OMHA, for the Part C
organization determination appeals process, or at the redetermination
and reconsideration levels of Part D appeals. However, the other
requirements for appeal requests are substantially similar between
levels of appeal and appeals processes, or there is a clear reason for
the differing requirements. For example, the requirements for Part A
and B appeal requests at the redetermination and reconsideration levels
are identical with the exception of the reconsideration requirement
that the name of the contractor be listed on the reconsideration appeal
request (Sec. Sec. 405.944 and 405.964). The rationale for the
requirement that the name of the contractor be included on
reconsideration appeal requests is that without this information, the
independent contractor does not have a method of determining which
contractor made the initial determination and redetermination, and is
unable to get the case file. Since the contractor doing the
redetermination is the same contractor who performed the initial
determination, it is not necessary that this information be included in
the redetermination appeal request.
By contrast, we do not believe there is a compelling reason to
require that a signature be included on redetermination,
reconsideration, and Council-level appeal requests, but not on OMHA
appeal requests. Removing the requirement that appellants sign their
appeal requests, would help promote consistency between appeal request
requirements, thus making the appeals process easier for parties to
understand.
Eliminating the requirement that appellants sign their appeal
requests would reduce the burden of developing the appeal request and
appealing dismissals of appeal requests for lack of a signature to the
next level of review (for example, Sec. Sec. 405.952(b), 405.972(b)).
Allowing adjudicators to review appeal requests without signatures
would allow them to focus their attention on the merits of the appeal,
rather than having to dismiss potentially meritorious appeals for a
lack of a signature.
When we promulgated the requirement for appellants to sign the
appeal requests in regulations, we included a signature on the appeal
request to ensure that the person requesting the appeal was a proper
party to the appeal. Through experience, we have found that, in
practice, little verification of the signature is possible. To
determine if the appeal requestor is a proper party to the appeal, the
adjudicator uses the name of the beneficiary and name of the party
listed on the appeal request, in addition to the information listed in
the case file.
The other appeal request requirements consist of fields that are
necessary for the adjudicators to properly process the appeal request.
As discussed previously, the name of the contractor who made the
redetermination is required for the independent contractor to review
the case file. The Part A and B redetermination appeal request
requirement to include the disputed service and/or item enables the
contractor to determine the merit of the appellant's claim.
Thus, we believe there is no need for a signature on an appeal
request at this time and propose to eliminate that requirement.
However, if, we find in the future that there are other reasons that
would warrant an appellant's signature on an appeal request (for
example, for a good-faith attestation), we would re-examine the
possibility of adding the requirement back in. However, given that our
existing statutory authority limits our ability to enforce certain
attestations, we find the signature requirement unnecessary.
We are inviting public comments on our proposal to revise
Sec. Sec. 405.944(b)(4), 405.964(b)(4), 405.1112(a), and
423.2112(a)(4) of the regulations to remove the requirement that the
appellant sign the appeal request.
B. Change to Timeframe for Vacating Dismissals (Sec. Sec. 405.952,
405.972, 405.1052, and 423.2052)
The regulations at Sec. Sec. 405.952(d), 405.972(d), 405.1012(e),
and 423.2052(e) allow adjudicators to vacate a dismissal of an appeal
request for a Medicare Part A or B claim or Medicare Part D coverage
determination within 6 months of the date of the notice of dismissal.
This allows sufficient time for adjudicators to carefully evaluate
their dismissals while taking into account the principle of
administrative finality.
Through experience, we have concluded that the timeframe for
vacating a dismissal would be better expressed in calendar days, rather
than months, for two reasons. First, all timeframes in the regulations
under part 405, subpart I and part 423 subpart U, associated with the
filing of appeal requests, adjudication periods, reopening of prior
determinations, and other time-limited procedural actions are expressed
in calendar days, not months. For example, see Sec. Sec. 405.942 and
423.2056. Second, applying a timeframe based on days, rather than
months, leads to more consistency in interpretation and actual
timeframes. A timeframe based on months could be subject to varying
interpretations, as the number of days in a consecutive 6-month period
varies from 181 to 184 days. For example, if an ALJ or attorney
adjudicator's dismissal is dated August 31 of one calendar year,
advancing the timeframe 6 months to February could be confusing for
parties and adjudicators because February does not contain 30 or 31
days. Also, given that February has only 28 or 29 days (in a leap
year), any 6-month period that includes February would be shorter than
other 6 month periods, leading to
[[Page 49516]]
some inconsistency in the actual timeframe for vacating a dismissal.
To provide more consistency and predictability for appellants and
adjudicators, and better conformity with other timeframes in the part
405, subpart I and part 423 subpart U, we are proposing to revise the
timeframe for vacating a dismissal from 6 months to 180 days in
Sec. Sec. 405.952(d), 405.972(d), 405.1052(e), and 423.2052(e).
C. Technical Correction to Regulations To Change Health Insurance Claim
Number (HICN) References to Medicare Numbers (Sec. Sec. 405.910,
405.944, 405.964, 405.1014, 405.1112, 423.2014, and 423.2112)
Section 501 of the Medicare Access and CHIP Reauthorization Act of
2015 (MACRA) (Pub. L. 114-10), added section 205(c)(2)(C)(xiii) of the
Act to prohibit Social Security Numbers (or derivatives) from being
displayed on Medicare cards. As a result, CMS is undertaking efforts to
issue new Medicare cards, which contain a randomly generated Medicare
Beneficiary Identifier (MBI), rather than the Social Security Number-
based Health Insurance Claim Number (HICN) that is on the current
Medicare cards. In order to ensure that appellants can easily submit
appointment of representative documentation and appeal requests, we
would accept this documentation with HICNs or MBIs. Consistent with
these efforts, we are proposing to remove references to the Social
Security Number-based HICN on Medicare cards that are included in the
Medicare appeals regulations, and to replace them with references to
Medicare number to clarify that either a HICN or MBI can be included on
appointment of representative documentation and appeal requests.
Accordingly, we are proposing to revise the following provisions of
Medicare regulations to remove the words ``health insurance claim''
from the phrase ``Medicare health insurance claim number'' so that
there is only a reference to ``Medicare number'': Sec. Sec.
405.910(c)(5), 405.944(b)(2), 405.964(b)(2), 405.1014(a)(1)(i),
405.1112(a), 423.2014(a)(1)(i), and 423.2112(a)(4).
D. Removal of Redundant Regulatory Provisions Relating to Medicare
Appeals of Payment and Coverage Determinations and Conforming Changes
(Sec. Sec. 423.562, 423.576, 423.602, 423.604, 423.1970, 423.1972,
423.1974, 423.1976, 423.1984, 423.1990, 423.2002, 423.2004, 423.2006,
423.2014, 423.2020, 423.2044, 423.2100, and 423.2136)
The January 17, 2017 final rule revised certain Medicare procedures
for appeals of payment and coverage determinations for items and
services furnished to Medicare beneficiaries and enrollees. Since the
publication of this final rule, we have identified four regulatory
provisions in part 423, subpart U that are redundant. In order to
reduce potential confusion, we are proposing to remove redundant
provisions at Sec. Sec. 423.1970, 423.1972, 423.1974, and 423.1976
and, where necessary, incorporate appropriate provisions in other
sections of the regulations.
Section 423.1970 of the regulations relating to the rights of
enrollees to an ALJ hearing provides--
In paragraph (a), that, if the amount remaining in
controversy after the independent review entity (IRE) reconsideration
meets the threshold requirement established annually by the Secretary,
an enrollee who is dissatisfied with the IRE reconsideration
determination has a right to a hearing before an ALJ;
In paragraph (b)(1), the methodology for computing the AIC
when the basis for appeal is the refusal by the Part D plan sponsor to
provide drug benefits;
In paragraph (b)(2), the methodology for computing the AIC
when the basis for appeal is an at-risk determination made under a drug
management program in accordance with Sec. 423.153(f); and
In paragraph (c), the requirements for aggregating appeals
to meet the AIC.
Section 423.2002 also contains provisions on the right to an ALJ
hearing. This section contains cross-references to the provisions in
Sec. 423.1970, and also--
Establishes a 60-calendar day timeframe for filing a
written request for an ALJ hearing following receipt of the written
notice of the IRE's reconsideration; and indicates the AIC requirement
must be met to be entitled to an ALJ hearing;
Provides the circumstances under which an enrollee may
request that an ALJ hearing be expedited;
Establishes a 5-calendar day presumption for receipt of
the reconsideration following the date of the written reconsideration,
unless there is evidence to the contrary; and
Provides that, for purposes of the section, requests for
hearing are considered as filed on the date they are received by the
office specified in the IRE's reconsideration.
Because Sec. Sec. 423.1970 and 423.2002 both address the right to
an ALJ hearing, and because there is a possibility that confusion may
arise from having two sections with the same title in the same CFR
subpart, we are proposing to remove Sec. 423.1970. Because Sec.
423.1970(a) is redundant of Sec. Sec. 423.2000(a) and 423.2002(a)(2)
in describing that an enrollee has a right to an ALJ hearing when the
enrollee is dissatisfied with an IRE reconsideration and meets the AIC
requirement, we believe Sec. 423.1970(a) should be eliminated. We are
proposing to relocate Sec. 423.1970(b) and (c) to new proposed Sec.
423.2006 (``Amount in controversy required for an ALJ hearing and
judicial review'') as paragraphs (c) and (d), respectively.
In addition, we are proposing to remove the reference to ``CMS'' in
Sec. 423.1970(b) (relocated to proposed Sec. 423.2006(c)) to clarify
that adjudicators, not CMS, ultimately compute the amount remaining in
controversy in determining whether the AIC threshold is met for an ALJ
hearing or review of an IRE dismissal, and judicial review.
We believe having one section titled ``Right to an ALJ hearing'' at
Sec. 423.2002 and another section titled ``Amount in controversy
required for an ALJ hearing and judicial review'' at Sec. 423.2006 is
more consistent with the corresponding rules in 42 CFR part 405,
subpart I for appeals of Medicare Part A and Part B initial
determinations (Sec. Sec. 405.1002 and 405.1006). For consistency with
Sec. 423.2000(a) and language that was removed from Sec. 423.1970(a),
we are also proposing to add language to Sec. 423.2002(a) providing
that the right to an ALJ hearing is available to enrollees who are
dissatisfied with the IRE's reconsideration determination.
In order to further increase consistency with Sec. 405.1006 and
consolidate the Medicare Part D appeals rules regarding the AIC, we are
proposing to incorporate provisions in proposed new Sec. 423.2006(a)
and (b) that are similar to those provisions contained at Sec.
405.1006(b) and (c), describing the amounts in controversy required for
an ALJ hearing and judicial review, respectively, including the annual
adjustment of these amounts. In order to more clearly state the AIC
requirements for appeals of Part D prescription drug plan coverage
[[Page 49517]]
determinations, without the need for multiple statutory and regulatory
cross-references, we are proposing that new Sec. 423.2006 would
include the following:
At proposed paragraph (a)(1), a provision similar to Sec.
405.1006(b)(1) that the required amount remaining in controversy must
be $100 increased by the percentage increase in the medical care
component of the Consumer Price Index for All Urban Consumers (U.S.
city average) as measured from July 2003 to the July preceding the
current year involved.
At proposed paragraph (a)(2), a provision similar to Sec.
405.1006(b)(2) that, if the figure in Sec. 423.2006(a)(1) is not a
multiple of $10, it is rounded to the nearest multiple of $10, and that
the Secretary will publish changes to the AIC requirement in the
Federal Register when necessary.
At proposed paragraph (b), a provision similar to Sec.
405.1006(c) that, to be entitled to judicial review, the enrollee must
meet the AIC requirements of this subpart and have an amount remaining
in controversy of $1000 or more, adjusted as specified in proposed
Sec. 423.2006(a)(1) and (2).
At proposed paragraph (c), a provision similar to current
Sec. 423.1970(b) explaining how the amount remaining in controversy is
calculated.
At proposed paragraph (d), the text currently found in
Sec. 423.1970(c) concerning aggregation of appeals to meet the amount
in controversy.
Finally, we are proposing to update or remove the cross-references
to Sec. 423.1970 in Sec. Sec. 423.562(b)(4)(iv), 423.576,
423.602(b)(2), 423.1984(c); 423.2002(a) introductory text and (a)(2),
and (b)(3), 423.2004(a)(2), and 423.2044(c) and to add a cross-
reference to Sec. 423.2006 in Sec. 423.1990(b)(3) in place of the
language ``established annually by the Secretary.''
Section 423.1972, titled ``Request for an ALJ hearing,'' provides
the procedures an enrollee must follow when filing a request for
hearing as follows:
Paragraph (a) provides that a written request must be
filed with the OMHA office specified in the IRE's reconsideration
notice.
Paragraph (b) provides the timeframe for filing a request.
Paragraph (c)(1) states that if a request for hearing
clearly shows that the AIC is less than that required under Sec.
423.1970, the ALJ or attorney adjudicator dismisses the request.
Paragraph (c)(2) provides that if, after a hearing is
initiated, the ALJ finds that the AIC is less than the amount required
under Sec. 423.1970, the ALJ discontinues the hearing and does not
rule on the substantive issues raised in the appeal.
With the exception of paragraph (c)(2), all of the provisions in
Sec. 423.1972 are duplicative of or incorporate by reference other
provisions found in Sec. 423.2002(a) and (d) (Right to an ALJ
hearing), Sec. 423.2014(d)(2) and (e) (Request for an ALJ hearing or a
review of an IRE dismissal), Sec. 423.2020 (Time and place for a
hearing before an ALJ), and Sec. 423.2052(a)(2) (Dismissal of a
request for a hearing before an ALJ or request for review of an IRE
dismissal). In order to eliminate the redundancy and potential
confusion, we are proposing to remove Sec. 423.1972 in its entirety.
As a part of this proposed change, we also are proposing to update or
remove the cross-references to Sec. 423.1972 in Sec. Sec. 423.604,
423.1984(c), 423.2014(d) introductory text and (e)(1), and 423.2020(a).
We do not believe it is necessary to retain Sec. 423.1972(c)(2) in
another location because ALJs have broad authority to regulate the
course of the hearing. In the rare circumstances described in Sec.
423.1972(c)(2) where an ALJ does not make a finding regarding the AIC
until after a hearing is initiated, the ALJ may discontinue the hearing
and issue a dismissal under Sec. Sec. 423.2002(a)(2) and
423.2052(a)(2).
Section 423.1974, titled ``Council review,'' provides that an
enrollee who is dissatisfied with an ALJ's or attorney adjudicator's
decision or dismissal may request that the Council review the ALJ's or
attorney adjudicator's decision or dismissal as provided in Sec.
423.2102. This provision is similar to Sec. 423.2100, titled
``Medicare Appeals Council review: general.'' To eliminate the
redundancy, we are proposing to remove the language of Sec. 423.1974
and incorporate it in Sec. 423.2100(a). This language would replace
the language in Sec. 423.2100(a). We also are proposing to update or
remove the cross-references to Sec. 423.1974 in Sec. Sec.
423.562(b)(4)(v) and 423.1984(d).
Section 423.1976, titled ``Judicial review,'' provides the
following:
In paragraph (a), that an enrollee may request judicial
review of an ALJ's or attorney adjudicator's decision if the Council
denied the enrollee's request for review and the AIC meets the
threshold requirement established annually by the Secretary.
In paragraph (b), that the enrollee may request judicial
review of a Council decision if it is the final decision of CMS and the
AIC meets the threshold established in paragraph (a)(2).
In paragraph (c), that, in order to request judicial
review, an enrollee must file a civil action in a district court of the
United States in accordance with section 205(g) of the Act.
With the exception of paragraph (a), these provisions are largely
duplicative of other provisions contained in Sec. 423.2136, also
titled ``Judicial review.'' To eliminate this redundancy, we are
proposing to remove the provisions of Sec. 423.1976 and revise Sec.
423.2136 as follows:
Section 423.2136(a) would be redesignated as Sec.
423.2136(a)(1). The cross-reference to Sec. 423.1976 would be removed,
and language from Sec. 423.1976(b) would be incorporated in Sec.
423.2136(a)(1)(i) and (ii) and revised by replacing ``CMS'' with ``the
Secretary'' for consistency with the language in section 1876(c)(5)(B)
of the Act and Sec. 423.2140, and replacing ``paragraph (a)(2) of this
section'' with ``Sec. 423.2006'' which we are proposing to add to the
regulations to address the AIC requirements.
Language at Sec. 423.1976(a) would be revised to
incorporate a reference to Sec. 423.2006 and the authorizing language
from Sec. 423.2136(a) (proposed Sec. 423.2136(a)(1)) and moved to new
Sec. 423.2136(a)(2).
We also are proposing to update or remove the cross-
references to Sec. 423.1976 in Sec. Sec. 423.562(b)(4)(vi), 423.576,
and 423.2136(b)(1). We seek comment on these proposed changes.
In summary, we are proposing to remove or relocate language as
shown in the following table:
----------------------------------------------------------------------------------------------------------------
Current section Proposed new section Proposed action Rationale
----------------------------------------------------------------------------------------------------------------
Sec. 423.1970(a)................. N/A........................ Remove................ Similar language
exists in Sec. Sec.
423.2000(a) and
423.2002(a)(2).
Sec. 423.1970(b)................. Sec. 423.2006............ Remove and incorporate Increases consistency
revised language at with Sec. 405.1006.
proposed new Sec.
423.2006(c).
Sec. 423.1970(c)................. ........................... Remove and incorporate
at proposed new Sec.
423.2006(d).
[[Page 49518]]
N/A................................ Sec. 423.2006(a)......... Add language
N/A................................ Sec. 423.2006(b)......... concerning AIC
computation not
previously outlined
in 42 CFR part 423.
Sec. 423.1972(a), Sec. N/A........................ Remove................ Similar language
423.1972(b), Sec. 423.1972(c)(1). exists in Sec. Sec.
423.2002(a) and (d),
423.2014(d)(2) and
(e), 423.2020, and
423.2052(a)(2) and
reduces redundancy.
Sec. 423.1972(c)(2).............. N/A........................ Remove................ Unnecessary.
Sec. 423.1974.................... N/A........................ Remove and incorporate Reduces redundancy.
into Sec.
423.2100(a).
Sec. 423.1976(a)................. N/A........................ Remove and incorporate
revised language at
new Sec.
423.2136(a)(2).
Sec. 423.1976(b)................. ........................... Remove and incorporate
revised language at
proposed new Sec.
423.2136(a)(1).
Sec. 423.1976(c)................. N/A........................ Remove................ Similar language
exists in Sec.
423.2136(b)(1).
----------------------------------------------------------------------------------------------------------------
E. Change to Timeframe for Council Referral (Sec. 405.1110 and Sec.
423.2110)
The regulations at Sec. Sec. 405.1110(a) and (b)(2) and
423.2110(a) and (b)(2) give CMS or its contractors 60 calendar days
after the date or issue date, respectively, of OMHA's decision or
dismissal to refer the case to the Council. In the case of Part A and
Part B appeals, CMS or its contractors are sent the decision notice
when they are a party to the hearing or soon after the hearing
occurred. For Part D appeals, as specified in Sec. 423.2046(a)(1), the
decision notice is sent to the enrollee, plan sponsor, and IRE.
Our regulations generally include regulatory timeframes that start
when CMS or its contractors receive the decision notice, rather than
the date the decision notice was issued. For example, Sec.
405.1010(b)(3), which addresses the timing of when CMS or its
contractor may elect to participate in an ALJ hearing, provides that
CMS or its contractor must send notice of its intent to participate, if
no hearing is scheduled, no later than 30 calendar days after
notification that a request for hearing was filed or, if a hearing is
scheduled, no later than 10 calendar days after receiving the notice of
hearing. The rationale for starting the timeframe in Sec.
405.1010(b)(3) after receipt of the notice was to ensure that CMS or
its contractors have sufficient time to conduct a thorough evaluation
of the facts and the case.
For the same reason, we are proposing to revise the timeframe in
Sec. Sec. 405.1110(a) and (b)(2) and 423.2110(a) and (b)(2) for CMS or
it contractors to refer a case to the Council such that the timeframe
would begin after the ALJ's or attorney adjudicator's decision or
dismissal is received. Starting the timeframe after CMS or its
contractor receives OMHA's written decision or dismissal would help
ensure that CMS and its contractors have sufficient time to decide
whether the case is the type of case that should be referred to the
Council for review. This proposed change would help ensure that even if
CMS and its contractors receive a delayed notice, they would have
sufficient time to decide whether the case should be referred to the
Council.
In order to ensure consistent implementation of this proposal, we
also are proposing to add new Sec. Sec. 405.1110(e) and 423.2110(e) to
provide that the date of receipt of the ALJ's or attorney adjudicator's
decision or dismissal is presumed to be 5 calendar days after the date
of the notice of the decision or dismissal, unless there is evidence to
the contrary. This would help facilitate the Council's determination on
the timeliness of the referral by establishing a date by which the
Council may presume that CMS or its contractor received the decision
from OMHA. This 5 day mailing presumption is consistent with the
presumption included in Sec. Sec. 405.1102(a)(2) and 423.2102(a)(3)
with respect to the timeframe for requesting Council review following
an ALJ's or attorney adjudicator's decision or dismissal.
For these reasons, we are proposing to revise the Council referral
timeframes in Sec. Sec. 405.1110(a) and (b)(2) and 423.2110(a) and
(b)(2), and proposing to add Sec. Sec. 405.1110(e) and 423.2110(e) as
discussed previously.
F. Technical Correction to Regulation Regarding Duration of Appointed
Representative in a Medicare Secondary Payer Recovery Claim (Sec.
405.910)
Section 405.910 sets forth provisions addressing the appointment of
representatives in a Medicare Parts A and B claims appeals, including
for secondary payer recovery claims. Specific requirements regarding
the duration of time that an appointment of representative instrument
is valid are provided under Sec. 405.910(e).
On February 27, 2015, we published a final rule entitled ``Medicare
Program; Right of Appeal for Medicare Secondary Payer Determinations
Relating to Liability Insurance (Including Self-Insurance), No-Fault
Insurance, and Workers' Compensation Laws and Plans (80 FR 10611). In
that final rule, we added paragraph (e)(4) to Sec. 405.910 in order to
provide applicable plans with the benefit of the existing rule for
Medicare secondary payers regarding the duration of appointment for an
appointed representative. Within this added provision, we included a
citation to Sec. 405.906(a)(1)(iv), as the regulation establishing
party status for applicable plans. This citation is an incorrect cross-
reference; and the correct cross-reference is Sec. 405.906(a)(4). We
are proposing to revise Sec. 405.910(e)(4) to correct the cross-
reference. This proposed correction would not alter any existing
processes or procedures within the Medicare claims appeals process.
G. Technical Correction to Actions That Are Not Initial Determinations
(Sec. 405.926)
Section 405.926 sets forth actions that are not considered initial
determinations subject to the administrative appeals process under part
405, subpart I. On October 4, 2016, we issued a final rule entitled
``Medicare and Medicaid Programs; Reform of Requirements for Long-Term
Care Facilities'' (81 FR 68688 through 68872) that moved the definition
of ``transfer and discharge'' in Sec. 483.12 to the definitions under
Sec. 483.5.
[[Page 49519]]
Accordingly, we updated the cross-reference to ``Sec. 483.5'' within
Sec. 405.926(f) to the cross-reference to ``Sec. 483.5(n)''. However,
the citation of Sec. 483.5(n) is an incorrect cross-reference.
To correct this error, we are proposing to revise Sec. 405.926(f)
to remove the incorrect reference to ``Sec. 483.5(n)'' and replace it
with the cross-reference ``Sec. 483.5 definition of `transfer and
discharge' ''. This proposed technical correction would serve to
correct an incorrect citation. It would not alter any existing
processes or procedures within the Medicare claims appeals process.
H. Changes To Enhance Implementation of Rule Streamlining the Medicare
Appeals Procedures (Sec. Sec. 405.970, 405.1006, 405.1010, 405.1014,
405.1020, 405.1034, 405.1046, 405.1052, 405.1056, 423.1014, 423.1990,
423.2002, 423.2010, 423.2016, 423.2032, 423.2034, 423.2036, 423.2052,
and 423.2056)
Since we published the January 17, 2017 final rule, we have
identified several provisions that, upon further review, pose
unanticipated challenges with implementation, which are explained in
this section. In addition, there are other regulatory provisions that
we believe require additional clarification and the correction of
technical errors and omissions. In the proposals listed in this
section, we seek to help ensure the provisions are implemented as
intended, provide clarification, and correct technical errors and
omissions. Our proposed changes are as follows.
1. Amount in Controversy (AIC) (Sec. 405.1006)
Section 405.1006 addresses the AIC required for an ALJ hearing and
judicial review, and Sec. 405.1006(d) provides the methodology for
computing the AIC. In general, the AIC is computed as the amount that
the provider or supplier bills for the items and services in the
disputed claim, reduced by any Medicare payments already made or
awarded for the items or services, and further reduced by any
deductible and/or coinsurance amounts that may be collected for the
items or services. In the January 17, 2017 final rule, we created
several exceptions to this general computation methodology for
situations where we believed an alternative methodology would more
accurately describe the amount actually in dispute. Among these
alternatives was the calculation methodology specified in Sec.
405.1006(d)(4), which states that when an appeal involves an identified
overpayment, the AIC is the amount of the overpayment specified in the
demand letter for the items or services in the disputed claim. For
appeals involving an estimated overpayment amount determined through
the use of statistical sampling and extrapolation, Sec. 405.1006(d)(4)
further provides that the AIC is the total amount of the estimated
overpayment determined through extrapolation, as specified in the
demand letter.
When we created this exception, we did not account for the
possibility that the amount of the overpayment or estimated overpayment
specified in the demand letter might change throughout the
administrative appeals process if, for example, an adjudicator finds
that some of the items or services for which an overpayment was
demanded are covered and payable, or alternatively, if an adjudicator
raises a new issue that results in the denial of additional items or
services. Even outside the administrative appeals process, the amount
of an overpayment may be revised by a CMS contractor (for example,
following a discussion period with the contractor that initially
determined the overpayment). Although some of these situations may
result in the issuance of a revised demand letter, such a letter may
not always be issued during the pendency of the appeals process.
To account for situations where the amount of an overpayment
specified in the demand letter does not reflect subsequent adjustments
to the amount remaining in controversy, we are proposing to revise
Sec. 405.1006(d)(4) to state that when an appeal involves an
identified overpayment, the AIC is the amount of the overpayment
specified in the demand letter, or the amount of the revised
overpayment if the amount originally demanded changes as a result of a
subsequent determination or appeal, for the items or services in the
disputed claim. For appeals involving an estimated overpayment amount
determined through the use of statistical sampling and extrapolation,
we are further proposing to revise Sec. 405.1006(d)(4) to state that
the AIC is the total amount of the estimated overpayment determined
through extrapolation, as specified in the demand letter, or as
subsequently revised.
2. Submissions by CMS and CMS Contractors (Sec. Sec. 405.1010 and
405.1012)
In Sec. 405.1010(b)(1), we stated that if CMS or a CMS contractor
elects to participate in the proceedings on a request for hearing
before receipt of a notice of hearing, or when notice of hearing is not
required, it must send written notice of its intent to participate to
the parties who were sent a copy of the notice of reconsideration, and
to the assigned ALJ or attorney adjudicator, or if the appeal is not
assigned, to a designee of the Chief ALJ. We discussed in the January
17, 2017 final rule that the requirement to notify the parties who were
sent a copy of the notice of reconsideration helps ensure that the
potential parties to a hearing, if a hearing is conducted, would
receive notice of the intent to participate (82 FR 5016). However, the
final regulation at Sec. 405.1010(b)(1) does not account for requests
for reconsideration that are escalated from the QIC level to the OMHA
level of appeal without a notice of reconsideration having been issued.
In order to help ensure that the potential parties to a hearing
would receive notice of CMS' or the contractor's intent to participate
and address reconsideration escalations from the QIC to OMHA, we are
proposing to revise Sec. 405.1010(b)(1) to require that, for escalated
requests for reconsideration, notice of the intent to participate would
also be sent to any party that filed a request for reconsideration or
was found liable for the services at issue subsequent to the initial
determination, which we believe is consistent with circumstances under
which a party would receive notice of a hearing under Sec. 405.1020.
(Section 405.1020(c)(1) also provides that a notice of hearing is sent
to all parties that participated in the reconsideration. However, we do
not believe this provision is necessary in circumstances where the QIC
has not issued a reconsideration because, in practice, there is
generally no opportunity for participation in these circumstances by
parties other than the party that filed the request for
reconsideration.) For the same reason, we also are proposing to revise
Sec. 405.1010(c)(3)(ii)(A), which currently requires that copies of
CMS or contractor position papers or written testimony that are
submitted before receipt of a notice of hearing must be sent to the
parties who were sent a copy of the notice of reconsideration. We are
proposing to revise Sec. 405.1010(c)(3)(ii)(A) to instead provide that
copies are sent to the parties that are required to be sent a copy of
the notice of intent to participate in accordance with Sec.
405.1010(b)(1). No corresponding revisions to Sec. 423.2010 are needed
because escalation is not available in Medicare Part D appeals.
In Sec. 405.1010(b)(3)(ii), we stated that if CMS or a CMS
contractor elects to participate after a hearing is scheduled, it must
send written notice of its intent to participate no later than 10
calendar days ``after receiving the notice of
[[Page 49520]]
hearing.'' Upon reviewing the revised rules, we noticed an
inconsistency between this language and the language in Sec.
405.1012(a)(1), which requires CMS or a CMS contractor electing to be a
party to a hearing to send written notice of its intent to be a party
no later than 10 calendar days ``after the QIC receives the notice of
hearing.'' We explained in the January 17, 2017 final rule (82 FR 5020)
that the timeframe in Sec. 405.1012(a)(1) was based on receipt of the
notice of hearing by the QIC because notices of hearing are currently
sent to the QIC in accordance with Sec. 405.1020(c). We believe these
requirements should be consistent and the timeframes should begin on
the same date, regardless of whether CMS or a CMS contractor is
electing to be a party or participant. We also believe that the
regulations should provide flexibility for CMS to designate another
contractor, other than the QIC, to receive notices of hearing under
Sec. 405.1020(c) if that contractor is then tasked with disseminating
the notice of hearing to other CMS contractors. Therefore, and as
discussed in this section with regard to notices of hearing, we are
proposing to revise Sec. 405.1020(c)(1) to provide for this
flexibility.
For conformity with proposed revised Sec. 405.1020(c)(1) and to
resolve the existing inconsistency in Sec. Sec. 405.1010(b)(3)(ii) and
405.1012(a)(1), we are proposing to revise both sections to provide
that written notice of the intent to participate or intent to be a
party must be submitted no later than 10 calendar days after receipt of
the notice of hearing by the QIC or another contractor designated by
CMS to receive the notice of hearing. No corresponding revision is
needed to the part 423, subpart U rules because notices of hearing are
sent to both the Medicare Part D plan sponsor and the IRE.
In Sec. 405.1010(c)(3)(i), we state that CMS or a CMS contractor
that filed an election to participate must submit any position papers
or written testimony within 14 calendar days of its election to
participate if no hearing has been scheduled, or no later than 5
calendar days prior to the hearing if a hearing is scheduled, unless
the ALJ grants additional time to submit the position paper or written
testimony. In the January 17, 2017 final rule (82 FR 5017), we
discussed that the requirement to submit any written testimony within
14 calendar days of the election to participate if no hearing has been
scheduled helps to ensure that the position paper and/or written
testimony are available when determinations are made to schedule a
hearing or issue a decision based on the record in accordance with
Sec. 405.1038.
Although Sec. 405.1010(c)(3)(i) allows an ALJ to extend the 5-
calendar day submission timeframe for cases in which a hearing is
scheduled, the regulation text may be unclear as to whether the same
discretion is afforded to ALJs or attorney adjudicators with respect to
the 14-calendar day submission timeframe for cases in which no hearing
has been scheduled. Our intent was to apply this discretionary
extension in both circumstances, as evidenced by the corresponding
regulation at Sec. 423.2010(d)(3)(i), which allows an ALJ or attorney
adjudicator to grant additional time to submit a position paper or
written testimony both in cases where a hearing has been scheduled and
in cases where no hearing has been scheduled (82 FR 5019). Accordingly,
to clarify our intent and help ensure consistency between the part 405
and part 423, we are proposing to revise Sec. 405.1010(c)(3)(i) to
clarify that an ALJ or attorney adjudicator may also extend the 14-
calendar day timeframe for submission of position papers and written
testimony in cases in which no hearing has been scheduled.
In Sec. 405.1012(b), we stated that if CMS or a CMS contractor
elects to be a party to the hearing, it must send written notice of its
intent to the ALJ and to ``the parties identified in the notice of
hearing.'' Upon reviewing the revised rules, we noticed an
inconsistency between this language and the language in Sec.
405.1010(b)(2), which states that if CMS or a CMS contractor elects to
participate after receipt of a notice of hearing, it must to send
written notice of its intent to participate to the ALJ and ``the
parties who were sent a copy of the notice of hearing.'' Although the
standard for who must receive notice is the same, the way in which it
is articulated is different, which we believe may lead to confusion. To
prevent potential confusion and help ensure consistency in the
regulations, we are proposing to revise Sec. 405.1012(b)(2) by
replacing the language ``identified in the notice of hearing'' with
``who were sent a copy of the notice of hearing''. No corresponding
revision is needed to the part 423, subpart U rules because only the
enrollee is a party to a Medicare Part D appeal and CMS, the IRE, and
the Part D plan sponsor may only request to be nonparty participants.
Finally, Sec. 405.1012(e)(1) states the circumstances under which
an ALJ or attorney adjudicator may determine that a CMS or contractor
election to be a party to a hearing made under Sec. 405.1012 is
invalid. Because Sec. 405.1012(a) only permits CMS or a contractor to
elect to be a party after the QIC receives a notice of hearing, and
only an ALJ may schedule and conduct a hearing, we believe the
determination as to whether an election made under Sec. 405.1012 is
valid should be left to the assigned ALJ. Therefore, we are proposing
in Sec. 405.1012(e)(1) to replace the phrase ``ALJ or attorney
adjudicator'' with ``ALJ.'' No corresponding revision is needed to the
part 423, subpart U rules because only the enrollee is a party to a
Medicare Part D appeal and CMS, the IRE, and the Part D plan sponsor
may only request to be nonparty participants.
3. Extension Requests (Sec. Sec. 405.1014 and 423.2014)
Prior to the January 17, 2017 final rule, Sec. 405.1014(c)(2)
provided that any request for an extension of the time to request a
hearing must be in writing, give the reasons why the request for a
hearing was not filed within the stated time period, and must be filed
with the entity specified in the notice of reconsideration. In the
January 17, 2017 final rule, this provision was relocated to Sec.
405.1014(e)(2) and revised, in part, to state that any request for an
extension of the time to request a hearing or review of a QIC dismissal
must be filed with the request for hearing or request for review. This
change was motivated by questions from appellants concerning whether a
request for an extension should be filed without a request for hearing
so that a determination could be made on the extension request before
the request for hearing was filed (82 FR 5038). However, in our attempt
to provide clarity to appellants, we created a requirement that, in its
strictest interpretation, would foreclose an appellant from requesting
an extension of the time to request a hearing or review after a request
for hearing is filed. The need for such a request to be made may arise
when an appellant--particularly an unrepresented beneficiary--is not
aware that a request for hearing is untimely at the time of filing. In
these situations, OMHA frequently requests that the appellant provide
an explanation for the untimely filing and, if the OMHA adjudicator
finds good cause for the untimely filing, the time period for filing is
extended in accordance with Sec. 405.1014(e)(3).
In order to remedy this situation, we are proposing to revise Sec.
405.1014(e)(2) to provide that requests for extension must be filed
with the request for hearing or request for review, or upon notice that
the request may be dismissed because it was not timely filed. We also
[[Page 49521]]
are proposing a corresponding revision to Sec. 423.2014(e)(3) for
extension requests filed by Medicare Part D enrollees.
4. Notice of Hearing (Sec. 405.1020)
In Sec. 405.1020(c)(1), we require that a notice of hearing be
sent to all parties that filed an appeal or participated in the
reconsideration, any party who was found liable for the services at
issue subsequent to the initial determination or may be found liable
based on a review of the record, the QIC that issued the
reconsideration, and CMS or a contractor that elected to participate in
the proceedings in accordance with Sec. 405.1010(b) or that the ALJ
believes would be beneficial to the hearing, advising them of the
proposed time and place of the hearing. However, this rule does not
account for requests for reconsideration that are escalated from the
QIC level to the OMHA level of appeal without a reconsideration having
been issued.
To help ensure that the QIC, and other CMS contractors who receive
notice of scheduled hearings through the QIC, receive notice of all
scheduled hearings, we are proposing to revise Sec. 405.1020(c)(1) to
require that notice be sent to the QIC that issued the reconsideration
or from which the request for reconsideration was escalated. As
discussed in section II.H.3. of this proposed rule with regard to CMS
and CMS contractor submissions, we also are proposing to provide future
flexibility for CMS to designate another contractor to receive notices
of hearing by revising Sec. 405.1020(c)(1) to state, in part, that the
notice of hearing may instead be sent to another contractor designated
by CMS to receive it. No corresponding revisions are needed in Sec.
423.2020(c)(1) because escalation is not available in Medicare Part D
appeals, and notices of hearing are sent to both the Medicare Part D
plan sponsor and the IRE.
5. Request for an In-Person or Video Teleconference (VTC) Hearing
(Sec. Sec. 405.1020 and 423.2020)
Section 405.1020(i)(1) and (i)(5) provides that if an unrepresented
beneficiary who filed the request for hearing objects to a video-
teleconference (VTC) hearing or to the ALJ's offer to conduct a hearing
by telephone, or if a party other than an unrepresented beneficiary who
filed the request for hearing objects to a telephone or VTC hearing, an
ALJ may grant the unrepresented beneficiary's or other party's request
for an in-person or VTC hearing if it satisfies the requirements in
Sec. 405.1020(i)(1) through (3), with the concurrence of the Chief ALJ
or a designee and upon a finding of good cause. Prior to the January
17, 2017 final rule, Sec. 405.1020(i) dealt exclusively with a party's
request for an in-person hearing and Sec. 405.1020(i)(5) required
concurrence of the Managing Field Office ALJ and a finding of good
cause for an ALJ to grant the request. (As we discussed in the January
17, 2017 final rule, the position of Managing Field Office ALJ was
replaced by the position of Associate Chief ALJ, and we replaced the
reference to ``Managing Field Office ALJ'' in Sec. 405.1020(i)(5) with
``Chief ALJ or a designee'' to provide greater flexibility in the
future as position titles change.) Managing Field Office ALJ
concurrence and a finding of good cause were not required prior to the
January 17, 2017 final rule for requests for a VTC hearing because VTC
was the default method of hearing.
When we revised Sec. 405.1020(i) in the January 17, 2017 final
rule to reflect the change from VTC to telephone hearing as the default
method for appearances by parties other than unrepresented
beneficiaries, we neglected to restrict the requirement for the
concurrence of the Chief ALJ or designee to requests for in-person
hearing, in accordance with Sec. 405.1020(b)(1)(ii) and (b)(2)(ii). In
addition, we neglected to clarify that, because VTC is the default
hearing method for unrepresented beneficiaries, a finding of good cause
is not required when an unrepresented beneficiary who filed the request
for hearing objects to an ALJ's offer to conduct a hearing by telephone
and requests a VTC hearing. Accordingly, we are proposing to revise
Sec. 405.1020(i)(5) to clarify that concurrence of the Chief ALJ or
designee is only required if the request is for an in-person hearing,
and that a finding of good cause is not required for a request for VTC
hearing made by an unrepresented beneficiary who filed the request for
hearing and objects to an ALJ's offer to conduct a hearing by
telephone. We also are proposing corresponding revisions to Sec.
423.2020(i)(5) for objections filed by Medicare Part D enrollees.
In reviewing the January 17, 2017 final rule, we also noted
potential confusion about whether Sec. 405.1020(e) or (i) applies to
objections to the place of a hearing when the objection is accompanied
by a request for a VTC or an in-person hearing. While an objection to a
hearing being conducted by telephone or VTC may broadly qualify as an
objection to the place of the hearing under Sec. 405.1020(e), our
intent was for Sec. 405.1020(i) to apply to such an objection when the
objection is accompanied by a request for a different hearing format,
because Sec. 405.1020(i) is specific to an objection to the scheduled
hearing format and request for an alternate hearing format. To mitigate
the potential confusion as to which provisions applies, we are
proposing to revise Sec. 405.1020(e) by adding paragraph (e)(5) to
make clear that it applies only when the party's or enrollee's
objection does not include a request for an in-person or VTC hearing.
We also are proposing a corresponding revision to Sec. 423.2020(e)
concerning a Medicare Part D enrollee's objection to the time and place
of hearing.36. Dismissal of a Request for a Hearing (Sec. Sec.
405.1052 and 423.2052)
Section 405.1052(a) describes the situations under which an ALJ may
dismiss a request for hearing (other than withdrawals of requests for
hearing, which are described in Sec. 405.1052(c)). Although paragraph
(a) pertains only to ALJ dismissals, paragraphs (a)(3), (4)(i), (5),
and (6) contain inadvertent references to attorney adjudicators.
Paragraph (a)(3) states that an ALJ may dismiss a request
for hearing when the party did not request a hearing within the stated
time period and the ALJ or attorney adjudicator has not found good
cause for extending the deadline, as provided in Sec. 405.1014(e).
Paragraph (a)(4)(i) provides that when determining whether
the beneficiary's surviving spouse or estate has a remaining financial
interest, the ALJ or attorney adjudicator considers whether the
surviving spouse or estate remains liable for the services that were
denied or a Medicare contractor held the beneficiary liable for
subsequent similar services under the limitation of liability
provisions based on the denial of the services at issue. (As discussed
in section II.H.10. of this proposed rule, we are proposing to change
the reference to ``limitation of liability'' to ``limitation on
liability.'')
Paragraph (a)(5) states that an ALJ or attorney
adjudicator dismisses a hearing request entirely or refuses to consider
any one or more of the issues because a QIC, an ALJ or attorney
adjudicator, or the Council has made a previous determination or
decision under part 405, Subpart I about the appellant's rights on the
same facts and on the same issue(s) or claim(s), and this previous
determination or decision has become binding by either administrative
or judicial action.
Paragraph (a)(6) states that an ALJ or attorney
adjudicator may conclude that an appellant has abandoned a request for
hearing when OMHA attempts to schedule a hearing and is unable to
contact the appellant after making reasonable efforts to do so.
[[Page 49522]]
As discussed of in the January 17, 2017 final rule (82 FR 4982),
our intent in finalizing the attorney adjudicator proposals was to
provide authority for attorney adjudicators to dismiss a request for
hearing only when an appellant withdraws his or her request for an ALJ
hearing, and not under any other circumstances. We further explained
that attorney adjudicators could not dismiss a request for hearing due
to procedural issues or make a determination that would result in a
dismissal of a request for an ALJ hearing (other than a determination
that the appellant had withdrawn the request for hearing) (82 FR 5008
and 5009). Therefore, we are proposing to revise Sec. 405.1052(a)(3),
(a)(4)(i), and (a)(6) to remove the reference to attorney adjudicators
and paragraph (a)(5) to remove the first reference to an attorney
adjudicator. We also are proposing corresponding corrections to Sec.
423.2052(a)(3), (5), and (6) for dismissals of Part D requests for
hearing.
Prior to the January 17, 2017 final rule, Sec. 405.1052(b)
required that notice of a dismissal of a request for hearing be sent to
all parties at their last known address. We explained in the final rule
that the requirement to send notice of the dismissal to all parties was
overly inclusive and caused confusion by requiring notice of a
dismissal to be sent to parties who have not received a copy of the
request for hearing or request for review that is being dismissed (82
FR 5086). Therefore, we revised this provision (and moved it to Sec.
405.1052(d)) to state that OMHA mails or otherwise transmits a written
notice of a dismissal of a request for hearing or review to all parties
who were sent a copy of the request for hearing or review at their last
known address.
However, in our effort to better tailor the list of recipients, we
neglected to specify that notice is also sent to the appellant--who
must receive notice of the dismissal, but would not have received a
copy of its own request for hearing or review--and to account for CMS
or a CMS contractor who elected to be a party to the appeal. We believe
that CMS or a CMS contractor that is a party to an appeal has an
interest in the outcome of the appeal and should be notified if the
request for hearing or review is dismissed. Section 405.1046 helps
ensure that CMS or CMS contractors who are a party to a hearing receive
notice of the decision by requiring that the decision be sent to all
parties at their last known address. In order to help ensure CMS and
CMS contractors are afforded similar notice of dismissals, and that the
appellant is notified of a dismissal of its request for hearing or
review, we are proposing to revise Sec. 405.1052(d) to require that
notice be sent to the appellant, all parties who were sent a copy of
the request for hearing or review at their last known address, and to
CMS or a CMS contractor that is a party to the proceedings on a request
for hearing. No corresponding revision to Sec. 423.2052 is needed
because only the enrollee is a party to a Medicare Part D appeal and
receives notice of the dismissal.
7. Remanding a Dismissal of a Request for Reconsideration (Sec. Sec.
405.1056, 405.1034, 423.2034, and 423.2056)
Section 405.1056(a)(1) provides that if an ALJ or attorney
adjudicator requests an official copy of a missing redetermination or
reconsideration for an appealed claim in accordance with Sec.
405.1034, and the QIC or another contractor does not furnish the copy
within the timeframe specified in Sec. 405.1034, the ALJ or attorney
adjudicator may issue a remand directing the QIC or other contractor to
reconstruct the record or, if it is not able to do so, initiate a new
appeal adjudication. Section 405.1056(a)(2) provides that if the QIC
does not furnish the case file for an appealed reconsideration, an ALJ
or attorney adjudicator may issue a remand directing the QIC to
reconstruct the record or, if it is not able to do so, initiate a new
appeal adjudication. In Sec. 405.1056(d), an ALJ or attorney
adjudicator will remand a case to the appropriate QIC if the ALJ or
attorney adjudicator determines that a QIC's dismissal of a request for
reconsideration was in error.
Occasionally, an ALJ or attorney adjudicator may need to remand a
request for review of a dismissal of a reconsideration request for
reasons similar to those specified in Sec. 405.1056(a)(1) and (2)
because the ALJ or attorney adjudicator is unable to obtain an official
copy of the dismissal determination, or because the QIC does not
furnish the case file for an appealed dismissal. By restricting the
bases for remand under Sec. 405.1056(a)(1) and (2) to appeals of
reconsiderations, we inadvertently made these reasons unavailable for
remands of requests for review of a dismissal under Sec. 405.1056(d).
Therefore, we are proposing to revise Sec. 405.1056(d) by
redesignating existing paragraph (d) as paragraph (d)(1), and adding
paragraph (d)(2) to state that an ALJ or attorney adjudicator may also
remand a request for review of a dismissal in accordance with the
procedures in paragraph (a) of the section if an official copy of the
notice of dismissal or case file cannot be obtained from the QIC. We
also are proposing corresponding revisions to Sec. 423.2056(d) for
Medicare Part D remands of a request for review of an IRE's dismissal
of a request for reconsideration. This proposed change would
necessitate two additional revisions.
First, Sec. Sec. 405.1056(g) and 423.2056(g), which discuss
reviews of remands by the Chief ALJ or designee, state that the review
of remand procedures are not available for and do not apply to remands
that are issued under Sec. Sec. 405.1056(d) or 423.2056(d),
respectively. In the January 17, 2017 final rule, we explained that
this limitation was due to the fact that remands issued on review of a
QIC's or IRE's dismissal of a request for reconsideration (that is,
based on a determination that the QIC's or IRE's dismissal was in
error) are more akin to a determination than a purely procedural
mechanism (82 FR 5069 through 5070). Because remands issued under new
proposed Sec. Sec. 405.1056(d)(2) and 423.2056(d)(2) would be
procedural remands, we are proposing to revise Sec. Sec. 405.1056(g)
and 423.2056(g) by replacing the references to paragraph (d) with a
reference to paragraph (d)(1), so that remands issued under paragraph
(d)(2) would be subject to the review of remand procedures in paragraph
(g).
Second, we are proposing to revise Sec. Sec. 405.1034(a)(1) and
423.2034(a)(1) to provide that the request for information procedures
in these paragraphs apply not only to requests for official copies of
redeterminations and reconsiderations, but also to requests for
official copies of dismissals of requests for redetermination or
reconsideration.
8. Notice of a Remand (Sec. 405.1056)
Section 405.1056(f) provides that OMHA mails or otherwise transmits
written notice of a remand of a request for hearing or request for
review to all of the parties who were sent a copy of the request for
hearing or review, at their last known address, and to CMS or a
contractor that elected to be a participant in the proceedings or party
to the hearing. However, Sec. 405.1056(f) does not require that notice
be sent to the appellant, who would not have received a copy of its own
request for hearing or review. For the same reasons described in
section II.H.6 above with regard to notices of dismissal, we are
proposing to revise Sec. 405.1056(f) to require that notice be sent to
the appellant, all parties who were sent a copy of the request for
hearing or review at their last known address, and to CMS or a
contractor that elected to be a participant in the proceedings or party
[[Page 49523]]
to the hearing. No corresponding revision to part 423, subpart U is
needed because Sec. 423.2056(f) already provides that notice is sent
to the enrollee, who is the only party to a Part D appeal.
In addition, Sec. 405.1056(f) provides that the notice of remand
states that there is a right to request that the Chief ALJ or a
designee review the remand. However, Sec. 405.1056(g) states that the
review of remand procedures are not available for and do not apply to
remands that are issued under Sec. 405.1056(d) (which, as noted in
section II.H.D.7. of this proposed rule, we are proposing to
redesignate as Sec. 405.1056(d)(1)). To resolve this discrepancy and
help ensure that parties receive accurate information regarding the
availability of the review of remand procedures, we are proposing to
revise Sec. 405.1056(f) to clarify that the notice of remand states
that there is a right to request that the Chief ALJ or a designee
review the remand, unless the remand was issued under Sec.
405.1056(d)(1). We are also proposing corresponding changes to Sec.
423.2056(d)(1).
9. Requested Remands (Sec. 423.2056)
Section 423.2056(b) provides that if an ALJ or attorney adjudicator
finds that the IRE issued a reconsideration and no redetermination was
made with respect to the issue under appeal or the request for
redetermination was dismissed, the reconsideration will be remanded to
the IRE, or its successor, to readjudicate the request for
reconsideration. However, when we finalized this provision in the
January 17, 2017 final rule, we did not account for situations in which
no redetermination was issued because the Medicare Part D plan sponsor
failed to meet the timeframe for a standard or expedited
redetermination, as provided in Sec. 423.590. In these situations,
Sec. 423.2056(b) does not provide a basis for remand because the
failure of the Part D plan sponsor to provide a redetermination within
the specified timeframe constitutes an adverse redetermination
decision, and the Part D plan sponsor is required to forward the
enrollee's request to the IRE within 24 hours of the expiration of the
adjudication timeframe in accordance with Sec. 423.590(c) (for
requests for standard redeterminations) and (e) (for requests for
expedited redeterminations). Accordingly, we are proposing to revise
Sec. 423.2056(b) to clarify that this reason for remand does not apply
when the request for redetermination was forwarded to the IRE in
accordance with Sec. 423.590(c) or (e) without a redetermination
having been conducted.
10. Other Technical Changes
In the January 17, 2017 final rule, we amended regulations
throughout 42 CFR part 405, subparts I and J; part 422, subpart M; Part
423, subparts M and U; and part 478, subpart B by replacing certain
references to ALJs, ALJ hearing offices, and unspecified entities with
a reference to OMHA or an OMHA office. We explained that these changes
were being made to provide clarity to the public on the role of OMHA in
administering the ALJ hearing program, and to clearly identify where
requests and other filings should be directed (82 FR 4992). However, we
neglected to revise two existing references to ALJs in Sec.
405.970(c)(2) and one existing reference to an ALJ in Sec. 405.970(d).
To correct our oversight, we are proposing to revise Sec.
405.970(c)(2) and (d) by replacing each instance of the phrase ``to an
ALJ'' with ``to OMHA'' to clarify that appeals are escalated to OMHA,
rather than an individual ALJ.
In the January 17, 2017 final rule, in order to reduce confusion
with MACs, we revised references to the Medicare Appeals Council
throughout part 405, subpart I; part 422, subpart M; and part 423,
subparts M and U by replacing ``MAC'' with ``Council'' (82 FR 4993).
However, we neglected to change one reference to ``MAC'' in Sec.
423.1990(d)(2)(ii). Accordingly, we are proposing to revise Sec.
423.1990(d)(2)(ii) by replacing ``MAC'' with ``Council.''
In Sec. 423.2010(d)(1), we stated that CMS, IRE, and/or Part D
plan sponsor participation in an appeal may include filing position
papers and/or providing testimony to clarify factual or policy issues
in a case, but it does not include calling witnesses or cross-examining
the witnesses of an enrollee to the hearing. This provision is similar
to Sec. 405.1010(c)(1), which describes the scope of CMS and CMS
contractor participation in Medicare Part A and Part B appeals and
provides, in part, that such participation does not include calling
witnesses or cross-examining the witnesses of a party to the hearing.
When finalizing Sec. 423.2010(d)(1) in the January 17, 2017 final
rule, which we based on Sec. 405.1010(c)(1), we inadvertently retained
the phrase ``to the hearing'' after ``enrollee''. We believe this
phrase is unnecessary in this context and reads awkwardly, and are
proposing to revise Sec. 423.2010(d)(1) to remove it.
Prior to the January 17, 2017 final rule, Sec. 423.2016(b)(1)
provided that an ALJ may consider the standard for granting an
expedited hearing met if a lower-level adjudicator has granted a
request for an expedited hearing. We revised this paragraph in the
January 17, 2017 final rule to account for the possibility that a
request for an expedited appeal could be granted by an attorney
adjudicator. However, we neglected to correct the existing reference to
a lower-level adjudicator having granted a request for an expedited
hearing. Because lower-level adjudicators do not conduct hearings, we
are proposing to revise Sec. 423.2016(b)(1) by replacing ``hearing''
with ``decision''.
Section 423.2032(c) describes the circumstances in which a coverage
determination on a drug that was not specified in a request for hearing
may be added ``to pending appeal.'' We inadvertently omitted the word
``a'' and are proposing to revise Sec. 423.2032(c) by removing the
phrase ``to pending appeal'' and adding ``to a pending appeal'' in its
place.
Prior to the January 17, 2017 final rule, Sec. 423.2036(g) stated,
in part, that an ALJ may ask the witnesses at a hearing any questions
relevant to the issues ``and allow the enrollee or his or her appointed
representative, as defined at Sec. 423.560.'' In the final rule, we
redesignated this paragraph as paragraph (d), but neglected to correct
the missing language at the end of the sentence. For consistency with
Sec. 405.1036(d), we are proposing to revise Sec. 423.2036(d) by
adding ``, to do so'' at the end of the paragraph, before the period.
Section 423.2036(e) discusses what evidence is admissible at the
hearing, and states that an ALJ may not consider evidence on any change
in condition of a Part D enrollee after a coverage determination, and
further provides that if an enrollee wishes for such evidence to be
considered, the ALJ must remand the case to the Part D IRE as set forth
in Sec. 423.2034(b)(2). Prior to the January 17, 2017 final rule,
Sec. 423.2034(b)(2) stated that an ALJ will remand a case to the
appropriate Part D IRE if the ALJ determines that the enrollee wishes
evidence on his or her change in condition after the coverage
determination to be considered in the appeal. In the final rule, we
moved this provision to Sec. 423.2056(e), but neglected to update the
cross-reference to it in Sec. 423.2036(e). Accordingly, we are
proposing to revise Sec. 423.2036(e) to replace the reference to
``Sec. 423.2034(b)(2)'' with the reference ``Sec. 423.2056(e)''.
In Sec. Sec. 405.952(b)(4)(i), 405.972(b)(4)(i), 405.1052(a)(4)(i)
and (b)(3)(i), and 405.1114(c)(1), when discussing determinations as to
whether a beneficiary's surviving spouse or estate has a remaining
financial interest in an
[[Page 49524]]
appeal, we refer to limitation on liability under section 1879 of the
Act as ``limitation of liability.'' To increase consistency with the
language used in the statute and help reduce confusion as to which
standard is being applied, we are proposing to replace the phrase
``limitation of liability'' with ``limitation on liability'' in each of
these sections.
We have identified one provision in part 405, subpart I, and two
provisions in part 423, subpart U, where we used incorrect terminal
punctuation at the end of a paragraph that is part of a list. To
correct our errors, we are proposing to revise Sec. Sec.
405.1046(a)(2)(ii), 423.2002(b)(1), and 423.2010(b)(3)(ii) by replacing
the period at the end of each paragraph with a semicolon.
Lastly, we are proposing to revise the authority citations for
parts 405 and 423 to meet current Office of the Federal Register
regulatory drafting guidance. The guidance requires that we use only
the United States Code (U.S.C.) citations for statutory citation unless
the citation does not exist.
III. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. In addition, appeals are considered to be an information
collection requirement that is associated with an administrative action
pertaining to specific individuals or entities (5 CFR 1320.4(a)(2) and
(c)). As a result, the burden for preparing and filing an appeal is
exempt from the requirements and collection burden estimates of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Consequently,
there is no need for review by the Office of Management and Budget
under the authority of the PRA.
IV. Regulatory Impact Statement
We have examined the impact of this rule as required by Executive
Order 12866 on Regulatory Planning and Review (September 30, 1993),
Executive Order 13563 on Improving Regulation and Regulatory Review
(January 18, 2011), the Regulatory Flexibility Act (RFA) (September 19,
1980, Pub. L. 96-354), section 1102(b) of the Act, section 202 of the
Unfunded Mandates Reform Act of 1995 (March 22, 1995; Pub. L. 104-4),
Executive Order 13132 on Federalism (August 4, 1999), the Congressional
Review Act (5 U.S.C. 804(2)), and Executive Order 13771 on Reducing
Regulation and Controlling Regulatory Costs (January 30, 2017).
Executive Orders 12866 and 13563 direct agencies to assess all
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits (including potential economic, environmental, public
health and safety effects, distributive impacts, and equity). A RIA
must be prepared for major rules with economically significant effects
($100 million or more in any 1 year). This rule does not reach the
economic threshold and thus is not considered a major rule.
The RFA requires agencies to analyze options for regulatory relief
of small entities. For purposes of the RFA, small entities include
small businesses, nonprofit organizations, and small governmental
jurisdictions. Most hospitals and most other providers and suppliers
are small entities, either by nonprofit status or by having revenues of
less than $7.5 million to $38.5 million in any 1 year. Individuals and
states are not included in the definition of a small entity. We are not
preparing an analysis for the RFA because we have determined, and the
Secretary certifies, that this proposed rule would not have a
significant economic impact on a substantial number of small entities.
In addition, section 1102(b) of the Act requires us to prepare an
RIA if a rule may have a significant impact on the operations of a
substantial number of small rural hospitals. This analysis must conform
to the provisions of section 603 of the RFA. For purposes of section
1102(b) of the Act, we define a small rural hospital as a hospital that
is located outside of a Metropolitan Statistical Area for Medicare
payment regulations and has fewer than 100 beds. We are not preparing
an analysis for section 1102(b) of the Act because we have determined,
and the Secretary certifies, that this proposed rule would not have a
significant impact on the operations of a substantial number of small
rural hospitals.
Section 202 of the Unfunded Mandates Reform Act of 1995 also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any 1 year of $100
million in 1995 dollars, updated annually for inflation. In 2018, that
threshold is approximately $150 million. This rule would have no
consequential effect on state, local, or tribal governments or on the
private sector.
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a proposed rule (and subsequent
final rule) that imposes substantial direct requirement costs on state
and local governments, preempts state law, or otherwise has Federalism
implications. Since this regulation does not impose any costs on state
or local governments, the requirements of Executive Order 13132 are not
applicable.
Executive Order 13771, titled Reducing Regulation and Controlling
Regulatory Costs, was issued on January 30, 2017 and requires that the
costs associated with significant new regulations ``shall, to the
extent permitted by law, be offset by the elimination of existing costs
associated with at least two prior regulations.'' OMB's interim
guidance, issued on April 5, 2017, https://www.whitehouse.gov/sites/whitehouse.gov/files/omb/memoranda/2017/M-17-21-OMB.pdf, explains that
``E.O. 13771 deregulatory actions are not limited to those defined as
significant under E.O. 12866 or OMB's Final Bulletin on Good Guidance
Practices.'' This proposed rule, if finalized, is considered a E.O.
13771 deregulatory action. Consistent with Executive Order 13771
requirements, when discounted from 2016 to infinity at 7 percent, this
proposed rule would annually save $9,497,685.00 a year.
Our proposal to remove the requirement that appellants sign appeal
requests would result in a slight reduction of burden to appellants by
allowing them to spend less time developing their appeal request and
appealing dismissals of appeal requests for lack of a signature to the
next level of review. Using the data from the number of appeal requests
received, we estimate that approximately 4,465,000 appeal requests per
year require a signature. We estimate that it takes 1 minute to sign
the appeal request. Therefore, the reduction in administrative time
spent would be 4,465,000 x .016 hour = 71,440.00 hours.
We used an adjusted hourly wage of $34.66 based on the Bureau of
Labor Statistics May 2016 website for occupation code 43-9199, ``All
other office and administrative support workers,'' which gives a mean
hourly salary of $17.33, which when multiplied by a factor of two to
include overhead, and fringe benefits, results in $34.66 an hour. The
consequent cost savings would be 71,440.00 x $34.66 = $2,476,110.40 for
time spent signing the appeal requests.
Based on a sampling of the number of appeal requests that are
dismissed for not containing a signature, we estimated that 284,486
appeal requests are dismissed per year for not containing a signature
on them, and 5 minutes to request that the adjudicator vacate the
dismissal or appeal the dismissal. For appellants, the reduction in
[[Page 49525]]
administrative time spent would be 284,486 x .0083 hours = 23,612 hours
with a consequent savings of 23,612 hours x $34.66 per hour =
$818,404.00. The total amount saved for appellants would be
$3,294,514.40, which consists of $2,476,110.40 for time spent signing
the appeal requests added to $818,404.00 for time saved appealing the
dismissed appeal requests.
When the cost of contractors dismissing appeal requests for the
lack of signature is factored in, the cost savings becomes $11,757,600.
This cost is calculated by multiplying the number of appeal requests
dismissed at the MAC and QIC levels multiplied by the cost that we pay
the contractors to adjudicate a dismissal. The average cost for a MAC
to dismiss an appeal request would be $25 x 200,000 appeals dismissed
for a lack of signature per year, which equates to $5,000,000. The
average cost for a QIC to dismiss an appeal request would be $80 x
84,470 appeal requests dismissed for a lack of signature per year,
which equates to a savings of $6,757,600. When these two costs are
added together the cost savings becomes $11,757,600.
In accordance with the provisions of Executive Order 12866, this
proposed rule was reviewed by the Office of Management and Budget.
V. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
List of Subjects
42 CFR Part 405
Administrative practice and procedure, Diseases, Health facilities,
Health professions, Medical devices, Medicare, Reporting and
recordkeeping, Rural areas, X-rays.
42 CFR Part 423
Administrative practice and procedures, Emergency medical services,
Health facilities, Health maintenance organizations (HMO), Medicare,
Penalties, Privacy, Reporting and recordkeeping requirements.
For reasons stated in the preamble, CMS proposes to amend 42 CFR
parts 405 and 423 as follows:
PART 405--FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED
0
1. The authority citation for part 405 is revised to read as follows:
Authority: 42 U.S.C. 263a, 405(a), 1302, 1320b-12, 1395x,
1395y(a), 1395ff, 1395hh, 1395kk, 1395rr, and 1395ww(k).
Sec. 405.910 [Amended]
0
2. Section 405.910 is amended--
0
a. In paragraph (c)(5), by removing the phrase ``health insurance
claim''; and
0
b. In paragraph (e)(4), by removing the reference ``Sec.
405.906(a)(1)(iv)'' and adding the reference ``Sec. 405.906(a)(4)'' in
its place.
Sec. 405.926 [Amended]
0
3. Section 405.926 is amended in paragraph (f) by removing the
reference ``Sec. Sec. 483.5(n) and 483.15'' and adding the reference
``Sec. 483.5 definition of `transfer and discharge' and Sec. 483.15''
in its place.
Sec. 405.944 [Amended]
0
4. Section 405.944 is amended--
0
a. In paragraph (b)(2) by removing the phrase ``health insurance
claim''; and
0
b. In paragraph (b)(4) by removing the phrase ``and signature''.
Sec. 405.952 [Amended]
0
5. Section 405.952 is amended--
0
a. In paragraph (b)(4)(i) by removing the phrase ``limitation of
liability'' and adding the phrase ``limitation on liability'' in its
place; and
0
b. In paragraph (d) by removing the phrase ``6 months'' and adding the
phrase ``180 calendar days'' in its place.
Sec. 405.964 [Amended]
0
6. Section 405.964 is amended--
0
a. In paragraph (b)(2) by removing the phrase ``health insurance
claim''; and
0
b. In paragraph (b)(4) by removing the phrase ``and signature''.
Sec. 405.970 [Amended]
0
7. Section 405.970 is amended in paragraphs (c)(2) and (d) by removing
the phrase ``to an ALJ'' each time it appears and adding the phrase
``to OMHA'' in its place.
Sec. 405.972 [Amended]
0
8. Section 405.972 is amended--
0
a. In paragraph (b)(4)(i) by removing the phrase ``limitation of
liability'' and adding the phrase ``limitation on liability'' in its
place; and
0
b. In paragraph (d) by removing the phrase ``6 months'' and adding the
phrase ``180 calendar days'' in its place.
0
9. Section 405.1006 is amended by revising paragraph (d)(4) to read as
follows:
Sec. 405.1006 Amount in controversy required for an ALJ hearing and
judicial review.
* * * * *
(d) * * *
(4) Overpayments. Notwithstanding paragraph (d)(1) of this section,
when an appeal involves an identified overpayment, the amount in
controversy is the amount of the overpayment specified in the demand
letter, or the amount of the revised overpayment if the amount
originally demanded changes as a result of a subsequent determination
or appeal, for the items or services in the disputed claim. When an
appeal involves an estimated overpayment amount determined through the
use of statistical sampling and extrapolation, the amount in
controversy is the total amount of the estimated overpayment determined
through extrapolation, as specified in the demand letter, or as
subsequently revised.
* * * * *
0
10. Section 405.1010 is amended by revising paragraphs (b)(1),
(b)(3)(ii), (c)(3)(i), and (c)(3)(ii)(A) to read as follows:
Sec. 405.1010 When CMS or its contractors may participate in the
proceedings on a request for an ALJ hearing.
* * * * *
(b) * * *
(1) No notice of hearing. If CMS or a contractor elects to
participate before receipt of a notice of hearing, or when a notice of
hearing is not required, it must send written notice of its intent to
participate to--
(i) The assigned ALJ or attorney adjudicator, or a designee of the
Chief ALJ if the request for hearing is not yet assigned to an ALJ or
attorney adjudicator; and
(ii) The parties who were sent a copy of the notice of
reconsideration or, for escalated requests for reconsideration, any
party that filed a request for reconsideration or was found liable for
the services at issue subsequent to the initial determination.
* * * * *
(3) * * *
(ii) If a hearing is scheduled, no later than 10 calendar days
after receipt of the notice of hearing by the QIC or another contractor
designated by CMS to receive the notice of hearing.
(c) * * *
(3) * * *
(i) Unless the ALJ or attorney adjudicator grants additional time
to submit the position paper or written testimony, a position paper or
written testimony must be submitted within 14 calendar days of an
election to
[[Page 49526]]
participate if no hearing has been scheduled, or no later than 5
calendar days prior to the hearing if a hearing is scheduled.
(ii) * * *
(A) The parties that are required to be sent a copy of the notice
of intent to participate in accordance with paragraph (b)(1) of this
section, if the position paper or written testimony is being submitted
before receipt of a notice of hearing for the appeal; or
* * * * *
Sec. 405.1012 [Amended]
0
11. Section 405.1012 is amended--
0
a. In paragraph (a)(1) by removing the phrase ``after the QIC receives
the notice of hearing'' and adding the phrase ``after receipt of the
notice of hearing by the QIC or another contractor designated by CMS to
receive the notice of hearing'' in its place;
0
b. In paragraph (b) by removing the phrase ``identified in the notice
of hearing'' and adding the phrase ``who were sent a copy of the notice
of hearing'' in its place; and
0
c. In paragraph (e)(1) by removing the phrase ``ALJ or attorney
adjudicator'' and adding the term ``ALJ'' in its place.
Sec. 405.1014 [Amended]
0
12. Section 405.1014 is amended--
0
a. In paragraph (a)(1)(i) by removing the phrase ``health insurance
claim''; and
0
b. In paragraph (e)(2) by removing the phrase ``with the request for
hearing or request for review of a QIC dismissal'' and adding the
phrase ``with the request for hearing or request for review of a QIC
dismissal, or upon notice that the request may be dismissed because it
was not timely filed,'' in its place.
0
13. Section 405.1020 is amended by revising paragraph (c)(1), adding
paragraph (e)(5), and revising paragraph (i)(5) to read as follows:
Sec. 405.1020 Time and place for a hearing before an ALJ.
* * * * *
(c) * * *
(1) A notice of hearing is sent to all parties that filed an appeal
or participated in the reconsideration; any party who was found liable
for the services at issue subsequent to the initial determination or
may be found liable based on a review of the record; the QIC that
issued the reconsideration or from which the request for
reconsideration was escalated, or another contractor designated to
receive the notice of hearing by CMS; and CMS or a contractor that
elected to participate in the proceedings in accordance with Sec.
405.1010(b) or that the ALJ believes would be beneficial to the
hearing, advising them of the proposed time and place of the hearing.
* * * * *
(e) * * *
(5) If the party's objection to the place of the hearing includes a
request for an in-person or VTC hearing, the objection and request are
considered in paragraph (i) of this section.
* * * * *
(i) * * *
(5) The ALJ may grant the request, with the concurrence of the
Chief ALJ or designee if the request was for an in-person hearing, upon
a finding of good cause and will reschedule the hearing for a time and
place when the party may appear in person or by VTC before the ALJ.
Good cause is not required for a request for VTC hearing made by an
unrepresented beneficiary who filed the request for hearing and objects
to an ALJ's offer to conduct a hearing by telephone.
* * * * *
0
14. Section 405.1034 is amended by revising paragraph (a)(1) to read as
follows:
Sec. 405.1034 Requesting information from the QIC.
(a) * * *
(1) Official copies of redeterminations and reconsiderations that
were conducted on the appealed claims, and official copies of
dismissals of a request for redetermination or reconsideration, can be
provided only by CMS or its contractors. Prior to issuing a request for
information to the QIC, OMHA will confirm whether an electronic copy of
the redetermination, reconsideration, or dismissal is available in the
official system of record, and if so will accept the electronic copy as
an official copy.
* * * * *
Sec. 405.1046 [Amended]
0
15. Section 405.1046 is amended in paragraph (a)(2)(ii) by removing the
period at the end of the paragraph and adding a semicolon in its place.
0
16. Section 405.1052 is amended by revising paragraphs (a)(3),
(a)(4)(i), (a)(5) and (6), (b)(3)(i), (d), and (e) to read as follows:
Sec. 405.1052 Dismissal of a request for a hearing before an ALJ or
request for review of a QIC dismissal.
(a) * * *
(3) The party did not request a hearing within the stated time
period and the ALJ has not found good cause for extending the deadline,
as provided in Sec. 405.1014(e).
(4) * * *
(i) The request for hearing was filed by the beneficiary or the
beneficiary's representative, and the beneficiary's surviving spouse or
estate has no remaining financial interest in the case. In deciding
this issue, the ALJ considers if the surviving spouse or estate remains
liable for the services that were denied or a Medicare contractor held
the beneficiary liable for subsequent similar services under the
limitation on liability provisions based on the denial of the services
at issue.
* * * * *
(5) The ALJ dismisses a hearing request entirely or refuses to
consider any one or more of the issues because a QIC, an ALJ or
attorney adjudicator, or the Council has made a previous determination
or decision under this subpart about the appellant's rights on the same
facts and on the same issue(s) or claim(s), and this previous
determination or decision has become binding by either administrative
or judicial action.
(6) The appellant abandons the request for hearing. An ALJ may
conclude that an appellant has abandoned a request for hearing when
OMHA attempts to schedule a hearing and is unable to contact the
appellant after making reasonable efforts to do so.
* * * * *
(b) * * *
(3) * * *
(i) The request for review was filed by the beneficiary or the
beneficiary's representative, and the beneficiary's surviving spouse or
estate has no remaining financial interest in the case. In deciding
this issue, the ALJ or attorney adjudicator considers if the surviving
spouse or estate remains liable for the services that were denied or a
Medicare contractor held the beneficiary liable for subsequent similar
services under the limitation on liability provisions based on the
denial of the services at issue.
* * * * *
(d) Notice of dismissal. OMHA mails or otherwise transmits a
written notice of the dismissal of the hearing or review request to the
appellant, all parties who were sent a copy of the request for hearing
or review at their last known address, and to CMS or a CMS contractor
that is a party to the proceedings on a request for hearing. The notice
states that there is a right to request that the ALJ or attorney
adjudicator vacate the dismissal action. The appeal will proceed with
respect to any other parties who filed a valid request for hearing or
review regarding the same claim or disputed matter.
[[Page 49527]]
(e) Vacating a dismissal. If good and sufficient cause is
established, the ALJ or attorney adjudicator may vacate his or her
dismissal of a request for hearing or review within 180 calendar days
of the date of the notice of dismissal.
0
17. Section 405.1056 is amended by revising paragraphs (d), (f), and
(g) to read as follows:
Sec. 405.1056 Remands of requests for hearing and requests for
review.
* * * * *
(d) Remanding a QIC's dismissal of a request for reconsideration.
(1) Consistent with Sec. 405.1004(b), an ALJ or attorney adjudicator
will remand a case to the appropriate QIC if the ALJ or attorney
adjudicator determines that a QIC's dismissal of a request for
reconsideration was in error.
(2) If an official copy of the notice of dismissal or case file
cannot be obtained from the QIC, an ALJ or attorney adjudicator may
also remand a request for review of a dismissal in accordance with the
procedures in paragraph (a) of this section.
* * * * *
(f) Notice of remand. OMHA mails or otherwise transmits a written
notice of the remand of the request for hearing or request for review
to the appellant, all of the parties who were sent a copy of the
request at their last known address, and CMS or a contractor that
elected to be a participant in the proceedings or party to the hearing.
The notice states that there is a right to request that the Chief ALJ
or a designee review the remand, unless the remand was issued under
paragraph (d)(1) of this section.
(g) Review of remand. Upon a request by a party or CMS or one of
its contractors filed within 30 calendar days of receiving a notice of
remand, the Chief ALJ or designee will review the remand, and if the
remand is not authorized by this section, vacate the remand order. The
determination on a request to review a remand order is binding and not
subject to further review. The review of remand procedures provided for
in this paragraph are not available for and do not apply to remands
that are issued under paragraph (d)(1) of this section.
0
18. Section 405.1110 is amended--
0
a. In paragraph (a) by removing the phrase ``after the date'' and
adding the phrase ``of receipt'' in its place; and
0
b. In paragraph (b)(2) by removing the term ``issued'' and adding the
term ``received'' in its place.
0
c. Adding paragraph (e).
The addition reads as follows:
Sec. 405.1110 Council review on its own motion.
* * * * *
(e) Referral timeframe. For purposes of this section, the date of
receipt of the ALJ's or attorney adjudicator's decision or dismissal is
presumed to be 5 calendar days after the date of the notice of the
decision or dismissal, unless there is evidence to the contrary.
Sec. 405.1112 [Amended]
0
19. Section 405.1112 is amended in paragraph (a)--
0
a. By removing the phrase ``health insurance claim''; and
0
b. By removing the phrase ``and signature''.
Sec. 405.1114 [Amended]
0
20. Section 405.1114 is amended in paragraph (c)(1) by removing the
phrase ``limitation of liability'' and adding the phrase ``limitation
on liability'' in its place.
PART 423--VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT
0
21. The authority citation for part 423 is revised to read as follows:
Authority: 42 U.S.C. 1302, 1306, 1395w-101 through 1395w-152,
and 1395hh.
Sec. 423.562 [Amended]
0
22. Section 423.562 is amended--
0
a. In paragraph (b)(4)(iv) by removing the reference ``Sec. 423.1970''
and adding the reference ``Sec. 423.2006'' in its place;
0
b. In paragraph (b)(4)(v) by removing the reference ``Sec. 423.1974''
and adding the reference ``Sec. 423.2100'' in its place; and
0
c. In paragraph (b)(4)(vi) by removing the reference ``Sec. 423.1976''
and adding the cross-reference ``Sec. 423.2006'' in its place.
Sec. 423.576 [Amended]
0
23. Section 423.576 is amended by removing the reference ``Sec.
423.1970 through Sec. 423.1976'' and adding the reference ``Sec.
423.2000 through Sec. 423.2140'' in its place.
Sec. 423.602 [Amended]
0
24. Section 423.602 is amended in paragraph (b)(2)by removing the
reference ``Sec. 423.1970'' and adding the cross ``Sec. 423.2006'' in
its place.
Sec. 423.604 [Amended]
0
25. Section 423.604 is amended by removing the reference ``Sec.
423.1972'' and adding the reference ``Sec. 423.2014'' in its place.
Sec. 423.1970 [Removed and reserved]
0
26. Section 423.1970 is removed and reserved.
Sec. 423.1972 [Removed and reserved]
0
27. Section 423.1972 is removed and reserved.
Sec. 423.1974 [Removed and reserved]
0
28. Section 423.1974 is removed and reserved.
Sec. 423.1976 [Removed and reserved]
0
29. Section 423.1976 is removed and reserved.
Sec. 423.1984 [Amended]
0
30. Section 423.1984 is amended--
0
a. In paragraph (c) by removing the reference ``Sec. 423.1970 through
Sec. 423.1972 and''; and
0
b. In paragraph (d) by removing the phrase ``Sec. 423.1974 and''.
Sec. 423.1990 [Amended]
0
31. Section 423.1990 is amended--
0
a. In paragraph (b)(3) by removing the phrase ``established annually by
the Secretary'' and adding the phrase ``specified in Sec. 423.2006''
in its place; and
0
b. In paragraph (d)(2)(ii) by removing the term ``MAC'' and adding the
term ``Council'' in its place.
0
32. Section 423.2002 is amended--
0
a. By revising paragraphs (a) introductory text and (a)(2);
0
b. In paragraph (b)(1) by removing the period at the end of the
paragraph and adding a semicolon in its place; and
0
c. By revising paragraph (b)(3).
The revisions read as follows.
Sec. 423.2002 Right to an ALJ hearing.
(a) An enrollee who is dissatisfied with the IRE reconsideration
determination has a right to a hearing before an ALJ if--
* * * * *
(2) An enrollee meets the amount in controversy requirements of
Sec. 423.2006.
* * * * *
(b) * * *
* * * * *
(3) An enrollee meets the amount in controversy requirements of
Sec. 423.2006.
* * * * *
Sec. 423.2004 [Amended]
0
33. Section 423.2004 is amended in paragraph (a)(2) by removing the
reference ``Sec. 423.1970'' and adding the reference ``Sec.
423.2006'' in its place.
0
34. Section 423.2006 is added to read as follows:
Sec. 423.2006 Amount in controversy required for an ALJ hearing and
judicial review.
(a) ALJ review. To be entitled to a hearing before an ALJ, an
enrollee must meet the amount in controversy requirements of this
section.
(1) For ALJ hearing requests, the required amount remaining in
controversy must be $100, increased by the percentage increase in the
medical
[[Page 49528]]
care component of the Consumer Price Index for All Urban Consumers
(U.S. city average) as measured from July 2003 to the July preceding
the current year involved.
(2) If the figure in paragraph (a)(1) of this section is not a
multiple of $10, it is rounded to the nearest multiple of $10. The
Secretary will publish changes to the amount in controversy requirement
in the Federal Register when necessary.
(b) Judicial review. To be entitled to judicial review, the
enrollee must meet the amount in controversy requirements of this
subpart at the time it requests judicial review. For review requests,
the required amount remaining in controversy must be $1,000 or more,
adjusted as specified in paragraphs (a)(1) and (2) of this section.
(c) Calculating the amount remaining in controversy. (1) If the
basis for the appeal is the refusal by the Part D plan sponsor to
provide drug benefits, the projected value of those benefits is used to
compute the amount remaining in controversy. The projected value of a
Part D drug or drugs must include any costs the enrollee could incur
based on the number of refills prescribed for the drug(s) in dispute
during the plan year.
(2) If the basis for the appeal is an at-risk determination made
under a drug management program in accordance with Sec. 423.153(f),
the projected value of the drugs subject to the drug management program
is used to compute the amount remaining in controversy. The projected
value of the drugs subject to the drug management program shall include
the value of any refills prescribed for the drug(s) in dispute during
the plan year.
(d) Aggregating appeals to meet the amount in controversy. (1)
Enrollee. Two or more appeals may be aggregated by an enrollee to meet
the amount in controversy for an ALJ hearing if--
(i) The appeals have previously been reconsidered by an IRE;
(ii) The enrollee requests aggregation at the same time the
requests for hearing are filed, and the request for aggregation and
requests for hearing are filed within 60 calendar days after receipt of
the notice of reconsideration for each of the reconsiderations being
appealed, unless the deadline to file one or more of the requests for
hearing has been extended in accordance with Sec. 423.2014(d); and
(iii) The appeals the enrollee seeks to aggregate involve the
delivery of prescription drugs to a single enrollee, as determined by
an ALJ or attorney adjudicator. Only an ALJ may determine the appeals
the enrollee seeks to aggregate do not involve the delivery of
prescription drugs to a single enrollee.
(2) Multiple enrollees. Two or more appeals may be aggregated by
multiple enrollees to meet the amount in controversy for an ALJ hearing
if--
(i) The appeals have previously been reconsidered by an IRE;
(ii) The enrollees request aggregation at the same time the
requests for hearing are filed, and the request for aggregation and
requests for hearing are filed within 60 calendar days after receipt of
the notice of reconsideration for each of the reconsiderations being
appealed, unless the deadline to file one or more of the requests for
hearing has been extended in accordance with Sec. 423.2014(d); and
(iii) The appeals the enrollees seek to aggregate involve the same
prescription drugs, as determined by an ALJ or attorney adjudicator.
Only an ALJ may determine the appeals the enrollees seek to aggregate
do not involve the same prescription drugs.
Sec. 423.2010 [Amended]
0
35. Section 423.2010 is amended--
0
a. In paragraph (b)(3)(ii) by removing the period at the end of the
paragraph and adding a semicolon in its place; and
0
b. In paragraph (d)(1) by removing the phrase ``to the hearing''.
0
36. Section 423.2014 is amended by revising paragraphs (a)(1)(i), (d)
introductory text, and (e)(1) and (3) to read as follows:
Sec. 423.2014 Request for an ALJ hearing or a review of an IRE
dismissal.
(a) * * *
(1) * * *
(i) The name, address, telephone number, and Medicare number of the
enrollee.
* * * * *
(d) When and where to file. The request for an ALJ hearing after an
IRE reconsideration or request for review of an IRE dismissal must be
filed:
* * * * *
(e) * * *
(1) If the request for hearing or review is not filed within 60
calendar days of receipt of the written IRE's reconsideration or
dismissal, an enrollee may request an extension for good cause.
* * * * *
(3) The request must be filed with the office specified in the
notice of reconsideration or dismissal, must give the reasons why the
request for a hearing or review was not filed within the stated time
period, and must be filed with the request for hearing or request for
review of an IRE dismissal, or upon notice that the request may be
dismissed because it was not timely filed.
* * * * *
Sec. 423.2016 [Amended]
0
37. Section 423.2016 is amended in paragraph (b)(1) by removing the
term ``hearing'' and adding the term ``decision'' in its place.
0
38. Section 423.2020 is amended by revising paragraph (a), adding
paragraph (e)(5), and revising paragraph (i)(5) to read as follows:
Sec. 423.2020 Time and place for a hearing before an ALJ.
(a) General. The ALJ sets the time and place for the hearing, and
may change the time and place, if necessary.
* * * * *
(e) * * *
(5) If the enrollee's objection to the place of the hearing
includes a request for an in-person or video-teleconferencing hearing,
the objection and request are considered in paragraph (i) of this
section.
* * * * *
(i) * * *
(5) The ALJ may grant the request, with the concurrence of the
Chief ALJ or designee if the request was for an in-person hearing, upon
a finding of good cause and will reschedule the hearing for a time and
place when the enrollee may appear in person or by video-teleconference
before the ALJ. Good cause is not required for a request for video-
teleconferencing hearing made by an unrepresented enrollee who filed
the request for hearing and objects to an ALJ's offer to conduct a
hearing by telephone.
* * * * *
Sec. 423.2032 [Amended]
0
39. Section 423.2032 is amended in paragraph (c) by removing the phrase
``to pending appeal'' and adding the phrase ``to a pending appeal'' in
its place.
0
40. Section 423.2034 is amended by revising paragraph (a)(1) to read as
follows:
Sec. 423.2034 Requesting information from the IRE.
(a) * * *
(1) Official copies of redeterminations and reconsiderations that
were conducted on the appealed issues, and official copies of
dismissals of a request for redetermination or reconsideration, can be
provided only by CMS, the IRE, and/or the Part D plan sponsor. Prior to
issuing a request for information to the IRE, OMHA will confirm whether
an electronic copy of the missing redetermination, reconsideration, or
dismissal is available in the official system of record, and if so will
accept the electronic copy as an official copy.
* * * * *
[[Page 49529]]
Sec. 423.2036 [Amended]
0
41. Section 423.2036 is amended--
0
a. In paragraph (d) by removing the reference ``Sec. 423.560.'' and
adding the phrase ``Sec. 423.560, to do so.'' in its place; and
0
b. In paragraph (e) by removing the reference ``Sec. 423.2034(b)(2)''
and adding the reference ``Sec. 423.2056(e)'' in its place.
Sec. 423.2044 [Amended]
0
42. Section 423.2044 is amended in paragraph (c) by removing the
reference ``Sec. 423.1970'' and adding the reference ``Sec.
423.2006'' in its place.
Sec. 423.2052 [Amended]
0
43. Section 423.2052 is amended--
0
a. In paragraph (a)(3) by removing the phrase ``or attorney
adjudicator'';
0
b. In paragraph (a)(5) by removing the phrase ``or attorney
adjudicator'' the first time it appears;
0
c. In paragraph (a)(6) by removing the phrase ``or attorney
adjudicator''; and
0
d. In paragraph (e) by removing the phrase ``6 months'' and adding the
phrase ``180 calendar days'' in its place.
0
44. Section 423.2056 is amended by revising paragraphs (b), (d), (f),
and (g) to read as follows:
Sec. 423.2056 Remands of requests for hearing and requests for
review.
* * * * *
(b) No redetermination. If an ALJ or attorney adjudicator finds
that the IRE issued a reconsideration and no redetermination was made
with respect to the issue under appeal or the request for
redetermination was dismissed, the reconsideration will be remanded to
the IRE, or its successor, to readjudicate the request for
reconsideration, unless the request for redetermination was forwarded
to the IRE in accordance with Sec. 423.590(c) or (e) without a
redetermination having been conducted.
* * * * *
(d) Remanding an IRE's dismissal of a request for reconsideration.
(1) Consistent with Sec. 423.2004(b), an ALJ or attorney adjudicator
will remand a case to the appropriate IRE if the ALJ or attorney
adjudicator determines that an IRE's dismissal of a request for
reconsideration was in error.
(2) If an official copy of the notice of dismissal or case file
cannot be obtained from the IRE, an ALJ or attorney adjudicator may
also remand a request for review of a dismissal in accordance with the
procedures in paragraph (a) of this section.
* * * * *
(f) Notice of a remand. OMHA mails or otherwise transmits a written
notice of the remand of the request for hearing or request for review
to the enrollee at his or her last known address, and CMS, the IRE,
and/or the Part D plan sponsor if a request to be a participant was
granted by the ALJ or attorney adjudicator. The notice states that
there is a right to request that the Chief ALJ or a designee review the
remand, unless the remand was issued under paragraph (d)(1) of this
section.
(g) Review of remand. Upon a request by the enrollee or CMS, the
IRE, or the Part D plan sponsor filed within 30 calendar days of
receiving a notice of remand, the Chief ALJ or designee will review the
remand, and if the remand is not authorized by this section, vacate the
remand order. The determination on a request to review a remand order
is binding and not subject to further review. The review of remand
procedures provided for in this paragraph are not available for and do
not apply to remands that are issued in paragraph (d)(1) of this
section.
0
45. Section 423.2100 is amended by revising paragraph (a) to read as
follows:
Sec. 423.2100 Medicare Appeals Council review: general.
(a) An enrollee who is dissatisfied with an ALJ's or attorney
adjudicator's decision or dismissal may request that the Council review
the ALJ's or attorney adjudicator's decision or dismissal.
* * * * *
0
46. Section 423.2110 is amended--
0
a. In paragraph (a) introductory text by removing the phrase ``after
the date'' and adding the phrase ``of receipt'' in its place; and
0
b. In paragraph (b)(2) by removing the term ``issued'' and adding the
term ``received'' in its place.
0
c. Adding paragraph (e).
The addition reads as follows:
Sec. 423.2110 Council review on its own motion.
* * * * *
(e) Referral timeframe. For purposes of this section, the date of
receipt of the ALJ's or attorney adjudicator's decision or dismissal is
presumed to be 5 calendar days after the date of the notice of the
decision or dismissal, unless there is evidence to the contrary.
Sec. 423.2112 [Amended]
0
47. Section 423.2112 is amended in paragraph (a)(4)--
0
a. By removing the phrase ``health insurance claim''; and
0
b. By removing the phrase ``and signature''.
0
48. Section 423.2136 is amended by revising paragraphs (a) and (b)(1)
to read as follows.
Sec. 423.2136 Judicial review.
(a) General rule. (1) Review of Council decision. To the extent
authorized by sections 1876(c)(5)(B) and 1860D-4(h) of the Act, an
enrollee may obtain a court review of a Council decision if--
(i) It is a final decision of the Secretary; and
(ii) The amount in controversy meets the threshold requirements of
Sec. 423.2006.
(2) Review of ALJ's or attorney adjudicator's decision. To the
extent authorized by sections 1876(c)(5)(B) and 1860D-4(h) of the Act,
the enrollee may request judicial review of an ALJ's or attorney
adjudicator's decision if--
(i) The Council denied the enrollee's request for review; and
(ii) The amount in controversy meets the threshold requirements of
Sec. 423.2006.
(b) * * *
(1) Any civil action described in paragraph (a) of this section
must be filed in the District Court of the United States for the
judicial district in which the enrollee resides.
* * * * *
Dated: July 16, 2018.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
Dated: September 5, 2018.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2018-21223 Filed 9-28-18; 11:15 am]
BILLING CODE 4120-01-P